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ABSTRACT 
 
 
The constant challenges imposed by the clinical procedures in obtaining adequate nerve 
repair and return of functional recovery to the injured site has buoyed the pursuit for artificial 
alternatives instead of the utilization of donor tissue grafts for surgical repair. Transected 
nerve injuries, having tremendous potential to cause permanent paralysis, neuropathies and 
chronic pain, requires the collective involvement of tissue-engineering and advanced drug 
delivery applications in combating the perceived challenges associated with its repair. 
Modern peripheral nerve repair strategies employ the use of polymeric-engineered nerve 
conduits incorporated with components of a delivery system. This allows for the controlled 
and sustained release of neurotrophic growth factors and other bioactives for improvements 
in the innate regenerative capacity of neural tissues. Although currently available synthetic 
hollow nerve conduits available for clinical use, as an alternative to the nerve autografts, 
have proven to be successful in the bridging and regeneration of primarily short nerve gap 
injuries, recent developments entail advancement of nerve conduits to be able to simulate 
the effectiveness of the autograft which includes, in particular, the ability to deliver growth 
factors and mimic peripheral nerve structure.  A critical factor influencing the level of success 
of peripheral nerve repair and regeneration is the development of appropriate sustained drug 
delivery systems for the release of neurotrophic factors and other small molecular weight 
drugs in addition to the provision of a mechanically stable, biocompatible and preferably 
biodegradable repair scaffold. 
 
This study, therefore, aimed to investigate and establish the proposed concept of pristine 
polymer particle intercalation as a novel strategy for achieving controlled and sustained 
release of bioactives from polymeric implants. An initial study involving an investigation into 
the drug release mechanisms of indomethacin from swellable sodium tripolyphosphate-
crosslinked chitospheres laden with pristine pH-responsive polymethylmethacrylate (PMMA) 
nanoparticles sought to prove the concept of particle intercalation as a modulator for drug 
release. Swelling and erosion studies, in conjunction with textural profiling, provided an 
understanding of the dominant and underlying drug release mechanisms of the chitospheres 
loaded with the pristine PMMA particles. Drug release studies showed that the pristine 
particle-intercalated chitospheres extended the release of indomethacin over 144 hours in a 
first-order compared to the 72 hours release achieved with the control. The study further 
revealed that in situ porogen leaching leading to porous network and polyelectrolyte complex 
formation were major mechanisms governing drug release from the chitospheres. Having 
 viii 
 
successfully proved the concept of pristine polymer particle intercalation, this technique was 
consequentially applied to the development of a nerve conduit for the dual and controlled-
release of proteins and small-molecule drugs. 
 
The design and fabrication of a hollow nerve conduit comprised a physically crosslinked 
interpenetrating network of a gellan-xanthan hydrogel matrix intercalated with pristine PMMA 
particles for provision sustained and concurrent release of two model compounds: bovine 
serum albumin (BSA) and diclofenac sodium. Analysis of a Box-Behnken experimental 
design demonstrated a near zero-order release of BSA and diclofenac sodium over 20 and 
30 days, respectively, modulated via a combination of pH-responsive (pH 7.4) dissolution of 
the intercalated pristine polymer particles and the unique gelling and erosion properties 
imparted by the graded addition of xanthan gum to the hydrogel blend. Moreover, the 
concentration-dependent intercalation of PMMA enhanced matrix resilience while alterations 
in the gellan-xanthan proportions yielded a means for customizing the mechanical 
characteristics, particularly matrix rigidity and flexibility, for the attainment of neuro-durable 
conduits. Optimization of the hydrogel conduit provided an effective means for the sustained 
delivery of the essential but costly neurotrophic growth factor, Nerve Growth Factor (NGF), 
over 30 days whilst maintaining its bioactivity. Further advancement of the hollow-lumen 
gellan-xanthan conduits involved implementation of intraluminal guidance scaffolds in an 
endeavour for simulating the native structural features of peripheral nerve tissue. An array of 
electrospun aligned nano-fibrous scaffolds formulated for the inclusion of physical, chemical 
and therapeutic guidance cues was achieved through the blending and incorporation of 
polyhydroxy butyric-co-valeric acid base polymer with magnesium-oleate and N-
acetylcysteine as potential neuro-active agents as indicated by the enhanced proliferation of 
PC12 neuronal cells. Integration of the two components, the hydrogel conduit and the nano-
fibrous scaffold, heralded the assembly of the final Biosimulated Nerve Repair Device 
(BNRD) which proved proficient in an in vivo rat sciatic nerve model in promoting nerve 
regeneration and re-establishment of functional recovery compared to the autograft gold 
standard repair as determined by behavioural assessments and morphometric and 
histological analysis of muscle and nerve tissues.  
 
The devised BNRD system for the surgical repair and therapeutic treatment of transected 
peripheral nerve injuries was successful in providing a long-term neuro-durable scaffold with 
release kinetics appropriate for the adequate promotion of tissue regeneration and healing 
bringing about restoration of functional recovery through emulating the positive 
characteristics of the autograft. The results obtained show promise for the rather challenging 
repair of peripheral nerves. 
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CHAPTER 1 
INTRODUCTION AND MOTIVATION FOR STUDY 
 
 
1.1. Background to the Study 
Peripheral nerve injuries can result in lifelong disability with the potential of diminishing a 
patient’s quality of life. Stressors such as neuropathic pain, poor or absence of functional 
recovery and muscle atrophy associated with nerve injuries further burden a patient’s state 
of health (Oliveira et al., 2012). Motor vehicle and workplace accidents resulting in bone 
fractures and deep tissue lacerations are frequently responsible for crush and severed nerve 
injuries (Ciaramitaro et al., 2010). Much research is focused on the traumatic injuries 
causing ligation of a peripheral nerve resulting in a gap defect between the severed nerve 
stumps. The limited innate ability of nerves to regenerate and the inhibitory mechanisms 
impeding neural tissue regeneration following injury to the nerves intensifies the search for 
an effective yet simple solution for the promotion of healthy tissue proliferation and reduction 
in the inflammatory processes hindering the healing capacity of the nervous system (Cao et 
al., 2009). 
 
The gold standard of treatment for severed peripheral nerve injuries is the nerve autograft 
which involves the harvesting of donor nerve tissue from elsewhere in a patient’s body and 
implanting it across the gap defect. Although this technique of nerve repair produces 
effective levels of nerve regeneration and functional recovery, its major drawbacks of 
multiple surgical incision sites, scarring, lack of donor tissue availability and donor tissue size 
mismatches restrains its clinical use particularly in long gap nerve injuries exceeding 10mm 
(Strauch and Strauch, 2013). The difficulties associated with insufficient donor tissue 
collection and resulting comorbidities necessitates the need for alternative treatment 
modalities. These alternative treatment techniques comprise artificially constructed materials 
as a replacement for the harvesting of native tissues. Polymer-engineered materials, 
preferably biodegradable, are crafted into tube-like devices, nerve conduits, to bridge the 
gap between severed nerves to assist regeneration. There are a number of commercialised 
synthetic nerve conduits that have been approved for clinical use in repair of short gap 
injuries however their success rate is still deemed inferior compared to the nerve autograft 
(Kehoe et al., 2012; Dinis et al., 2015). 
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Research studies employing in vivo animal models have shown that nerve conduits, 
synthesised from a range of natural and synthetic polymers, modified to incorporate 
neurotrophic factors (NTFs), seeded cells or extra-cellular matrix components enhance 
regeneration in comparison to conduits offering none of the former (Pabari et al., 2011; 
Kehoe et al., 2012). When considering the inclusion of NTFs within a conduit (Figure 1.1), 
the release kinetics of the delivery system is of particular importance with regards to initial 
burst release, the quantity of NTFs released, and the pattern of its sustained release 
thereafter. Failure of tailoring release kinetics from a conduit affects the potential of axonal 
regeneration. The release of high doses resulting from uncontrolled burst release may hinder 
axonal sprouting due to a reduction in the extent of affinity binding for the receptor sites 
resulting in a lower therapeutic effect achieved in the target tissues (Goodman and Gilman, 
2008). Whereas suboptimal doses of NTFs evidently does not elicit an adequate effect on 
nerve regeneration, large doses are detrimental as they may hinder axonal growth due to the 
down regulation of TrkA and loss of affinity of TrkA to the growth factors, i.e. nerve growth 
factor (NGF), in order to initiate a growth response (Allen and Dawbarn, 2006; Ichihara et al., 
2008; Kemp et al., 2011; Siniscalco et al., 2011). Therefore, the prinicipal aim of this 
research project was to investigate a suitable means of controlling the release of bioactives 
using the intercalation of pristine polymer particles within a scaffold-based matrix system. A 
crosslinked polysaccharide blend was formulated into a hydrogel nerve conduit for the 
sustained and simultaneous delivery of NGF and diclofenac sodium via the intercalation of 
pristine polymer particles.  Although the delivery of exogenous NTFs have proven 
advantageous in attaining an improved quality of peripheral nerve regeneration, its 
performance on nerve repair lies short in comparison to the nerve autograft. 
 
Currently, increasing efforts are being made to the design of nerve conduits that are able to 
closely mimic the structure and function of native nerve tissues (Daly et al., 2012; Dinis et 
al., 2015; Sridharan et al., 2015). This strategy is thought to improve the promotion of nerve 
regeneration to a level equal to or above that of a nerve autograft (Conti et al., 2004; Allen et 
al., 2013; Ma et al., 2013; Tavangarian et al., 2013). To achieve this degree of resemblance 
to native nerve tissues, numerous physical, chemical, and biological factors (Figure 1.2) 
have to be taken into consideration when incorporating multi-functioning components into a 
nerve conduit (Shakhbazau et al., 2012; Georgiou et al., 2013).  
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Peripheral nerve injury initiates processes of inflammation, rapid nerve destruction due to 
Wallerian degeneration and the onset of pain syndromes (Subramanian et al., 2009). To 
allow swift recovery and return of physical functioning to the patient, a multifaceted approach 
is required to target all these injury mechanisms. The use of implantable polymeric 
multifunctional drug delivery technology can aid tissue regeneration, prevent further 
destruction and alleviate pain syndromes through controlled and targeted drug delivery 
applications. An additional advancement of this research project intends to equip the 
previously described hydrogel nerve conduit with multi-functional intraluminal support 
structures as a strategy for guided axonal regeneration and improved outcomes of functional 
recovery via artificial simulation of the autograft. 
 
 
 
Figure 1.1: Basic consideration aspects of neurotrophic factor delivery.  
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Figure 1.2: Key components of a peripheral nerve regeneration design strategy. 
 
1.2. Rationale and Motivation for the Study 
An estimated 2 million people globally suffer from peripheral nerve injuries every year 
(Sridharan et al., 2015). Approximately 500 000 nerve repair procedures are performed on 
an annual basis in the USA and Europe collectively with over $7 billion being incurred due to 
paralysis resulting from nerve injuries (Belkas et al., 2004; Ichihara et al., 2008). Traumatic 
peripheral nerve injuries are becoming common in clinical practice due to the increased 
incidence of road and motor vehicle accidents. The gold standard of peripheral nerve injury 
treatment, the autograft, presents with many drawbacks such as limited donor tissue 
availability and secondary deformities resulting from multiple surgery sites. Due to the 
complications of long-term disability and poor functional recovery of the affected site, 
peripheral nerve injuries remain a challenge for neurosurgeons and reconstructive surgeons. 
Although a number of autograft alternatives are commercially available as polymeric bridging 
devices for the repair of transection nerve injuries, their clinical efficacy is yet to be 
considered adequate (Kehoe et al., 2012). 
 
•Balance between rigidity and flexibility
•Maintenance of in vivo structural integrity 
•Physiological resemblance to native tissues
Scaffold design
•Premature erosion: loss of structural support
•Lenthgy erosion: tissue compression and foreign body reaction
Biodegradation
•Allow gas and nutrient exchange to occur
•Prevent infiltration of fibrotic tissue
Permeability
•Prevention of axonal misdirection towards target tissues
•Presence of a basal lamina type structure for cell support
•Presence of  fasicular-based structures 
Guidance cues
•Sustained delivery of NTFs
•Cultured Schwann cells for the production of NTFs
Provision of critical growth mediators
•Maintain stability during sterilization, storage and handling
Processing stability
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Peripheral nerve repair by the body ensue complex stages, of which the mechanisms are not 
yet completely understood, of neurodegeneration and inflammatory responses before 
commencement of axonal regeneration. During these physiological processes’ attempt at 
nerve regeneration, site-specific controlled-release bioactive-loaded implants offer effective 
delivery of neurotrophic growth factors and other therapeutic drugs to alleviate pain and 
terminate inflammatory responses in addition to provision of a structural support for guided 
nerve regrowth. This is accomplished through enhanced bioavailability and maintenance of 
effective therapeutic drug levels over prolonged periods by virtue of a finely controllable 
drug-release mechanism. Improved systemic side-effect profiles and decreased dosing 
frequency greatly impacts the level of patient compliance towards a treatment regimen. By 
providing such features using an implantable device, issues of patient compliance and 
multiple-dosing regimens, either via the oral route or injectable administration, are eliminated 
and disease progression decreases.  
 
Bridging devices alone may promote the regeneration of tissues across a nerve gap defect 
however; functional recovery is often incomplete and poor. For successful nerve 
regeneration to occur leading to outcomes of improved functional recovery, artificial nerve 
conduits should possess attributes, as listed in Figure 1.1, that aim to mimic the 
physiological anatomy of nerve tissue, hence the superior clinical recovery outcomes 
following nerve autograft procedures.  
 
The aim of this research is to design a nerve conduit with features that may simulate the 
native architecture of nerve tissue for the improvement of peripheral nerve regeneration and 
functional recovery by providing the sustained release of neurotrophic factors (nerve growth 
factor), inflammatory agents for the management of inflammation and pain syndromes 
(diclofenac sodium) and the inclusion of structural scaffolds for enhanced axonal direction at 
a cellular level. 
 
1.3. The Mechanism of Action of the Biosimulated Nerve Repair Device  
The novel feature of this drug delivery design is the intercalation of pristine polymer particles 
(3Ps) within the matrix of a polymeric implant to obtain an intercalated network system 
offering a dual-mechanism controlled-release system using the difference in solubility 
profiles of the polymers where each polymeric component undergoes dissolution at a 
different pH and rate. The drug-release mechanism, governed by fluid penetration into the 
implant, results in swelling of the bioactive-loaded 3P intercalated matrix. The pH-responsive 
dissolution, at pH > 7.0, of the intercalated 3Ps out of the matrix may result in the formation 
of core microenvironment pore structures as shown in Figure 1.3. The formation of hollow or 
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gelled core microenvironments (HCMs or GCMs) acts as drug reservoirs that either promote 
or inhibit release of bioactive. The formation of HCMs or GCMs is dependent on the gelling 
and erosion properties of the matrix. In this approach, depending on the polymeric 
composition of the matrix, a combination of HCMs and GCMs may be formed which control 
the release of drug thereby offering a dual-mechanism release. GCMs may be able to 
provide sustained drug-release as the gelled microenvironment further retards the escape of 
drug molecules compared to hollow microenvironments which impose no barrier to the 
release of entrapped drug molecules.  
  
The design of this drug delivery system allows the bioactive and HCM or GCM forming 3Ps 
to be incorporated into the implant in a single step during the fabrication process. Preformed 
hollow cylindrical conduits incorporate the bioactive and control-release component by 
injecting a drug-loaded nanoparticle or hydrogel formulation into the lumen of the conduit, 
either prior or post implantation, involving the need for additional steps during the fabrication 
and the surgical fixation procedures. Furthermore, axons in transected peripheral nerve 
injury require some form of a guidance cue, in addition to growth factors, to improve re-
innervation of the target organ and eliminate misdirection of the sensory and motor neurons. 
After peripheral nerve injury, a weak fibrin network is formed by the body to guide 
regenerating nerves, however, even though the nerve fibers are able to bridge the gap 
functional recovery still remains poor. Therefore it is thought that incorrect re-innervation of 
motor and sensory neurons may be occurring. Hence, there is a need for a mechanically 
stable architecture to guide axons for enhanced motor neuron re-innervation and improved 
functional recovery of the affected site or limb. 
 
An additional advancement to the project involves the design and inclusion of guidance cues 
within the hydrogel nerve conduit to enhance the innate regeneration capacity of the injured 
nerves (Figure 1.4). The incorporation of guidance cues will be achieved via the inclusion of 
intra-luminal fibers that not only acts as a solid physical guidance cue to direct axon growth 
but the fibers could be chemically modified and designed to provide the release of a number 
of therapeutic agents to assist the nerve in regenerating itself (Figure 1.5). Such a design 
offers an additional “trio” of novel features: 
1. Physical guidance cues provide directional influence, axon attachment and growth 
for re-innervation of the target organ/muscle. The presence of a physical substrate 
and its surface textural properties (rough vs smooth) allows the attachment or 
alignment of Schwann cells along the intra-luminal fibers and forms a guide for 
regenerating axons via expression of p75 and TrK receptors in addition to the 
synthesis of endogenous growth factors.  
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2. Chemical guidance cues via surface modification of the intra-luminal fibers with 
polymers and molecules containing specific functional groups that serve as guidance 
cues. Certain functional groups, such as amines, presenting a positive charge could 
improve the adhesion and attachment of regenerating cells. The delivery of 
exogenous and the enhanced synthesis of endogenous growth factors from the fibre-
adhered Schwann cells serve as chemotactic stimuli for axonal growth and direction. 
3. Therapeutic guidance cue via incorporation of bioactive agents such as growth 
factors, anti-inflammatories, corticosteroids and vitamin B12 with the fibers. Different 
growth factors such as NGF and BDNF or GDNF act as agents for promoting the 
growth of sensory and motor neurons, respectively. This further allows improved re-
innervation and misdirection of motor and sensory neurons. The inclusion of 
essential nutrients assists with attaining healthy and functional newly regenerated 
nerve tissues and the release of anti-inflammatory drugs reduce pain, swelling and 
further inflammation-mediated tissue destruction thus prompting recovery. 
 
Additionally, the alignment of intraluminal fibers within the hydrogel nerve conduit as a 
luminal filler may enhance the structural integrity of the conduit post implantation and 
hydration. The force exerted by the intraluminal fibers on the walls of the conduit could 
prevent the conduit from possible kinks or collapse via the reduction of void space. 
Moreover, the entrapment of therapeutic agents within the intraluminal fibers prevents 
extensive escape of these agents out of the conduit and into the surrounding tissues. In this 
manner any released bioactive molecules will remain for a longer time inside the conduit 
lumen where it will be readily available to the regenerating axons. This final assembled 
system would provide a two-step release of bioactives: 1) release from conduit walls during 
the initial stages of nerve regeneration 2) maintenance release of therapeutic agents from 
the intraluminal fibers to further facilitate axonal regeneration and target re-innervation. 
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Figure 1.3: Schematic outlining the mechanism of action of pristine-polymer-particle 
intercalation upon dissolution and bridging repair function of a transected nerve injury. 
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Figure 1.4: Schematic depicting the components and design of a) the independent hydrogel 
nerve conduit delivery system and b) the incorporation of the intraluminal support scaffolds. 
 
The intraluminal fibers may be able to mimic the natural structure and fascicles of nerves 
thus improving the regeneration potential. These combined features of the proposed design 
create a suitable environment within the conduit lumen that cultivates neuronal regeneration 
(Gu et al., 2014).  
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Figure 1.5: Schematic diagram of axonal attachment and growth along the proposed design 
of intra-luminal fiber structures via the following cues: a) physical b) chemical c) therapeutic. 
 
1.4. Novelty of the Study 
The novelty of this study lies in the intercalation of pristine polymer particles within a polymer 
matrix for the control of drug release and the enhancement of matrix strength and resilience 
by the formation of interionic complexes and varying degrees of porosity, via its pH-
responsive feature, making the matrix a suitable system for prolonged drug delivery and 
tissue engineering applications. Furthermore, a polysaccharide gel blend comprising two 
types of naturally synthesised polymers is utilized for the tuning of mechanical strength, 
flexibility and biodegradability. This novel blend, comprising an interpenetrating gel network 
system, has the ability to absorb water to simulate the physiological consistency of native 
tissues while simultaneously providing the release of small molecular therapeutic agents and 
bio-macromolecules pertinent for tissue healing. Furthermore, the provision of a set of “trio 
guidance cues” as opposed to only one offers axonal guidance for enhanced re-innervation 
of target muscles and organs for improved outcomes of functional recovery. Guidance cues 
are provided by means of longitudinally aligned structural intraluminal fibers modified with 
topographical cues, chemotactic agents and cell adhesion factors to imitate an environment 
as offered with the nerve autograft – the gold standard of treatment. 
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1.5. Possible Therapeutic Applications of the Delivery System 
1. Function as conduits for artificial replacement of and drug delivery to segments of 
damaged arteries, veins, heart valves and ureters. 
2. Localised and prolonged drug delivery for the treatment of neuropathic pain and 
neuralgias. 
3. Incorporation of other classes of neurotrophic factors for combined delivery of bioactives 
from a single device for a synergistic effect on the promotion of tissue regeneration. 
4. Enhanced tissue regeneration via the provision of a microenvironment capable of 
simulating attributes of physiological tissue imperative for the survival of cells including 
the localised delivery of therapeutic agents and key nutrients.  
5. The long-term sustained delivery of small molecular weight and therapeutically potent 
drugs to injured tissues. 
 
1.6. Aim and Objectives of the Study 
The aim of this research was to design and develop a suitable biodegradable and 
biocompatible nerve repair conduit for the treatment of transected peripheral nerve injuries 
utilizing a particle-intercalation technique for controlled dual-drug delivery of therapeutic 
bioactives and modulation of mechanical properties while incorporating the components of 
independent multifunctional intraluminal structural support scaffolds. 
The aforementioned nerve repair device was formulated to meet the following essential 
design criteria: 
1. The hydrogel nerve repair device was formulated to maintain adequate structural and 
mechanical stability to endure surgical implantation of the device while ensuring tissue 
textural biocompatibility. 
2. The nerve repair device would allow for controlled-release and simultaneous delivery of at 
least two bioactive agents over a duration of at least 30 days. 
3. The intercalation of pH-responsive polymer particles should assist in extending bioactive 
release rates over the required duration of time while modulating the matrix textural 
properties at physiological pH. 
4. For guided axonal regeneration, the intraluminal structural support scaffolds was 
designed as to allow sufficient cellular interaction while providing ample pathway for 
axonal elongation and traverse through the device. 
5. The hydrogel matrix component of the device was fabricated in a way as to prevent the 
degradation of sensitive protein and peptide-based growth factors during loading and 
entrapment thereby preserving in vivo bioactivity of such agents. 
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For pragmatic fulfilment of the aim, the following objectives will be undertaken:  
i. To select biodegradable polymers, synthetic or natural, for the fabrication of the hydrogel 
conduit and intra-luminal fibers of suitable mechanical strength, swelling and erosion 
properties. 
ii. To investigate a suitable and reproducible method of conduit and fibre fabrication utilizing 
mould-casting and electrospinning techniques. 
iii. To determine device synthesis variables and their upper and lower limits for generation of 
a 3-factor Box-Behnken experimental design for formulation optimisation purposes. 
iv. To perform physicochemical and physicomechanical characterisation analyses on the 
formulated device components utilizing Fourier Transform Infrared (FTIR) spectroscopy, 
Scanning Electron Microscopy (SEM), Differential Scanning Calorimetry (DSC), Textural 
analysis (TA), Thermogravimetric (TGA) and X-ray diffraction (XRD). 
v. To assess the individual and combined in vitro swelling, erosion and bioactive release 
properties of the conduit and intraluminal fibres. 
vi. To perform cell studies to evaluate the effect of the proposed trio cues on cell 
biocompatibility and proliferation. 
vii. To assess the in vivo performance on nerve regeneration and functional recovery 
outcomes in a rat sciatic nerve injury model for evaluation of preclinical potential of the 
device.  
 
1.7. Potential Therapeutic Benefits of this Study 
1. The development of an innovative but cost-effective nerve repair device, in terms of 
appropriate material selection and simple fabrication techniques, for the treatment of 
short and long gap peripheral nerve injuries through promotion of tissue regeneration 
and guidance. 
2. Enhancement of bioavailability and therapeutic efficacy by delivering prolonged site-
specific drug release and improving patient adherence by eliminating the need for 
frequent oral or injectable drug administrations, particularly at the injury site. 
3. The potential of such information being published in peer-reviewed journals and 
presented at pharmaceutical conferences both local and international. 
4. The probability of obtaining a patent and marketing of this drug delivery concept to the 
industry for potential clinical use. 
5. The contribution of noteworthy data pertaining to the regenerative mechanisms 
employed during physiological repair of damaged neural tissues. 
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1.8. Overview of this Thesis 
Chapter One of this thesis provides an introduction and background to this study, discusses 
the rationale and novelty and highlights the aim, objectives and potential benefits of this 
study. 
Chapter Two of this thesis provides a comprehensive literature review, focusing on the 
various controlled-release strategies for the delivery of neurotrophic factors in peripheral 
nerve repair applications. It discusses the importance of the parameters controlling release 
kinetics in achieving the delivery of optimal bioactive doses. It further illustrates the 
physicochemical processes involved in bioactive release and highlights the essential 
features of an ideal nerve repair conduit. 
Chapter Three of this thesis describes the proof-concept study evaluating the ability of the 
novel pristine-polymer-particle intercalation strategy on extending bioactive released and 
modulating matrix textural properties using a hydrophilic chitosan model-matrix system. In 
situ particulate leaching and polyelectrolyte complexation as mechanisms underlying the 
particle-intercalation strategy are discussed.  
Chapter Four of this thesis details the formulation and integration of pristine-polymer-
particle intercalation into an interpenetrating network hydrogel conduit according to a 3-factor 
Box-Behnken experimental design. An extensive analysis into the physicomechanical, 
physicochemical and in vitro dissolution characteristics of the system in response to pre-
determined variants is discussed following statistical optimization of the experimental design 
model. 
Chapter Five of this thesis describes the formulation and development of electrospun 
intraluminal guidance scaffolds according to a 3-factor Box-Behnken experimental design. It 
discusses the physicochemical, physicomechanical and in vitro cell biocompatibility 
properties in response to variations in chemical composition of the formulations.  
Chapter Six of this thesis describes the fabrication and in vitro analysis of the optimized 
formulation components, a hydrogel conduit and nanofibrous guidance cues leading to the 
assembly of the final Biosimulated Nerve Repair Device. This is followed by evaluation of the 
in vivo performance of the device in the rat sciatic nerve model providing comparative 
evaluations between various experimental groups to the gold standard of treatment. 
Histopathological and behavioural studies were utilized to assess the level of peripheral 
nerve regeneration and functional recovery of the operated limb, respectively. 
Chapter Seven of this thesis presents the conclusions of the research study and outlines 
the recommendations for future advancement and use of the device. 
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1.9. Concluding Remarks 
This chapter highlighted the challenges associated with current peripheral nerve repair 
treatments and outlines mechanical and controlled-release strategies for the potential overall 
improvement of regeneration and functional recovery of peripheral nerve injuries. It entailed 
the proposed mechanism of action of the device in terms of its architectural structure and the 
required implementations for its successful fabrication and functioning. In addition, this 
chapter presented the rationale, aim, objectives, novelty and potential therapeutic benefits of 
the research study. 
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CHAPTER 2 
A REVIEW OF BIOACTIVE RELEASE FROM NERVE CONDUITS AS A 
NEUROTHERAPEUTIC STRATEGY FOR NEURONAL GROWTH IN 
PERIPHERAL NERVE INJURY 
 
 
Abstract 
Peripheral nerve regeneration strategies employ the use of polymeric engineered nerve 
conduits merged with components of a delivery system. This allows for the controlled and 
sustained release of neurotrophic growth factors for the enhancement of the innate 
regenerative capacity of the injured nerves. This review focuses on the delivery of 
neurotrophic factors (NTFs) and the importance of the parameters that control release 
kinetics in the delivery of optimal quantities of NTFs for improved therapeutic effect and 
prevention of dose dumping. Studies utilizing various controlled-release strategies, in 
attempt to obtain ideal release kinetics have been reviewed in this article. Release strategies 
discussed include affinity-based models, crosslinking techniques and layer-by-layer 
technologies. Currently available synthetic hollow nerve conduits, an alternative to the nerve 
autografts, have proven to be successful in the bridging and regeneration of primarily the 
short transected nerve gaps in several patient cases. However, current research 
emphasizes on the development of more advanced nerve conduits able to simulate the 
effectiveness of the autograft which includes, in particular, the ability to deliver growth 
factors.   
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2.1. Introduction 
The persistence of peripheral nerve injuries as a challenge has over the years stimulated a 
significant response in the amount of research produced towards the investigation of 
strategies to overcome the ordeals of this debilitating clinical condition. The peripheral motor 
and sensory nerves form an extensive and intricate network encompassing a substantially 
large area of the body. This extensive placement of nerve tissue makes the peripheral 
nervous system susceptible to trauma inflicted by external forces to any site of the body 
(Raimondo et al., 2011). Injuries to peripheral nerves are becoming increasingly common 
due to frequent incidents of trauma resulting from motor vehicle accidents, fractures, 
lacerations, crush injuries and surgical complications that cause direct or indirect nerve 
compression from oedema and haematomas (Bian et al., 2009; Dodla et al., 2009; Kemp et 
al., 2011; Lin and Marra, 2012; Barghash et al., 2013). Peripheral nerve injuries greatly 
impair the ability to feel normal sensations and exercise muscle movements due to 
denervation of adjacent tissues and muscles bringing about the loss of sensory and motor 
function (Tomassoni et al., 2013). This results in paralysis, chronic pain and neuropathies 
leading to severe disability and a diminished quality of life in those patients who have 
sustained such injuries (Dodla et al., 2009; Moore et al., 2010; Dubový, 2011; Raimondo et 
al., 2011; Cobianchi et al., 2013; Jeon et al., 2013; Wu et al., 2013).  
 
Initially, strategies focused on the design of a support structure to perform a similar neuronal 
function as the gold standard of treatment, a nerve autograft, thereby eradicating the need of 
obtaining a donor nerve via lengthy or multiple surgical procedures as well as eliminating the 
concerns of donor tissue availability, resulting morbidities and additional injuries and scarring 
Bian et al., 2009; Moore et al., 2009; Pettersson et al., 2010; Cunha et al., 2011; Bozkurt et 
al., 2012; Cho et al., 2012; Strauch and Strauch, 2013). A nerve autograft involves the 
transplantation of a donor nerve across a nerve gap defect. In certain cases, a cable graft is 
required wherein several donor nerves are attached together to create an appropriate sized 
graft to fit the recipient nerve. Although nerve autografts have a good success rate in the 
regeneration of nerve across gaps of less than 10mm, it becomes less feasible for longer 
gap defects largely due to the difficulty in extracting sufficient donor nerve tissue and 
obtaining nerves of appropriate size in diameter to match that of the damaged nerve (Cunha 
et al., 2011). Such concerns led to the fabrication and application of artificial synthetic and 
natural polymeric nerve conduits to span gaps and guide the regrowth of transected nerves 
by providing a means of structural support and barrier function against the infiltration of scar-
forming tissue using hollow polymeric tubing (Pfister et al., 2008; Angius et al., 2012; Lin et 
al., 2013; Mohammadi et al., 2013). To name a few, commercialised polymer nerve conduits 
currently on the market and approved for clinical use in humans are NeuroTube, NeuroFlex, 
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NeuroMatrix, NeuroLac and NeuroGen which are principally composed of collagen with the 
exception of NeuroTube and NeuroLac which are instead fabricated using polyglycolic acid 
and poly lactide-co-ε-caprolactone, respectively (Pfister et al., 2008; Pabari et al., 2011; 
Kehoe et al., 2012; Madduri et al., 2012). Although they are able to bridge nerve gaps, 
provide a regenerative and protective environment for damaged nerves and have been 
reported to perform therapeutically well in certain cases, their efficacy in nerve regeneration 
of large nerve gaps does not fully emulate that of an autologous nerve graft. Furthermore, 
their fairly simple design as a hollow tube does not provide the complete features required 
for optimal nerve regeneration and functional recovery as listed in Table 2.1 (Pfister et al., 
2008; Deumens et al., 2010; Xu et al., 2011; Daly et al., 2013). The deficiency in the success 
rate of tissue regeneration with these hollow conduits has prompted the development of 
newer types of nerve conduits (Jiang et al. 2010). 
 
This chapter discusses the recent strategies employed for the delivery of growth factors for 
the application of peripheral nerve regeneration. Characteristics of an ideal nerve conduit 
necessary for the regeneration of nervous tissue has been briefly mentioned however this 
article focuses more on the release kinetics of growth factor entrapped polymeric systems. 
An attempt has been made to highlight the effects of the mechanisms that govern the 
release of incorporated growth factors from the delivery system as this determines the final 
dose of growth factor released and its impact on tissue regeneration.  
 
2.2. Modern Development of Nerve Conduits and the Inclusion of Neurotrophic 
Growth Factors 
Nerve conduits under current development have evolved considerably compared to their 
hollow polymer tube counterparts in terms of the significant modifications in scaffold design 
and selection of polymer materials. Despite the major advances and various approaches in 
the design of nerve conduits and repair strategies, the issue of insufficient functional 
recovery after peripheral nerve injury remains an obstacle that is yet to be overcome (Dalton 
et al., 2008; Oh et al., 2008; Ma et al., 2013). Research in this field of tissue regeneration 
has focused immensely on the fabrication of nerve conduits able to provide multiple features 
that may possibly enhance nerve regrowth and restore functional recovery in a smaller time 
frame as opposed to previous strategies based solely on bridging nerve gap defects 
(Yamamoto et al., 2013). Formerly, research was primarily concentrated on the bridging of 
nerve gaps and evaluation of the results thereafter with little concern for the determination of 
the extent of functional recovery achieved and degree of similarity to physiological tissues 
(Ichihara et al., 2008). Currently, escalating focus is being placed on producing nerve 
conduits that are able to closely mimic the structure and function of native nerve tissues. 
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This strategy is thought to improve the promotion of nerve regeneration to a level equal to or 
above that of a nerve autograft (Evans et al., 2002; Huang and Huang, 2006; Tang et al., 
2012; Marquardt et al., 2013). To achieve this degree of resemblance to native nerve 
tissues, numerous physical, chemical and biological factors have to be taken into 
consideration when incorporating multiple-functioning components into a nerve conduit 
(Quaglia, 2008; Tang et al., 2013). Table 2.1 lists the pertinent characteristics of a basic 
peripheral nerve conduit model. The improvement in axonal regeneration when Schwann 
cells are supplied together with rod-like physical guidance cues in a nerve conduit is shown 
in Figure 2.1. 
 
Table 2.1: Salient features of an ideal nerve conduit 
Conduit Features and 
Requirements 
Importance and 
Function 
References 
 
 
Mechanical attributes 
 
• Should not bend, buckle or kink 
post-implantation 
• Be able to maintain structural 
integrity to support tissue growth 
 
Bian et al., 2009; 
Cunha et al., 2011; 
Kehoe et al., 2012 
 • Overly pliable conduits are unable to 
withstand pressure from growing 
and surrounding tissues 
• Rigid conduits may cause 
compression and damage to 
growing and surrounding tissues 
    e.g. blood vessels and nerve stumps 
• Sufficient flexibility to withstand body 
movements, particularly at joint sites 
Ichihara et al., 
2008; Kehoe et al., 
2012; Madduri and 
Gander, 2012 
 
Biodegradation rate • Should degrade at a rate 
corresponding to tissue regeneration 
• Pre-mature disintegration removes 
provision of support structure 
• Lengthy degradation may cause 
compression and inflammation of 
newly generated tissues 
Ichihara et al., 
2008; Tavangarian 
and Li, 2012 
Semi-Permeability • Should allow exchange of oxygen 
and nutrients and elimination of 
waste products between internal and 
external environment of conduit 
• Prevent infiltration of inflammatory 
cells and fibrotic tissue 
• Prevent escape of neurotrophic 
growth factors secreted by damaged 
nerve stumps and from system 
Ichihara et al., 
2008; Cunha et al., 
2011; Kehoe et al., 
2012 
 
Physical and 3D guidance 
cues 
• Cylindrical and channel-based 
structures for growth cone guidance  
• Prevent axonal misdirection during 
regeneration towards distal nerve 
Jiang et al., 2010; 
Bozkurt et al., 2012; 
Kehoe et al., 2012 
Ability to deliver growth 
factors or Schwann cells 
 
• Enhancement of functional recovery 
and axonal regeneration 
• Important for neuronal survival and 
Conti et al., 2004; 
Ichihara et al., 
2008, Shakhbazau 
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differentiation 
• Schwann cells for support of axon 
regeneration and re-myelination 
et al., 2012; Allen et 
al., 2013; Marquardt 
and Sakiyama-
Elbert, 2013; 
Mohammadi et al., 
2013 
 
Processing requirements • Maintenance of stability during 
handling, sterilization, storage and 
surgical procedures 
Kehoe et al., 2012 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Comparison between the inclusion of rods (act as physical guidance cues) and 
sheets of a collagen-based engineered neural tissue (EngNT) seeded with Schwann cells 
within conduits in vivo. Flat sheets of EngNT were compared to rods that were made by 
rolling the sheets, as an approach to delivery within a repair device (a). The different device 
designs were compared after 4 weeks recovery in a 5 mm rat sciatic nerve gap model, in 
terms of the distribution of regeneration within and around the EngNT in cross sections (b). 
Three zones were compared within each device group – the EngNT (zone 1), a region 25 
μm from the EngNT surface (zone 2) and the remaining area within the conduit (zone 3). An 
empty conduit was also included (Georgiou et al., 2013) (Reproduced with permission from 
Elsevier B.V. Ltd. © 2013).  
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2.2.1. Neurotrophic Factors for Improved Peripheral Nerve Regeneration 
While peripheral nerves possess the inherent ability to regenerate and sprout new axons, 
this innate capacity is often insufficient for the regrowth of an adequately healthy and 
functional nerve (Soller et al., 2012; Cobianchi et al., 2013). For the promotion of axonal 
growth and functional recovery many studies have concentrated on the effects of sustained-
delivery technologies on the enhancement of nerve regeneration. This includes neurotrophic 
factors within the nerve conduits, particularly in gap defects of 10mm and larger. The use of 
neurotrophic factors has been widely studied in vitro and in vivo and has been proven to 
enhance nerve regeneration across gaps by enhancing both the rate and quality of nerve 
regeneration and potentially restoring a marked functional recovery (Markus et al., 2002; 
Boyd and Gordon, 2003; Willerth and Sakiyama-Elbert, 2007; Moore et al., 2010; Vishnoi 
and Kumar, 2013). Some leading studies have shown the benefits of utilising combinations 
of neurotrophic factors that have been incorporated into nerve conduits to determine whether 
neural regeneration would be further enhanced when compared to the use of single agents 
(Cao and Shoichet, 2003; Madduri et al., 2010a). Elements which critically influence the 
regeneration capacity and rate of damaged nerves supplied with exogenous neurotrophic 
factors (NTFs) are (i) the doses of the neurotrophic factors and its release kinetics at the site 
of the target tissue; and (ii) the effects of initial burst release and whether the employment of 
single or multiple neurotrophic factors are used to create a synergistic effect on the 
promotion of nerve growth.  
 
2.2.2. Impediments Associated with the Inclusion of NTFs 
The ability of a scaffold-based delivery system to release therapeutically adequate quantities 
of NTFs and other bioactives is generally influenced by the type of materials used to 
fabricate the delivery system and the mechanisms that govern the release of NTFs and 
bioactives to the target tissue as this determines the rate and the quantity of release of the 
incorporated bioactives. Furthermore, the selection of materials, the method of incorporation 
of NTFs and bioactives into the delivery system during fabrication and the end degradation 
products of the materials used may affect the bioactivity of the NTFs and bioactive agents 
(Giteau et al., 2008). The delivery of proteins is considered problematic due to their complex 
nature and stability (Machado et al., 2013; Tobinaga et al., 2014). Maintaining bioactivity of 
proteins is crucial as they are highly prone to degradation and instability by exposure to light, 
heat, oxygen, agitation, acidic environments and chemicals (Fu et al., 2000; Lam et al., 
2001; Ozkan et al., 2009).  
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2.3. Requirements for Optimal Peripheral Nerve Regeneration 
For the successful peripheral nerve regeneration to occur, the injured tissues require four 
basic components, namely 1) a scaffold; 2) the inclusion of cells; 3) growth factors; and 4) 
extra cellular material (ECM) molecules, for the neuronal survival, optimal growth and 
ultimate regeneration potential (Figure 2.2). Artificial nerve conduits must be designed in a 
way that is able to provide a scaffold for the support of growing tissues in conjunction with at 
least one other component to create a basis for the model of a multi-functioning nerve 
conduit (Bian et al., 2009; Dodla et al., 2003; Johnson and Soucacos, 2008). By utilizing 
elements such as scaffold design, growth factor delivery, supply of extracellular matrix 
proteins and a substrate or matrix for the attachment of growing cells, the promotion of 
axonal regeneration and functional recovery can be significantly improved. These features 
are required for neural cell proliferation and maintenance of cell shape in addition to guiding 
and provision of mechanical strength to developing axons (Platt et al., 2003; Leinninger et 
al., 2004; Sohier et al., 2006). The implementation of these components into a nerve conduit 
delivery system will enable a degree of control over the length and processes of the 
Wallerian degeneration phase (Pettersson et al., 2010; Shim and Ming, 2010; Kehoe et al., 
2012). Wallerian degeneration is a term describing the rapid breakdown of axons and myelin 
sheaths after injury to neural tissues (Figure 2.3) (Yong and Guoping, 2009). Although it is a 
process triggered for the creation of a microenvironment supportive for nerve regeneration, it 
additionally initiates the onset of inflammation and intensification of pain (Wagner et al., 
1998; Biondi et al., 2008; Dubový, 2011; Allodi et al., 2012; Kehoe et al., 2012; Li et al., 
2013; Tang et al., 2013). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Schematic representation of the basic components required for peripheral nerve 
regeneration and the factors concerned with the delivery of growth factors. 
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Figure 2.3: Degeneration and regeneration after peripheral nerve injury. (A) Normal neuron 
and nerve fiber. (B) Wallerian degeneration. The axotomy results in fragmentation of the 
distal axon and myelin sheaths. Schwann cells proliferate and macrophages invade the 
distal nerve segment and phagocytose degrading materials. (C) Schwann cells in the distal 
segment line up in bands of Bungner. Axonal sprouts advance embedded in the Schwann 
cells and attracted by gradients of neurotrophic factors. (D) Axonal reconnection with end 
organs and maturation and remyelination of the nerve fiber (Allodi et al., 2012) (Reproduced 
with permission from Elsevier B.V. Ltd. © 2010). 
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2.4. Bioactive Release Kinetics and its Effects on Optimal Dosing of Growth Factors 
In regards to peripheral nerve regeneration, the release kinetics of the selected delivery 
system is important particularly with regards to the phenomenon of initial burst release, the 
quantity of NTFs released and the pattern of its sustained release thereafter. Burst release, 
defined as a large and immediate release of bioactives and drug from a delivery system 
within the first 24 hours of placement into dissolution media or biological fluids, can result in 
overdose effects and dose dumping of the therapeutic agents (Huang and Brazel, 2001). 
Factors which need to be modified to achieve desirable release kinetics of growth factors are 
represented in the Figure 2. Inappropriate quantities of NTFs released from a nerve conduit 
or other incorporated delivery system significantly affects the potential of axonal 
regeneration. The release of high doses resulting from marked or uncontrolled initial burst 
release may hinder axonal sprouting due to a reduction in the extent of affinity-binding for 
the receptor sites since a lower therapeutic effect will then be achieved in the target tissues 
(Goodman and Gilman, 2008). It has previously been noted that suboptimal doses of NTFs 
evidently does not elicit an adequate effect on the regeneration of nerves but too-high doses 
are non-beneficial as it may hinder axonal growth due to the down regulation of TrkA and 
loss of affinity of TrkA to the growth factors, such as nerve growth factor (NGF), in order to 
initiate a growth response (Conti et al., 2004; Allen and Dawbarn, 2006; Kemp et al., 2011; 
Siniscalco et al., 2011).  
 
A study by Conti and co-workers proved that high doses of NGF had an inhibitory effect on 
the neurite growth in dorsal root ganglia (DRG) explanted from wild-type and knockout mice 
(Conti et al., 2004). It was noted that DRG cultures exposed to the low dose of a 5ng/ml 
NGF solution exhibited neurite extension of 482µm in 24 hours whereas an increased NGF 
solution of 200ng/ml only supported neurite outgrowth to 173µm over 24 hours. However, 
another study using a heparin-immobilization based delivery system for NGF showed that 
doses of 20ng/ml and 50ng/ml elicited greater axonal regeneration and fiber density 
compared to 5ng/ml dose across a 17mm gap in the rat sciatic nerve (Lee et al., 2003). 
Animal studies conducted on sensorimotor and behavioural recovery by Kemp and co-
workers, 2011, showed that NGF concentrations of 800pg/µl provided optimum axonal 
growth in the early stages of peripheral nerve regeneration compared to animals receiving 
twice the NGF concentration. However, long-term analysis of peripheral nerve regeneration 
revealed that animals receiving 80ng/day for three weeks displayed improved behavioural 
recovery (Kemp et al., 2011). 
 
Further research is required to evaluate the role of delivery systems, release mechanisms 
and release kinetics on the optimal delivery of NTFs in the most beneficial doses for 
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enhanced axonal sprouting. Such factors must be tailored to deliver NTF doses that 
correspond to the regeneration rate of the injured tissues. Furthermore, understanding the 
mechanisms behind the phenomenon of initial burst release and factors controlling the 
characteristics of sustained release profiles will allow researchers to gain a deeper insight 
and knowledge on modification techniques to regulate the delivery of incorporated 
bioactives. This enables the rational selection of bioactive agents in the correct doses to be 
employed in the design of nerve conduits and prevent the economical and therapeutic waste 
of these rather expensive proteins (Huang and Brazel, 2001). 
 
2.4.1. Affinity-Based Delivery Systems for the Sustained Release of GDNF and NGF 
Several researchers have focused on in vitro and in vivo studies utilising heparin-containing 
affinity-based delivery systems for the sustained release of growth factors in peripheral 
nerve and spinal cord injuries (Sakiyama-Elbert et al., 2000a, Sakiyama-Elbert et al., 2000b; 
Lee et al., 2003; Taylor et al., 2004; Maxwell et al., 2005; Wood et al., 2009). The release of 
growth factors in affinity-based delivery systems is controlled by a cell-based degradation 
mechanism of the matrix into which the growth factor is immobilised as opposed to passive 
diffusion-based release from biodegradable polymers (Sakiyama-Elbert et al., 2000; Lee et 
al., 2003). In a representative study, a fibrin-based matrix incorporated with a heparin-
binding peptide, heparin and NGF for potential use in nerve conduits was developed to 
achieve prolonged release of NGF in addition to protecting the bioactive protein from 
degradation. The release mechanism of the delivery system was designed to release 
bioactives in response to cellular activities during regeneration via enzymatic factors using a 
cross-linked heparin-binding peptide to immobilise heparin into the fibrin matrix (Sakiyama-
Elbert and Hubbell, 2000). Interestingly, the immobilised heparin-conjugated protein was 
able to slow the diffusion-controlled release of NGF from the fibrin matrix providing a 
sustained release of growth factor and minimised initial burst release (Sakiyama-Elbert and 
Hubbell, 2000). An earlier study by Sakiyama-Elbert and Hubbell, 2000, involving the 
development of growth factor-heparin-peptide complexes bound within a fibrin matrix, 
confirmed satisfactory release of basic fibroblast growth factor through analysis of neurite 
extension in DRG cultures (Sakiyama-Elbert and Hubbell, 2000b).  
 
An investigation by Wood and co-workers, 2009, on the effectiveness of silicone conduits 
containing the fibrin immobilized heparin-neurotrophic factor conjugates on nerve 
regeneration across a 13mm sciatic nerve gap was performed using glial-derived 
neurotrophic factor (GDNF) and NGF (Figure 2.4) (Wood et al., 2009). The GDNF-containing 
delivery system showed better results in terms of the myelinated fiber count and nerve fiber 
density compared to the NGF-containing delivery system, however, neither was superior in 
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performance to the nerve isograft. Using the same heparin affinity-based delivery system, 
the release of NGF exceeded the nerve regenerative effects of the isograft in vivo across a 
13mm gap. In another study, Taylor and co-workers, 2004, demonstrated that the ratio of 
heparin to growth factor can be modified by increasing the heparin content to achieve a 
sustained and well-defined zero-order release of neurotrophin-3 (NT-3) over 14 days for the 
repair of spinal cord injuries (Taylor et al., 2004). Changing the concentration of heparin 
varies the number of available binding sites to the incorporated growth factors and as a 
result the release rate of growth factors can be modulated by consequently increasing its 
retention time within the fibrin matrix (Willerth and Sakiyama-Elbert, 2007). 
 
The studies discussed above confirm that affinity-based delivery systems are efficient in 
promoting neural regeneration as the release rate is allowed to be modulated by the 
regenerating cells. The neurotrophic factors complexed to peptide-bound heparin form a 
non-diffusible protein complex allowing it to be restricted to and diffuse out of the matrix 
system at a slowed rate (Wood et al., 2009).  In addition, the proteolytic cleavage of the 
growth factors can be prevented in this manner thereby providing a method for reducing the 
potential loss of as well as increasing the bioavailability of the bioactives at the site of injury 
(Wood et al., 2009; Madduri and Gander, 2012). Affinity-based delivery systems can be used 
to immobilise a number of growth factors into scaffolds fabricated from a variety of natural 
and synthetic polymers making it suitable for many tissue engineering applications 
(Sakiyama-Elbert, 2011). Chu and co-workers, 2011, designed a polycation-heparin complex 
to control the delivery of growth factors over 30 days. The polycation, poly (ethylene argininyl 
aspartate diglyceride) (PEAD) improved loading efficiency and bioactivity of the growth 
factors while providing a linear mode of release kinetics (Chu et al., 2011). Further 
modification to the initial affinity-based approach have resulted in the development of 
photocrosslinked heparin-alginate, methylcellusose-SH3 and PEG-heparin hydrogels for the 
controlled and prolonged release of growth factors for bone repair, spinal cord injuries, 
wound-healing and vascular therapies (Nie et al., 2007; Jeon et al., 2011; Pakulska et al., 
2013). 
 
Minor burst release effects, reported in these studies, could be attributed to a passive 
diffusion mechanism. The degree of burst release is dependent on the concentration 
gradient that exists between the NGF rich matrix and the regenerating tissues. As this 
concentration gradient is brought into equilibrium by the slowly diffusing NGF from the fibrin 
matrix, the amount of NGF released is reduced and the release kinetics of the system 
becomes more uniform until a near zero-order release behaviour is observed. Although 
passive diffusion may be minimally controlled by external factors, the diffusion rate can be 
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substantially decreased by the crosslinking action of the peptide and immobilization of the 
heparin into the fibrin matrix which may be considered as the rate-limiting step for the 
passive release process of the growth factors (Sakiyama-Elbert and Hubbell, 2000a; Moore 
et al., 2010). Hence, the affinity-based technique of protein delivery has been shown to 
provide a sustained delivery of bioactives by remarkably slowing down the bioactive release 
processes which can be tailored by increasing the ratio of bound heparin to NTFs to delay 
the release of the heparin-binding NTFs (Hubbell, 2008). 
 
 
 
 
 
 
 
 
 
 
Figure 2.4: Schematic representation of surgical implantation of nerve guidance conduit 
containing the affinity-based delivery system. A 13 mm nerve gap was repaired with a 15 
mm silicone conduit containing fibrin matrices with or without delivery system and growth 
factor and sutured to the transected proximal and distal stumps, incorporating 1 mm of nerve 
on either end. The delivery system consisted of a bi-domain peptide cross-linked into the 
fibrin matrix at one domain while the other binds heparin by electrostatic interactions. The 
growth factor can then bind to the bound heparin, creating a matrix-bound, non-diffusible 
complex, which can be retained for cell mediated degradation of the fibrin matrix (Wood et 
al., 2009) (Reproduced with permission from Elsevier B.V. Ltd. © 2009). 
 
2.4.2. NTF-loaded Crosslinked Polymer Conduits 
Crosslinked polymer conduits offer a relatively simple approach for the entrapment of NTFs. 
The nature of crosslinking, either physical or chemical, affects the release behaviour of the 
incorporated bioactive molecules by influencing the water-uptake, swelling and erosion 
characteristics of the polymer material. Crosslinking not only affects the polymer but can 
have an effect on the entrapment of NTFs depending on the crosslinking agent used, its 
mechanism of action and the chemical structure of the NTFs. Effects of crosslinking on NTFs 
comprise of mainly interaction of specific chemical moieties between the crosslinker and the 
NTF or via the differences in the electrostatic charge. A few studies have shown the effects 
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of ionic and covalent crosslinking on the release of NTFs from nerve conduits and 
microsphere-loaded NTFs (Chan et al., 2008; Chang, 2009; Yang et al., 2011). In a study by 
Madduri and co-workers, 2010, poly (lactic-co-glycolic) acid (PLGA)-coated crosslinked and 
non-crosslinked collagen tubes were evaluated for in vitro release as potential sustained-
release peripheral nerve conduits (Madduri et al., 2010b). Collagen tubes, physically 
crosslinked using a dehydro-thermal treatment (DHT), were loaded with equal doses of 
GDNF and NGF. Exterior coating of the collagen tubes restricted the incorporated NTFs 
within the collagen tube lumen preventing the escape of the NTFs through the walls of the 
tube. Reducing the chance of NTF loss via escape or leakage from the conduit ensures that 
the bioavailability of the loaded dose is not compromised and that the full intact dose 
becomes available to the damaged tissues over the entire regeneration period (Xu et al., 
2002; Xu et al., 2003; Xu et al., 2011). 
 
Mechanical strength, one of the factors that determine the degradation properties of the 
scaffold, was controlled by the induction of crosslinking and PLGA-coatings. Non-crosslinked 
collagen tubes released high quantities of NTFs within the first 2-3 days whereas the 
crosslinked collagen tubes were able to minimise burst release to a level that was indistinct. 
The crosslinking process, achieved through a reaction between the free amino and 
carboxylic acid groups in collagen, was able to retard the degradation of the collagen tubes 
in the presence of collagenase (Madduri et al., 2010b). This allowed crosslinked tubes to 
deliver a sustained-release of NTFs over 30 days whereas non-crosslinked tubes rapidly 
degraded within 2 days. Regarding the dose of NTFs used, 80ng of GDNF alone was 
sufficient for the regeneration of the sciatic nerve across a 10mm gap within 14 days of 
implantation of the PLGA-coated crosslinked collagen nerve conduits as opposed to tissue 
growth in conduits, spanning a similar gap length, without the inclusion of NTFs being noted 
after 30 days (Ahmed et al., 2005; Chen et al., 2005; Madduri et al., 2010b; Huang et al., 
2012). Similarly, genipin-crosslinked chitosan nerve conduits immobilized with NGF 
developed by Yang and co-workers, 2011, provided a sustained release of NGF over 60 
days. A burst release of 2.1ng/day of NGF was reports during the first 3 days progressing to 
a steady decrease in NGF release over the following 20 days. The release kinetics stabilized 
to exhibit zero-order release over the next 40 days with a consistent quantity of 0.22-0.25ng 
of NGF being released daily. Likewise, poly caprolactone (PCL) tubes internally lined with a 
coat of genipin-crosslinked gelatin were able to deliver NGF over 60 days in a zero-order 
manner delivering less than 1ng daily. In vivo studies showed that the crosslinked tubes 
produced the regeneration of more axons compared to non-crosslinked tubes and the 
autografts (Chang, 2009). 
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The mechanism of genipin crosslinking involves a reaction with amine groups which in this 
case was present in both the polymer as well as the NTF. The use of genipin as a 
crosslinker enhanced the ability of the delivery system in mitigating burst release and 
obtaining a zero-order release profile by altering the swelling and degradation properties of 
chitosan in addition to effectively trapping NGF molecules within the polymer network via its 
reaction with –NH2 groups (Butler et al., 2003; Jin and Hourston, 2004; Chang, 2009; Yang 
et al., 2011). In the studies described, the primary mechanism controlling the release of 
NTFs is polymer degradation along with passive-diffusion during the initial release phase. 
Crosslinking is effective in modifying water-uptake ability, swelling and degradation 
processes to control the release of bioactives and minimise burst release to achieve 
sustained and prolonged delivery. Burst release results from swelling of the conduit walls 
initiated by water-uptake into the polymer chains. Swelling produces the formation of a 
hydration layer which facilitates the transport of bioactives via diffusion which occurs 
spontaneously and over which little control can be exerted (Figure 2.5). This hydration layer 
creates a diffusion pathway for the entrapped bioactives. With time the hydration layers 
increase as the polymer swells thereby lengthening the pathway of diffusion that the 
bioactive molecule must cross before it is finally released into the conduit lumen. This 
mechanism brings about a decrease in release rates over time providing zero-order release 
kinetics (Conti et al., 2007). Combined with slower degradation rates, smaller quantities of 
bioactives can be delivered over a prolonged time whereas rapid degradation releases large 
amounts of bioactives in a shorter time.  
 
 
 
 
Figure 2.5: Representation of the design and release from the collagen crosslinked conduits 
via water-uptake and swelling initiated diffusion. 
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2.4.3. Microsphere Technologies for the Delivery of NTFs 
Microspheres, usually fabricated from polymeric materials, are spherically shaped particles 
with diameters in the micrometre range and well-known for their capability to deliver drugs 
and bioactive molecules. Microspheres are frequently used for NTF encapsulation employing 
different methods of fabrication involving the use of ionic and covalent crosslinkers, double 
emulsion methods and spray drying to evaluate the varying degrees of crosslinking, effects 
on swelling, encapsulation efficiencies and degradation characteristics as the factors 
controlling the release of incorporated proteins (Aral and Akbuğa, 1998; Shu and Zhu, 2000; 
Mi et al., 2003; Buranachai et al., 2010; Ye et al., 2010; Yang et al., 2011).  Several studies 
have shown promising results in the ability of microspheres to deliver sustained and constant 
quantities of bioactives as they can effectively be combined with more than one delivery 
system to control the release kinetics (Vishnoi and Kumar, 2013; Silva et al., 2009; Park et 
al., 2010). Careful selection of a suitable method for microsphere preparation is required as 
the different techniques affect the final outcome on encapsulation efficiency, release kinetics 
and preservation of bioactivity of the growth factors (Figure 2.6) (Ye et al., 2010). 
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Figure 2.6: Typical W/O/W double emulsion method to prepare microspheres containing 
protein drug (upper panel) and microscopic events during fabrication process (lower panel). 
The sequence of fabrication is primary emulsion, secondary emulsion, solvent 
extraction/evaporation (not shown), (freeze-)drying, and drug release test. With negligible 
partition of protein into oil phase (A), the organic solvent–water interface during W1/O 
emulsion results in protein denaturation (B). During generation of secondary emulsion, water 
channels connecting internal (W1) and external (W2) aqueous phases (E) allow proteins to 
escape from droplets (C), and provide more chances of protein denaturation by increased 
surface area of the oil–water interface (D). The water channels become pores (F) of 
microspheres hardened by freeze-drying. Ice crystal (G) is known to provide a hazardous 
condition inducing protein denaturation (I). Irreversible aggregation (H) between protein 
molecules can be formed if stabilizer or cryoprotectant is not added. Normally, microspheres 
made by double emulsion have a broad range of particle size distribution as well as different 
protein amount in each microparticle. In a release test, a burst release of protein at the initial 
period (< 24 h) is mostly due to the protein release (K) from the proteinaceous film on the 
particle surface (D). With time, proteins are release from particles (J) by diffusion and 
degradation (L) of polymer (e.g., PLGA). Microparticle degradation cumulates acidic 
products inside particles (M), which further facilitates protein denaturation (N). Protein 
adsorption on hydrophobic polymer surface (O) often leads to incomplete release of protein 
drugs (Ye et al., 2010) (Reproduced with permission from Elsevier B.V. Ltd. © 2010). 
 
2.4.4. Crosslinked Chitosan Microspheres 
Chitosan microspheres have been widely applied for protein delivery applications with 
various degrees of success in achieving sustained zero-order release kinetics for periods 
ranging from 3 days to over 2 months using growth factors, hormones and bovine serum 
albumin as model proteins (Yuan et al., 2007; Karnchanajindanun et al., 2011; Wu et al., 
2011; Zhang et al., 2011; Jose et al., 2012). Sinha and co-workers, 2004, extensively 
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reviewed the applications of chitosan microspheres for various categories of drugs while 
stating the favourable degradation, biocompatibility and hydrophilic characteristics and 
simpler processing procedures that chitosan offers (Sinha et al., 2004). 
 
For the application of peripheral nerve injuries, chitosan-PCL microspheres for the delivery 
of GDNF were expected to release therapeutically sufficient quantities of GDNF in a 
controlled manner. Having a brush-like chain structure, the authors proposed that the PCL 
side-chains could act as hooked branches for the entrapment of GDNF by increasing the 
potential of protein entanglement onto the PCL chains. Depending on the quantities of 
chitosan, PCL and the crosslinker used, release profiles varied from near first-order to zero-
order kinetics over 49 days. Reduced burst release and zero-order kinetics resulted from the 
release mechanisms, swelling, diffusion and degradation, being primarily governed by the 
increasing amounts of PCL and genipin (crosslinker) used in the microsphere formulations 
(Wu et al., 2011). 
 
A study by Zeng and co-workers, 2011, investigated the effects of crosslinking on bioactive 
release and encapsulation efficiency of NGF-loaded microspheres and obtained similar 
results to studies described above. Chitosan microspheres were ionically crosslinked using 
various concentrations of sodium tripolyphosphate (STPP) to control burst release and 
provide a slow and sustained release of NTF over 7 days. Increase in STPP concentration 
resulted in a lower NGF encapsulation efficiency but showed a reduction in the initial burst 
release and offered slow and sustained release of NGF. This is attributed to the high 
crosslinking density obtained, when STPP concentrations are increased, which prevented 
swelling of the microspheres and inhibited the rate and reduced the quantity at which NGF is 
released. STPP of concentrations 1%, 5% and 10% produced microspheres that exhibited 
burst release of 45.5%, 24.6% and 18.4%, respectively of the total encapsulated dose within 
12 hours. The release of NGF from the crosslinked chitosan microspheres occurred in 3 
stages: 1) a rapid burst release triggered by swelling, 2) a slower diffusion-based release 
through pores and channels within the microspheres and 3) a further slowed release phase 
dominated by erosion-based release through chitosan biodegradation or in combination with 
diffusion of NGF (Zeng et al., 2011). 
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Multichannel chitosan-PCL nerve conduits were fabricated to house the microsphere 
delivery system (Liao et al., 2013). The design of the conduit was such that it resulted in 
longitudinal arrays of hollow cylindrical channels running across the entire length of the tube 
(Figure 2.7). In addition to the delivery of NGF the provision of physical guidance cues in the 
form of these longitudinal channels furthers the promotion of axonal regeneration and 
accurate direction of growth (Bozkurt et al., 2012; Ke et al., 2014). The NGF-loaded 
microspheres embedded into these channels were able to significantly retard the release of 
NGF in comparison to microspheres alone. The authors proposed that the release behaviour 
and quantity of the microsphere-encapsulated NGF can be independently controlled by 
changing the initial loading dose of NGF in the microspheres. To explore this concept, 
crosslinked chitosan microspheres loaded with initial NGF doses of 5 and 10ng/mg 
microsphere were studied in vitro over 60 days for differences in release kinetics and 
quantity of NGF released (Liao et al., 2013). There was no significant difference in the burst 
release and cumulative release of NGF between the high and low loading doses. Both types 
of microspheres exhibited burst release of approximately 10% and over 60 day study period 
almost all of the loaded NGF had been released. Despite similar release profiles in terms of 
percentage cumulative release, it is clear that the higher NGF-loaded microspheres will 
release a greater amount of growth factor compared to the microspheres loaded with a low 
initial dose as amount of growth factor present is increased (Liao et al., 2013).  
 
Figure 2.7: Representation of the internal design and configuration of the multi-channel 
conduits providing physical cues for enhanced regeneration.  
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Crosslinking effects, similar to those described in the study by Zeng and co-workers (Zeng et 
al., 2011) were observed by Liao and co-workers, (Liao et al., 2013). Increasing STPP ratios 
ranging from 1 to 6 of crosslinker:chitosan solution resulted in significantly inhibited swelling 
of the microspheres by 116% to 70% which controlled swelling to restrain diffusion-based 
burst release. However, in contrast to the previous reports (Zeng et al., 2011; Liao et al., 
2013) the encapsulation efficiency was directly proportional to the crosslinker ratios.  
 
2.4.5. NTF-loaded PLGA Microspheres 
PLGA microspheres have been extensively investigated for the encapsulation and controlled 
release of various proteins (Morlock et al., 1997; Péan et al., 1999; Lam et al., 2000; Takada 
et al., 2003; Jaklenec et al., 2008; Ye et al., 2010; Rui et al., 2012). NGF-loaded PLGA 
microspheres fabricated by Péan and co-workers, 1998, for injectable administration to the 
brain also exhibited first-order release kinetics over 12 weeks. Burst release was attributed 
to the highly porous structure of the microspheres allowing easy penetration of water into the 
matrix thereby allowing rapid release of NGF via diffusion osmotic pumping (Figure 2.8) 
(Péan et al., 1998; Fredenberg et al., 2011). The prolonged release period was thought to 
arise from adsorption and entanglement of the protein onto the polymer chains (Péan et al., 
1998). NGF-encapsulated PLGA microspheres prepared by spray freeze-drying technique 
achieved a biphasic release over 30 days. The release pattern consisted of an inclining 
rapid-release phase gradually stabilizing to a zero-order release after medication of the 
microspheres with zinc carbonate to reduce burst release and enhance sustained release 
(Lam et al., 2001). PLGA microspheres loaded into chitin tubes manufactured by the double 
emulsion/solvent evaporation technique, releasing BSA as the model protein, provided a 
first-order release profile over 84 days as investigated by Goraltchouk and co-workers 
(Goraltchouk et al., 2006).  
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Figure 2.8: The complex picture of physicochemical processes taking place within PLGA 
matrices, leading to drug release. The influence of processes on drug release and on other 
processes is illustrated by arrows. Note that some arrows point in both directions 
(Fredenberg et al., 2011) (Reproduced with permission from Elsevier B.V. Ltd. © 2011). 
 
Concerning peripheral nerve regeneration, double-walled PLGA-PLLA microspheres loaded 
with GDNF into the inner walls of a bi-layered PCL nerve conduit to achieve sustained 
delivery for a minimum period of 50 days was developed (Kokai et al., 2010). The efficacy of 
the delivery system was evaluated in a rat sciatic nerve model of gap 15mm over a study 
period of 6 weeks. Each nerve conduit was loaded with an approximate dose of 95ng GDNF. 
The microspheres were embedded into the walls of a PCL conduit which then received 
another porous layer of pure PCL. This assembly of polymers and microspheres exhibited 
an initial burst release during the first day followed by a slower near zero-order release over 
the next 64 days. The release kinetics of the GDNF-loaded microsphere-embedded nerve 
conduits was able to support the regeneration of blood vessels, intercellular fibers and 
Schwann cells, in vivo, compared to the negative controls (Kokai et al., 2010). NTF release 
can further be controlled by a combination of polymer degradation and diffusion processes 
(Figure 2.9). The additional layer of PLLA surrounding the GDNF-loaded PLGA 
microspheres not only increased the time of NTF release by slowing the process of diffusion 
but also provided a strategy for protection of the GDNF protein by containment of the growth 
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factor within the core of the two-layered microsphere structure. Furthermore, this double-wall 
of polymers may assist in the prevention of excessive NTF loss as it remains confined within 
the microsphere core. The inner solid PCL layer, into which the microspheres are 
embedded, further delay the ultimate release of GDNF as this layer has to erode in order for 
microspheres to be released into the lumen of the conduit where the microspheres can 
undergo biodegradation for the diffusion and release of the entrapped GDNF. The outer 
porous PCL layer of the nerve conduit allows for cellular infiltration and exchange of 
metabolic substances and nutrients which are vital for the proliferation of physiological 
tissues (Kokai et al., 2009; Kehoe et al., 2012). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.9: Representation of the double-walled PLGA-PLLA microspheres, a) release of 
microspheres from solid PCL layer via degradation of PCL, b) degradation of microspheres 
and subsequent release of GDNF, c) release of GDNF by diffusion through degradation-
formed pores and channels in the microsphere matrix. 
 
Researchers have proposed that microsphere delivery systems for NGF composed of PLGA 
exhibited significant initial burst release phases followed by a slow continuous release 
pattern where the subsequent release of growth factor in the slowed-release phase could be 
lower than the initial burst release (Xu et al., 2002). Furthermore, it is thought that the acidic 
degradation products of PLGA may cause inactivation of the protein-based NGF creating a 
concern for the maintenance of NGF stability and ultimate bioactivity (Xu et al., 2002; Luan 
et al., 2006; Giteau et al., 2008). The erosion behaviour of PLGA dominates its ability in 
controlling release kinetics and inhibiting initial burst release. The interior of PLGA 
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microspheres degrade at a faster rate than the polymer surface on the outside and this bulk-
degradation coupled with its autocatalytic mechanism increases the potential for large 
amounts of entrapped bioactives to be released over a short time frame (Sackett and 
Narasimhan, 2011; Versypt et al., 2012). 
 
2.4.6. Miscellaneous Microsphere Delivery Systems for NTF Delivery 
Xu and co-workers (Xu et al., 2002) fabricated polyphosphoester (PPE) microspheres for the 
delivery of NGF. The PPE polymer, P(DAPG-EOP), used for synthesizing the NGF-loaded 
microspheres has a phosphate backbone composed of oligomeric D,L-lactide blocks and 
has been previously shown to exhibit near zero-order release kinetics of drugs used in 
delivery systems for the application of other disease conditions, by virtue of its collective 
mechanisms of surface erosion and bulk degradation (Nair and Laurencin, 2007). PPEs are 
degraded via hydrolytic and enzymatic cleavage of the phosphate bonds at physiological 
conditions resulting in the formation of phosphates, alcohols and diols as the ultimate 
breakdown products. Hence it is advantageous in tissue engineering applications as 
compared to the hydrolysis-induced degradation of PLGA resulting in acidic compounds 
which may further lower the pH of the entire delivery system and the local surrounding 
tissues leading to inflammation and inactivation of acid-labile bioactives (Nair and Laurencin, 
2006 and 2007; Sokolsky-Papkov et al., 2007 and Fredenberg et al., 2011). During the first 
week 45% of the loaded NGF was released with an initial burst release of approximately 4%. 
A slower release phase exhibiting sustained near zero-order release kinetics was observed 
over the subsequent weeks with an average NGF release rate of 0.5ng/mg microspheres per 
day. At the end of the 10 week study period 60% of the total encapsulated NGF was 
released (Xu et al., 2002).  
 
In vivo studies were performed using the rat sciatic nerve regeneration model where a 
silicone nerve conduit containing the PPE microspheres was implanted across a 10mm 
nerve gap followed by a subsequent study utilizing P(BHET-EOP/TC) conduits as the 
microsphere carrier. Each conduit, loaded with an NGF dose of 100ng, was able to within 2 
weeks promote a positive growth of nerve fibers compared animals received a conduits filled 
with a 50ng/ml NGF saline solution. After 3 months, all animals receiving NGF-loaded 
microspheres showed a positive muscle reflex, an epineurium-surrounded regenerated 
nerve cable bridging the 10mm nerve gap containing myelinated axons, thicker myelin 
sheaths and higher fiber densities compared to the controls. The silicone nerve conduits with 
the NGF-releasing microspheres generated a higher population of axons and fiber density 
though PPE nerve conduits which prevailed in the regeneration of larger axons and thicker 
myelin. The authors proposed that the investigated strategy of NGF delivery would be 
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favourable compared to the nerve autograft and its associated issues of loss function at 
donor sites, insufficient collection of grafting materials and the formation of neuromas (Xu et 
al., 2002).  
 
GDNF-loaded silk microspheres dispersed throughout a silk conduit were successful in 
releasing GDNF for Schwann cell migration and nerve tissue proliferation over six weeks 
(Lin et al., 2011).  The aqueous solubility of silk offered ideal processing characteristics for 
the incorporation of growth factors unable to resist harsh fabrication procedures when using 
polymers requiring acidic and organic solvents (Wang et al., 2007; Uebersax et al., 2007; 
Wen et al., 201). Crystalline beta-sheet formation in silk forms physical crosslinks which 
reinforces the structure of silk imparting enhanced mechanical strength and degradation 
properties (Wang et al., 2007; Wang et al., 2010). In another study, photochemically 
crosslinked collagen microspheres were utilised to preserve NGF bioactivity and with the 
addition of tween 20, collagen microspheres significantly improved zero-order release of 
BSA while simultaneously eliminating burst release (Chan et al., 2008). 
 
2.5. Multiple Layer Strategies and Polyelectrolyte Complexes for the Controlled 
Release of NTFS 
Another strategy for controlling the release of NTFs is the deposition of bioactive molecules 
between layers of polymers varying in size, number, material selection and its ionic charge. 
In this manner, release kinetics of NTFs can be regulated by changing the quantity of 
polymeric material in the following ways: 1) by delaying water penetration to hydrate the 
consequent polymer layers before reaching the NTF layer interface, 2) by increasing the 
diffusion pathway that must be crossed by the NTF molecules before becoming available to 
the target tissues and 3) by extending polymer erosion or degradation before exposure of 
the NTF layer (Conti et al., 2007; Kokai et al., 2010). As noted in a study by Yang and co-
workers, 2011, electrostatic properties can assist the enhanced entrapment of NTFs via ionic 
interaction between NTF and crosslinker or NTF and polymer. With layer-by layer deposition 
or blending of oppositely charged polymers, various polyelectrolyte complexes (PECs) can 
be formed for immobilizing NTFs and controlling its release (Luo and Wang, 2014; Tsai et 
al., 2014). The outcome on release profiles utilising PECs can be seen in a study conducted 
by Pfister and co-workers, 2008, using a multiple-layered PLGA-coated system. Hollow 
nerve conduits were fabricated to control the release of NGF by altering the position of NGF 
between various concentric layers of PLGA and an alginate-chitosan PEC (Figure 2.10). 
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Figure 2.10: Representation of the different conduits and the various positioning of NGF, 
alginate-chitosan, and PLGA layers. 
 
Conduit A, consisting of NGF centrally placed within the alginate-chitosan PEC was capable 
of providing a single-phase near-perfect zero-order release kinetics with an indistinct initial 
burst release. It is thought that the firm entrapment of NGF within the PEC layer was due to 
electrostatic interaction between the positively charged NGF and the negatively charged 
alginate (Chaudhari et al., 2013). Unlike conduit A, a biphasic release pattern was reported 
for the 15-day study period with conduits B, C and D. An escalating rapid-release phase was 
noted during the first week followed by a plateaued effect achieving a near zero-order 
release over the final week. Conduit B, having the NGF layer deposited just outside the PEC 
layer had the highest burst release, particularly during the rapid-release phase. Conduit D, 
having the NGF layers interposed between additional layers of PLGA was more efficient in 
minimising burst release and significantly prolonging the delivery of NGF at the end of 15 
days (Pfister et al., 2008). Using a similar concept of PEC formation, Xu and co-workers, 
2011, developed a multi-layered nerve conduit using a layer-by-layer electrostatic self-
assembly technique to create a PDLLA/chondroitin sulphate/chitosan PEC of varying layers. 
NGF was immobilised onto the conduit via carbodiimide crosslinking. The nerve conduits 
were evaluated for their in vitro release kinetics of NGF and its effect on the potential of 
nerve regeneration across a 10mm gap in the rat sciatic nerve model (Xu et al., 2011).  
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Despite a high initial burst release over the first day followed by a sharply plummeting 
release of NGF over the next day, the multi-layered PEC system was successful in providing 
a zero-order profile with a sustained release of 1ng NGF daily for over 50 days. Implantation 
of the conduit across a 10mm sciatic nerve gap in the rat proved the conduit to be closely 
matched to the outcomes of the autograft when comparing the two in terms of myelination, 
axon diameter and nerve conduction velocity over a period of 3 to 6 months (Xu et al., 2011). 
PECs, particularly those fabricated from multi-layered techniques, are being extensively 
investigated for the delivery of proteins and their use in tissue engineering applications 
(Cooper et al., 2005; Gucht et al., 2011; Luo and Wang, 2014; Tsai et al., 2014). Besides 
presenting a milder method of immobilisation for delicate proteins, PECs offer improved 
physicomechanical strength with a minimised swelling and erosion propensity thereby 
prolonging bioactive release (Cooper et al., 2005; Li et al., 2009). To obtain various release 
kinetics, proteins can be deposited onto the surface of a pre-formed PEC layer, in between 
PEC multi-layers or distributed within a PEC layer for a steadier release (Cooper et al., 
2005). PECs have been used for the delivery of proteins and peptides for several controlled 
release applications and should be further studied for their use in delivering NTFs in 
peripheral nerve injury. 
 
2.6. Combined Delivery of Neurotrophic Factors: Effects on Neuronal Regeneration 
The simultaneous delivery of two or more NTFs from nerve conduits may be more beneficial 
in peripheral nerve regeneration than the delivery of a single NTF. Each NTF has a unique 
therapeutic mechanism of promoting regeneration of and sustaining neuronal cells. The co-
delivery of NTFs may enhance nerve regeneration by targeting and promoting various 
different pathways of neuronal growth and survival in addition to reducing the initial loading 
and daily doses of NTFs thereby providing perhaps a more cost-effective route in utilising 
NTFs. Schwann cells (SCs), forming the predominant component of glial cells in the 
peripheral nervous system, are known to express a number of receptors for ECM molecules 
and NTFs (Chernousov and Carey, 2000; Evans et al., 2002). It is proposed that NTFs 
exhibit their actions by binding to two receptor types, namely the p75NTR receptor and the 
Trk class of receptors comprising TrkA (NGF), TrkB (BDNF) and TrkC (NT-3) located on 
SCs and neurons throughout the nervous system (Patapoutian and Reichardt, 2001; Allen et 
al., 2013; Morcuende et al., 2013). SCs have been reported to particularly express high 
levels of the p75NTR receptor which NTFs act on to modulate the migration, proliferation 
and myelination capacities of SCs in peripheral nerves (Johnson et al., 1988; Taniuchi et al., 
1988; Cosgaya et al., 2002). The binding of NTFs to the p75NTR receptor is thought to 
occur with a similar low affinity across all NTFs whereas binding activity to the Trk class of 
receptors is more specific (Carter et al., 1996; Syroid et al., 2000). NGF, having particular 
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affinity for TrkA, functions to promote the survival and maintenance of sensory neurons 
whereas binding to p75NTR receptor sites on SCs enhances myelination of axons (Piirsoo et 
al., 2010; Allen et al., 2013). Similarly, the neurotrophin BDNF is reported to be a potent 
promoter of myelination via activation of the p75NTR receptors located on SCs whereas 
activation of the same receptors by NT-3 enhances SC migration. It was noted by 
researchers that although NT-3 had positive effects on SC migration, activation of SC-TrkC 
receptors inhibited myelination (Cosgaya et al., 2002; Yamauchi et al., 2004; Piirsoo et al., 
2010). GDNF has been investigated for its actions in the promotion of motor neuron survival, 
SC migration and the induction of myelination of small axons via activation of the Ret 
tyrosine kinase (Höke et al., 2003; Iwase et al., 2005; Piirsoo et al., 2010; Catrina et al., 
2013). In this regard, cautious NTF selection for combined therapy is necessary as the 
delivery of more than one NTF may prove to confer either synergistic or opposing biological 
activity. Furthermore, the activation of specific receptors and its resulting effects on the 
different cell types found in peripheral nerves must be taken into account. 
 
In an interesting study by Madduri and co-workers, 2010, it was shown that GDNF-releasing 
nerve conduits promoted only axonal elongation in chicken embryonic DRG whereas a 
combined-release of GDNF and NGF enhanced axonal elongation in addition to the 
promotion of branching of the nerve tissue. It was noted, in DRG assays, that optimal growth 
occurred at doses of 1-10ng/ml of GDNF or NGF but combined GDNF and NGF required a 
total reduced dose range of 0.1-1ng/ml for an optimal growth response. Furthermore, in vivo 
studies across a 10mm nerve gap showed significantly improved axonal outgrowth when 
using a combination of 40ng GDNF and NGF each in comparison to 80ng GDNF alone 
(Madduri et al., 2010a). To enhance the synergistic effect of the GDNF/NGF combination, a 
variety of collagen and silk fibroin nerve conduits were designed for the extended and 
simultaneous release of the growth factors in a zero-order fashion (Catrina et al., 2013). 
 
The selection of NTFs for combined delivery to achieve a synergistic response in the 
enhancement of axonal regeneration must be carefully determined as not all NTFs may work 
synergistically for a heightened effect.  Another investigation, using concentration gradients 
of NTFs, showed that combined concentrations of NGF and BDNF had no significant effect 
of synergism when evaluated for axonal growth response in DRG however a combination of 
NGF and NT-3 was shown to be successful in achieving synergism at concentrations of 
80ng/ml/mm each. The NGF/NT-3 combination of growth factors was more effective in 
axonal regeneration compared to a single dose of NGF of 133ng/ml/mm concentration and 
capable of guiding axons over 12.5mm distance as opposed to that of 7.5mm, respectively 
(Cao and Shoichet, 2003). 
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2.7. Cell-Engineered Applications for Peripheral Nerve Regeneration 
Another technique of delivering neurotrophic factors to injured peripheral nerves involves the 
exogenous culturing of support cells into the matrix of natural or synthetic-based conduits. 
Such cells, Schwann cells (SCs), mesenchymal, neural and embryonic stem cells, interact 
via various molecular pathways to bring about peripheral nerve regeneration by providing 
substrates and molecules that partake a pivotal regulatory function in axonal migration and 
proliferation (Evans et al., 2002; Gu et al., 2011). The purported positive interactions 
between support cells and peripheral nerves led to the inclusion of these cells into nerve 
conduits ̶ a growing field of interest as an alternative to the nerve autograft. 
 
Schwann cells, being the principal support cells of the peripheral nervous system, are 
capable of secreting neurotrophic factors in addition to providing an ECM-scaffold system 
that fulfils the fundamental requirements for an environment sustainable of neural cell growth 
(Goto et al., 2010). Several studies have investigated methods of SC transplantation and 
over-expression of genes encoding specific proteins as a promising outlook for peripheral 
nerve regeneration (Hadlock et al., 2000; Evans et al., 2002; Mosahebi et al., 2003; Goto et 
al., 2010; Shakhbazau et al., 2012). Studies have shown the regenerative potential of 
genetically modified SCs over-expressing fibroblast growth factor, in short and long gap 
sciatic nerve defects of 5mm and 15mm, respectively (Haastert et al., 2006; Jungnickel et 
al., 2006). A group of investigators designed isogenic NGF-transduced SCs for the supply of 
NGF immediately after nerve injury and during the early stages of nerve regeneration when 
endogenous neurotrophin levels are particularly low (Shakhbazau et al., 2012). The over-
expression of NGF from the transplanted SCs was able to provide long-term and increased 
delivery of the NTF for at least two weeks after induction of sciatic nerve injury. In the 
presence of proliferating SCs, bands of Büngner are formed which guide axonal 
regeneration and target tissue innervation from the proximal to the distal stump of the 
transected nerve thus enhancing nerve regeneration potential (Evans et al., 2002; Goto et 
al., 2010). Since, it is thought that SCs secrete a number of NTFs comprising of NFG, BDNF 
and GDNF which act through different mechanisms to enhance and accomplish complete 
nerve regeneration, the incorporation of SCs may be considered a valuable addition in 
enhancing the functionality of nerve conduits (Goto et al., 2010; Madduri and Gander, 2010; 
Gu et al., 2011). The same group of researchers later developed a method for the regulation 
of GDNF expression using dendrimers and lentiviral transduction for the modification SCs 
paired with the administration of doxycycline for improved functional recovery in a rat nerve 
model (Shakhbazau et al., 2013). Similarly upcoming research has focused on the ability of 
modified SCs to deliver GDNF for axonal regeneration (May et al., 2013; Santosa et al., 
2013). 
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Although SCs are popular for the investigation of cell and gene-based therapy in neural 
regeneration strategies, neural and mesenchymal-derived stem cells have likewise shown 
significance in the ability to deliver NTFs such as BDNF, GDNF and NGF (Garcıá et al., 
2004; Nourizadeh et al., 2011; Ma et al., 2012; Wang et al., 2012). Such cell-based delivery 
applications may offer several advantages in terms of providing suitable release kinetics for 
the delivery of multiple NTFs in therapeutically adequate quantities where concerns of 
protein degradation and inactivation from manufacturing processes may be eradicated 
thereby ensuring complete bioactivity of these physiologically delivered NTFs (Dove, 2002; 
Madduri and Gander, 2010). 
 
2.8. Concluding Remarks 
The therapeutic benefits offered by the use of neurotrophic growth factors for the application 
in enhancing regeneration and healing of transected and damaged peripheral nerves are 
noteworthy. The full potential of such potent growth factors can only be harvested if 
employed in a delivery system capable of precisely releasing adequate quantities of growth 
factor for a sufficient amount of time following the most desirable release kinetics, preferably 
zero-order release or a via a delivery system that offers a gradient-based release of NTFs. 
Burst release mechanisms must be further investigated so that minimal quantities of 
bioactives are released upon in vivo implantation of the nerve conduit resulting in potential 
hindrance of nerve growth. Furthermore, bioactivity of entrapped NTFs must be ascertained 
as fabrication procedures influence their ultimate therapeutic potency. In conjunction with in 
vitro release studies, animal models are valuable in assessing the effects and differences of 
the observed release kinetic profiles as similar release kinetics cannot be simply assumed to 
occur in vivo. In vitro studies cannot fully emulate the biological and physiological conditions 
present in the body especially after subjection of internal organs to injury. Hence different 
studies on different types of nerve conduits may present with similar release kinetics 
compared to each other but have different regeneration effects on the regeneration potential 
on tissues. Although numerous new polymeric nerve conduits delivery systems have been 
proposed with several designs suggesting great promise in the significant improvement of 
peripheral nerve regeneration, further work must be carried out to smooth out concerns 
associated with release kinetics, ideal NTF selection and dosing in accordance to tissue 
requirements, the length of treatment and restoration of functional recovery.   
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CHAPTER 3 
 PROOF OF CONCEPT: DESIGN OF CHITOSPHERES LOADED WTH PRISTINE 
POLYMER PARTICLES FOR EXTENDED DRUG DELIVERY VIA 
POLYELECTROLYTE COMPLEXATION AND PARTICULATE LEACHING 
 
 
Abstract 
The aim of this study was to investigate the drug release from swellable chitospheres laden 
with pristine polymethylmethacrylate (PMMA) nanoparticles. Chitosan matrices were 
prepared by sodium tripolyphosphate crosslinking from a chitosan suspension containing the 
model BCS class II drug, indomethacin. PMMA particles were added to the chitospheres as 
the modulator for drug release. Swelling and erosion studies in conjunction with textural 
profiling provided an understanding of the dominant and underlying drug release 
mechanisms of the ionically crosslinked chitospheres loaded with the pristine PMMA 
particles. A series of drug release studies performed in PBS pH 7.4 showed that the pristine 
particle-loaded chitospheres released indomethacin over 144 hours in a first-order manner 
with 50% drug release occurring over 48 hours. The study also revealed that in situ porogen 
leaching for pore creation and polyelectrolyte complex formation were the main mechanisms 
of release from the chitospheres. The results of this study may be utilized for the 
development of neuro-implants for controlled delivery of bioactives to the brain where 
scaffolds of superior mechanical strength and reduced swelling properties are required. 
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3.1. Introduction 
Chitosan matrices, particularly spheres, formed from ionotropic and covalent crosslinking 
have long been used as a three-dimensional matrix for the study of release profiles of 
numerous drugs with the intent to modulate drug release profiles in a manner that provides 
drug release of appropriate kinetic order and therapeutic effectiveness (Gupta and Kumar, 
2000; Mi et al., 2003; Sarkar et al., 2013). These multiparticulate spherical matrices (Ko et 
al., 2002; Lin et al., 2005; Pasparakis et al., 2006; Srinatha et al., 2008; Kotadia et al., 2009; 
Harris et al., 2010; Yang et al., 2011; Jonassen et al., 2012; Rampino et al., 2013) comprise 
chitosan alone or blended with other property-modifying natural or synthetic polymers that 
have been widely used for the oral delivery of therapeutic agents and for long-term sustained 
delivery of proteins, peptides and other essential growth factors for tissue regeneration 
applications and gene delivery technologies (Anal et al., 2003; Vimal et al., 2013). 
 
Chitosan is readily soluble in acidic pH, with the resultant protonated amine group available 
for ionic interaction with multivalent ions for immediate gelation (Jonassen et al., 2012; 
Shenvi et al., 2014). The cationic nature of chitosan also makes it simple for producing 
physically crosslinked gelling matrices and furnishes the ability to electrostatically interact 
with counter ionic polymers to form polyelectrolyte complexes (PECs) (Cerf et al., 2014; 
Nath et al., 2015). Previously reviewed PEC applications show that PECs have unique 
physicochemical and mechanical properties to that of the parent polymers and offer an 
additional dimension to the delivery system and enhanced properties for tailoring drug 
release patterns to the desired site (Hamman, 2010). Sodium tripolyphosphate (STPP) has 
been frequently used as an ionic crosslinking agent for chitosan matrices due to its rapid 
crosslinking action and safety compared to gluteraldehyde, epichlorohydrin and ethylene 
glycol diglycidly ether that have proven physiological toxicity (Mi et al., 1999; Shu and Zhu, 
2002; Li and Huang, 2012; Shenvi et al., 2014).Chitosan-based multiparticulates can 
instantly be synthesised using STPP which forms either intermolecular or intramolecular 
linkages that stabilize the positively charged amino groups of chitosan resulting in 
crosslinking (Mi et al., 1999, 2003). Previous studies, aiming to extend the release of 
indomethacin from crosslinked chitosan and other multiparticulate systems over 12-24 hours 
have been reported (Mi et al., 2002; Yuksel et al 2011). However, the poor mechanical 
strength of these matrices limits its use in the pharmaceutical industry and the prolonged 
release of drug and loading efficiency still needs to be improved (Shu and Zhu, 2000). 
Strategies aimed at improving mechanical strength of and more particularly the controlled 
release of drug from chitosan beads includes the use of genipin as a covalent crosslinker as 
opposed to ionic crosslinkers. Yang and co-workers (2011) investigated the mechanical 
properties of STPP/genipin co-crosslinked chitosan beads whereas Harris and co-workers 
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(2010) employed a series of chitosan hydrochloride genipin crosslinking reactions for the 
controlled release of drugs and proteins. Another widespread method employed for 
enhancing the drug delivery properties of chitosan beads involve the polyelectrolyte 
complexation of chitosan with anionic polymers either via blending of polymers prior to bead 
formation or coating of the beads employing a series of layering techniques using mainly 
alginates (Wang et al., 2011; Gong et al., 2011; Zhang et al., 2011; Torelli-Souze et al., 
2012; Zhou et al., 2013) and pectins (Maestrelli et al., 2012; Ribeiro et al., 2014). 
 
Therefore, the present study makes use of chitospheres to investigate drug release profiles 
when pristine (previously unmodified and drug-free) polymer nanoparticles of a polymethyl 
methacrylate (PMMA) polymer are distributed throughout the matrix. The electrostatic 
interaction between the native polymers producing the PEC can significantly improve the 
mechanical properties, particularly resilience and hardness, in addition to prolonging drug 
release. 
 
The use of PMMA is to control drug release from the chitospheres. PMMA (as the pristine 
nanoparticles) is an anionic copolymer of polymethacrylic acid and methyl methacrylate 
(Eudragit S100, Evonik, Midrand, Gauteng, South Africa). PMMA is soluble at a pH value of 
> 7.0 and electrostatic interactions between anionic PMMA and cationic chitosan may assist 
in prolonging drug release. Incorporating it as pristine particles within the chitospheres 
allows the PMMA to function as a porogen and simultaneously form a PEC after the pH-
responsive dissolution of the particles. This technique of inducing porosity and PEC 
formation holds promise for improving matrix resilience and extending drug release as the 
matrix undergoes hydration. Such PECs between chitosan and polymethacrylate copolymers 
are possible and have been previously confirmed where polymethacrylates, in solubilised 
solution form, were used as surface coating agents for pH-controlled release of entrapped 
drugs (Lorenzo-Lamosa et al., 1998; Moustafine et al., 2008; Hamman, 2010). A PEC was 
inadvertently formed at the PMMA film-chitosan bead interface upon coating, however the 
primary use of the PMMA coating was for its gastro-protective and enteric drug-releasing 
properties. To our knowledge, this is the first report of in situ polyelectrolyte synthesis in 
addition to in situ porogen leaching. The anti-inflammatory drug, indomethacin, is a BCS 
Class II drug with good permeability and poor aqueous dissolution that limits its 
bioavailability (Obitte et al., 2014). Transition changes of indomethacin from crystalline to 
amorphous states within the loaded chitospheres may potentially improve its solubility and 
hence enhance bioavailability (Yuksel et al., 2011; Priemel et al., 2013). Such changes 
induced within the chitospheres by addition of PMMA and its pH-responsive dissolution may 
significantly prolong drug release. 
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The aim of this study was to determine the mechanistic interactions of PMMA as pristine 
particles with chitospheres and evaluate its modulating ability to prolong drug release in 
comparison to conventional chitosan spheres. This work involved the preparation of the 
chitospheres via inotropic gelation in order to investigate the shift in drug release profiles 
induced by the incorporation of PMMA pristine particles in varying ratios. Analysis of the 
drug release profiles using non-linear kinetic modelling and the corroboration thereof with 
further characterisation such as SEM imaging, textural profiling, swelling and erosion studies 
were undertaken in order to determine the mechanisms governing drug release from the 
modified chitospheres. 
  
3.2. Materials and Methods 
3.2.1. Materials 
Chitosan (Poly D-glucosamine, deacetylated chitin, medium molecular weight), indomethacin 
(>99% TLC), sodium tripolyphosphate (technical grade, 85%) and dialysis tubing cellulose 
membrane (molecular weight cut-off = 14 000Da) were purchased from Sigma Aldrich Co 
(St. Louis, MO, USA). Eudragit S100 was purchased from Evonik (Midrand, Johannesburg, 
South Africa) and was used without further modifications as the pristine PMMA particles. 
Acetic acid glacial (98.5%) and ethanol (99% absolute) were purchased from AceChem 
(Johannesburg, Gauteng, South Africa) and LabChem (Edenvale, Gauteng, South Africa) 
respectively. Milipore water was used for all the preparations. 
 
3.2.2. Synthesis of chitospheres 
Chitospheres were prepared by the conventional method of ionotropic gelation, adapted 
from Bodmeier, et al. (1989) and Shu and Zhu, (2000), using STPP as the ionic crosslinking 
agent. A 2%w/v chitosan solution was prepared by dissolving chitosan in 1M acetic acid at 
room temperature until homogenous. The model drug, indomethacin (1%w/v) was dissolved 
in pure ethanol and added to the chitosan solution. After evaporation of ethanol, PMMA (as 
the pristine PMMA nanoparticles), was added to the chitosan-indomethacin solutions in the 
following ratios of chitosan to pristine PMMA particles: 2:1, 1:1 and 1:2 (Table 3.1). This 
produced a homogenous distribution of drug throughout the polymer solution.  
Multiparticulates from a chitosan-indomethacin solution were prepared without the addition 
of pristine PMMA particles as a control formulation. The indomethacin loaded chitosan-
PMMA particle suspensions were then dropped through a 21 gauge hypodermic needle at a 
flowrate of 0.4mL/min into STPP crosslinking solutions of 1%, 2% and 3% w/v to form 
chitospheres. The chitospheres were left to cure in the crosslinking solutions for 30 minutes 
(Mi et al., 1999; Shu and Zhu, 2000 and 2002) before being separated, washed and 
collected. The chitospheres were washed with 1M acetic acid to remove excess drug and 
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any uncrosslinked chitosan from the surface. The chitospheres were then dried at 50˚C for 
48 hours and stored in a desiccator before further physicomechanical characterization and 
drug-release profiling.  
 
Table 3.1: List of chitospheres prepared with different concentration ratios of chitosan and 
PMMA. 
 
 
 
 
 
 
 
 
 
 
 
3.2.3. Characterization of chitospheres 
3.2.3.1. Evaluation of size, surface morphology and pore formation 
The chitosphere size was assessed using a digital Vernier calliper (Krafft, DV150GW, 
Schoellerstr Düren, Germany). The mean diameter was measured on multiple chitospheres 
(n=12). Diameter measurements were taken at four different angles of individual 
chitospheres. Measurement of height, for irregularly shaped or flat-based chitospheres, was 
taken for the calculation of volume. For the evaluation of the surface morphology, dry 
chitospheres were fixed to aluminium stubs using double-sided adhesive carbon tape and 
then sputter coated with gold-palladium for 40 seconds using an EPI sputter coater (SPI 
Module TM sputter-coater and control unit, West Chester, PA, USA). Samples were viewed 
using a FEI Quanta 400 FEG-SEM scanning electron microscope (FEI, Hillsboro, OR, USA) 
and images were taken of the chitosphere surface and microstructure. 
 
3.2.3.2. Porositometric characterization of chitospheres 
The surface area and pore size of hydrated chitospheres were evaluated using a 
Porositometric Analyzer (Micromeritics ASAP 2020, Norcross, GA, USA). After 24 hours 
exposure to dissolution medium of pH 7.4, hydrated chitosphere samples of 100mg were 
frozen at -85˚C and lyophilized (Freezone 12, Labcono, Kansas City, USA) before degassing 
samples for elimination of residual moisture and contaminants. A glass filler rod inserted into 
the sample tube reduced the total free space volume in the tube thus hastening the 
STPP crosslinking Chitosan : pristine PMMA particles ratio w/w 
1% Control (chitosan only) 
2:1 
1:1 
1:2 
2% Control 
2:1 
1:1 
1:2 
3% Control 
2:1 
1:1 
1:2 
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degassing stage involving an evacuation and heating phase. Thereafter, the sample tube 
was transferred to the analysis port for determination of surface area, pore size and pore 
volume in accordance with the BET and BJH models. An evacuation rate of 50.0mmHg/s 
with a temperature ramp rate of 10˚C/min, target temperature of 40˚C and a hold 
temperature of 30˚C for 900min was used. The BET linear equation (Equation 3.1) was used 
to determine the monolayer capacity. 
 
p/na(p0-p) = 1/nam ˟ C + (C – 1)p/nam ˟ Cp0                                                            Equation 3.1 
 
Where, na refers to the quantity of N2 adsorbed at the relative pressure p/p0, nam was the 
monolayer capacity and C was exponentially related to the enthalpy of adsorption in the first 
adsorbed layer. 
 
Using the molecular cross-sectional value am, the surface area was determined from the 
monolayer capacity employing Equations 3.2 and 3.3. 
 
As(BET) = nam ˟ L ˟ am                                                                                           Equation 3.2 
as(BET) = As(BET)/m                                                                                            Equation 3.3 
 
Where As(BET) and as(BET) are the total and specific surface areas, respectively, of the 
adsorbent of mass m and L is the Avogadro constant. 
 
3.2.3.3. Swelling and matrix erosion determination 
Swelling and degradation studies were performed simultaneously. Samples of 50mg drug-
free chitospheres were placed in a cellulose dialysis membrane and immersed in 100ml of 
PBS pH 7.4 in an orbital shaking incubator (LM-530-2, MRC Laboratory Instruments Ltd., 
Hahistadrut, Holon, Israel) maintained at 37˚C and set at 50rpm for sample agitation. 
Samples were removed at predetermined time intervals and chitosphere size and mass were 
measured for the determination of change in volume and swelling ratio, respectively, lightly 
blotted with tissue paper to remove excess water. The wet chitospheres were then left to air-
dry for 72 hours to ensure complete removal of residual moisture before being weighed to 
determine the eroded mass. 
 
3.2.3.4. Determination of drug entrapment efficiency 
For the determination of indomethacin entrapment, drug-loaded chitospheres prepared from 
2ml aliquots of the polymer-drug solution (n=3) were ground into a fine powder and 
dispersed in 50mL of PBS pH 7.4 for 72 hours under agitation to allow complete dissolution 
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of the drug. Thereafter 5mL samples were removed, filtered through a 0.22µm filter and 
assayed for drug content using UV-spectroscopy (Implen NanoPhotometer, Implen GbmH, 
München, Germany) at a wavelength of 319nm. For additional validation of drug entrapment 
efficiency (DEE), drug loss resulting from leaching processes while curing of chitospheres in 
the crosslinking solution was determined using UV-spectroscopy by measuring the 
absorbance of the STPP medium samples at 319nm after formation of the chitospheres. The 
%DEE was calculated from the actual and theoretical drug loading of the chitospheres. All 
tests were performed and analysed in triplicate. 
 
3.2.3.5. Determination of molecular vibrational transitions and analysis of PEC 
formation 
Samples of chitospheres (both drug-loaded and drug-free) from each formulation (listed in 
Table 3.1) were analysed for the degree of crosslinking and interactions between the native 
polymers (chitosan and PMMA) for PEC formation. Samples were analysed over an FTIR 
spectra of wavelength between 4000-600cm-1 using a PerkinElmer Spectrum 2000 ATR-
FTIR (PerkinElmer 100, Llantrisant, Wales, UK) spectrometer fitted with a single-reflection 
diamond MIRTGS detector. 
 
3.2.3.6. Determination of thermophysical properties of the chitospheres and native 
polymers 
The thermodynamic properties of the chitospheres were determined using a Temperature 
Modulated Differential Scanning Calorimeter (TMDSC) (Mettler Toledo, DSC, 
STAReSystem, Swchwerzenback, ZH, Switzerland). Powdered chitospheres samples of 
15mg were sealed in aluminium crucibles and heated over a temperature range between 25-
300˚C at a heating rate of 10˚C/min. TMDSC curves were plotted as sample size against 
temperature and the integral value, onset and endset of melting was determined. The 
determination of change in sample weight as a function of temperature was performed using 
a Thermogravimetric analyser (TGA) (PerkinElmer, TGA 4000, Llantrisant, Wales, UK). 
Samples were heated at a rate of 10˚C/min from 0-900˚C under continuous nitrogen purging. 
Thermograms were generated as percentage weight vs. temperature and analysed using 
Pyris TM software (PerkinElmer, Llantrisant, Wales, UK). 
 
3.2.3.7. Textural profiling to determine physicomechanical properties of chitospheres 
Textural analysis characterization using a Texture Analyser (TAXT.plus StableMicrosystems, 
Surrey, UK) was undertaken on hydrated chitospheres. The Matrix Resilience (MR), 
Deformability Modulus (DF) and Fracture Energy (FE) were determined. MR (N.sec) was 
determined by the ratio of the areas under the compression and decompression curves 
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generated by Force-Time textural profiles. This represented the ability of the chitospheres to 
recover to its original form after application of an external deforming stress. The Area under 
the Curve (AUC) from a Force-Distance textural profile allowed the determination of the FE 
(N.m) which is the energy required to rupture a hydrated swollen chitospheres. The DM 
(N/mm) is an indication of the chitosphere matrix hardness and was computed from the 
gradient of the Force-Distance profile from zero to the point of peak force.  The textural 
analysis parameters utilized include a pre-test and post-test speed of 1.00mm/sec, a test 
speed of 0.5mm/sec, a trigger force of 0.5N and a load cell of 5kg. The target mode was set 
to 50% strain for MR and force for DF and FE. 
 
3.2.3.8. In vitro drug release studies on chitosphere formulations and kinetic 
modelling of release data 
In vitro release studies were performed using chitospheres prepared from 2mL samples of 
the chitosan-pristine PMMA particle suspension so that each sample had approximately 
20mg of indomethacin. The average mass of chitospheres prepared from a 2mL sample is 
listed in Table 3.2. After drying at 50˚C the chitospheres were placed into jars containing 
100mL PBS of pH 7.4 (n=3). Samples were kept in an orbital shaking incubator maintained 
at 37˚C and set at 50rpm for sample agitation. At predetermined time intervals 5mL of 
release medium were sampled and replaced with a fresh, equal volume of release medium 
to maintain sink conditions. Samples were filtered using 0.22μm PVDF syringe filters and 
analysed for the drug quantity by UV absorbance at wavelength 319nm. To gain further 
insight into the drug-release mechanisms, the drug-release profiles were kinetically modelled 
using the models listed in Table 3.3. Furthermore, the difference and similarity between the 
various dissolution profiles of the chitospheres and that of the Control were determined using 
fit factors of F1 as the difference factor and F2 as the similarity factor using Equations 3.4 
and 3.5, respectively (Yuksel et al., 2000; Shah and Deshpande, 2014).  
 
F1 = [( ∑nt=1(Rt - Tt)/ (∑nt=1Rt)] x 100             Equation 3.4 
 
F2 = 50 x log [( 1 + (1 + (1/n) ∑nt=1(Rt - Tt) 2)-0.5 x 100]             Equation 3.5 
 
Where Rt and Tt refers to the percentage of drug released at time t of the control and the 
test formulations, respectively, and n indicates the number of sampling points. 
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Table 3.2: The average mass of chitospheres containing approximately 20mg of 
indomethacin (n=3). 
Formulation Average Weight (mg) 
Control (No pristine particles) 1% STPP 101.30 ±0.294 
Control (No pristine particles) 2% STPP 139.60 ±0.989 
Control (No pristine particles) 3% STPP 
 
139.97 ±0.188 
2:1 1% STPP 115.50 ±0.081 
2:1 2% STPP 132.73 ±0.205 
2:1 3% STPP 
 
158.90 ±1.358 
1:1 1% STPP 127.46 ±0.047 
1:1 2% STPP 141.8 ± 0.489 
1:1 3% STPP 
 
189.76 ±1.681 
1:2 1% STPP 159.53 ±0.094 
1:2 2% STPP 174.27 ±0.531 
1:2 3% STPP 228.97 ±1.114 
 
Table 3.3: Models and parameters utilized for kinetic modelling of release data. 
Model Name Parameters Significance Reference 
    
Zero-order 
C = K0t 
K0 = zero-order 
rate constant 
t = time 
 
Describes drug 
dissolution from 
dosage forms that 
do not disintegrate 
but release drug 
slowly 
 
Dash et al., 
2010 
First-order 
LogC = LogC0 – kt/2.303 
C0 = initial 
concentration of 
drug 
K = first-order 
constant 
Describes drug 
dissolution from 
porous matrices 
Dash et al., 
2010 
    
Higuchi 
Q = Kt1/2 
Q = % drug 
release 
K = design 
variable of the 
system 
t = time 
 
Describes drug 
release occurring 
via diffusion in one 
dimension 
Dash et al., 
2010 
Singhvi and 
Singh, 2011 
Hixson-Crowell 
Q01/3 – Qt1/3 = KHCt 
Q0 = initial 
amount of 
drug loaded 
Qt = amount 
of drug 
released in 
time t 
KHC = rate 
constant 
t = time 
 
 
Describes drug 
release from matrix 
systems undergoing 
a change in surface 
area and diameter 
Dash et al., 
2010 
Singhvi and 
Singh, 2011 
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Korsmeyer-
Peppas 
Mt / M ͚ = Ktn 
Mt / M ͚ = 
fractional drug 
release at 
time t 
K = rate 
constant 
t = time 
n = release 
exponent 
 
Employed to find the 
mechanism of drug 
release by 
calculating the value 
of n. If n < 0.45 it 
corresponds to 
Fickian diffusion, 
0.45 < n < 0.89 to 
non-Fickian 
anomalous transport, 
n = 0.89 to Case II 
transport and n > 
0.89 to Super case II 
transport 
Dash et al., 
2010 
Singhvi and 
Singh, 2011 
 
3.3. Results 
3.3.1. Analysis of volume, surface morphology, erosion and pore formation as per 
SEM imaging 
It was noted that chitospheres made from chitosan alone had a more flattened morphology 
and were lower in volume compared to the chitospheres made from the formulations 
containing increased polymer mass contributed by the addition of the PMMA pristine 
polymer particles. Furthermore, increase in concentration of the STPP crosslinking solution 
produced chitospheres more spherical in shape and with larger volumes (Figure 3.1). The 
equation used to calculate the volume of the chitospheres was that of a sphere cap due to its 
shape. Chitospheres were not completely spherical but rather had a small flattened base 
due to the drying process while resting on the base of a dish as seen in Figure 3.2. Thus, the 
equation employed offered a more accurate determination of the chitospheres volume. 
Chitospheres rounder in shape had a height closer to the value of its diameter, hence, 
having a larger volume capacity compared to those with a flattened base.  
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Figure 3.1: Depiction of the comparison of volume across the different formulations used to 
fabricate PMMA-loaded chitospheres (n=12). 
 
The difference in volume between chitospheres containing PMMA particles and the Controls 
may be possibly due to the formation of larger droplets at the end of the needle as a result of 
increased viscosity of the chitosan/PMMA suspension imparted by the addition of a large 
volume of powdered particles also increasing the total polymer mass content dispensed in 
each droplet (Kulkarni et al., 2011). The surface morphology of the Control chitospheres 
were found to be fairly smooth in comparison to those containing pristine PMMA particles 
with slight folds occurring around the middle of the chitosphere surface whereas closer 
inspection of the surface of PMMA-containing chitospheres revealed a rough surface where 
the presence of PMMA particles is clearly noted on the chitosphere surface. SEM images of 
the degraded chitospheres samples were taken at 1, 2 and 5 days after exposure to PBS. 
Chitospheres containing pristine PMMA particles maintained their spherical shape and most 
of the structural integrity compared to the Control samples which appeared cracked and 
fragmented and the 2:1 chitospheres samples, which underwent a slight change in shape. 
This may suggest that not only does the addition of pristine PMMA particles enhance the 
mechanical strength of the chitospheres but a polyelectrolyte complex (PEC) may be formed 
upon hydration between the cationic chitosan and anionic PMMA producing chitospheres 
that are robust in their structural shape. An array of pores is evident on the surface of 
chitospheres containing larger quantities of pristine PMMA particles, namely the 1:1 and the 
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1:2 chitospheres. These pores are probably formed from the dissolution and leaching out of 
the intercalated pristine PMMA particles; as such pore structures cannot be identified on the 
chitosan-only chitospheres. Furthermore, it is noted that the 2:1 chitospheres and, upon 
closer inspection, the 1:1 and 1:2 chitospheres underwent a process of detachment of the 
outermost layer. This suggests the occurrence of initial surface erosion whereas the Control 
chitospheres, which does not exhibit this trait of surface flaking, may degrade by bulk 
degradation of the matrix (Zhang et al., 2002). 
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Figure 3.2: SEM images depicting the surface morphology of the 2%w/v STPP crosslinked 
chitospheres and their appearance at Days 1, 2 and 5 after degradation studies (n=3). 
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3.3.2. Porositometric analysis of chitospheres post hydration 
Porositometric analysis of chitospheres hydrated in pH 7.4 dissolution medium revealed the 
differences in surface area, pore size and pore volume when chitospheres are prepared with 
varying concentrations of PMMA particles. The results listed in Table 3.4 show that the 
Controls (PMMA-particle free matrices) exhibited a high surface area but a smaller pore size 
and cumulative pore surface area compared to the chitospheres. The 1:1 chitospheres 
contained the largest pores and smallest surface area. Increasing the PMMA-particle content 
decreases the total surface area and increases pore size in terms of pore width, diameter 
and volume. The pore size and volume reflects the cumulative surface area of pores on the 
sample where pores larger in diameter and depth contribute to a larger pore surface area but 
smaller BET total surface area.  However, further increase in PMMA-particle concentration 
(1:2 chitospheres) relative to chitosan results in a slight decline in pore size with a BET 
surface area similar to that of the 2:1 chitospheres. The lower BET surface areas of the 
chitospheres compared to that of the Controls, despite formation of pores, may further 
suggest that pore formation occurs only on the surface of sphere (as visualised by SEM) and 
not throughout the entire sphere which would  result in an apparent increase in the total 
surface area of the sample. Although exhibiting a lack of pores, the significantly larger 
surface area of the Control multiparticulates, 25.5898m2/g, may be contributed by the 
formation of cracks on the surface as imaged by SEM in Figure 3.2. The technique of 
nitrogen gas adsorption over a range of relative pressures for the determination of pore 
characteristics produce adsorption isotherms (Figure 3.3) which provide insightful 
information regarding the pore size distribution in terms of pore width categorised as micro- 
(<2nm), meso- (2-50nm) and macropore (>50nm) ranges (Sing et al., 1985; Groen et al., 
2003). According to this classification, the pore size distribution of the chitospheres lies 
within the mesopore range. The control matrices and the 2:1 chitospheres presented a Type 
II isotherm with a H2 hysteresis loop indicating an unrestricted monolayer-multilayer 
adsorption of a nonporous adsorbent. The 1:1 and 1:2 chitospheres exhibit a Type IV 
isotherm, indicating existence of a multilayer material, with a H3 hysteresis loop suggestive 
of complete pore filling including capillary condensation which occurs in the presence of 
mesopores (Sing et al., 1985; Groen et al., 2003). The presence of a H2 and H3 hysteresis 
loop denotes an interconnected pore system of random distribution within the chitosphere 
matrix (Groen et al., 2003). The initiation of the shift from a Type II isotherm and H2 
hysteresis towards a Type IV isotherm and H3 hysteresis can be seen in Figure 3.3b, 
corresponding to the isotherm generated for the 2:1 chitospheres where the PMMA particles, 
in the lowest concentration, are introduced. 
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Table 3.4: Porosity analysis of chitospheres after hydration in PBS pH 7.4 for 24 hours. 
Porositometric parameters Control 2:1 1:1 1:2 
Surface area     
Single point surface area (m²/g)    4.3590 8.7846 7.0496 11.3063 
BET surface area (m²/g)    25.5898 12.6663 7.5959 12.4776 
BJH Adsorption cumulative surface area of 
pores between 17.000 Å and 3000.000 Å 
diameter (m²/g) 
8.5990 10.940 7.572 14.690 
BJH Desorption cumulative surface area of 
pores between 17.000 Å and 3000.000 Å 
diameter (m²/g) 
57.6271 25.3956 10.3718 16.1719 
     
Pore volume     
Single point adsorption total pore volume 
(cm³/g)   
0.0192 0.0194 0.0278 0.0451 
BJH Adsorption cumulative volume of 
pores                       
between 17.000 Å and 3000.000 Å diameter 
(cm³/g)   
0.0285 0.0524 0.0549 0.0883 
BJH Desorption cumulative volume of 
pores                      between 17.000 Å and 
3000.000 Å diameter (cm³/g)   
0.0591 0.0526 0.0547 0.0879 
     
Pore size     
Adsorption average pore width (4V/A by 
BET) (nm) 
2.9945 6.1330 14.6279 14.4678 
BJH Adsorption average pore diameter 
(4V/A) (nm) 
13.2699 19.1567 28.9953 24.0334 
BJH Desorption average pore diameter 
(4V/A) (nm) 
4.0991 8.2890 21.1114 21.7308 
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Figure 3.3: Isotherm linear plots of the 2%w/v STPP crosslinked chitosphere STPP 
formulations a) Control b) 2:1 c) 1:1 d) 1:2 (n=1). 
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3.3.3. Determination of drug entrapment and drug loss 
The concentration of the STPP crosslinking solution had insignificant effects (p<0.05) on the 
drug loss and drug entrapment efficiency (DEE). The quantity of drug lost during the 
crosslinking curing period and that entrapped within the chitospheres were very similar 
across the varying crosslinking concentrations. Generally, it was noted that increasing the 
quantity of pristine PMMA particles slightly enhanced DEE by minimising the percentage of 
drug lost into the crosslinking solution during the curing process (Table 3.5). Being prepared 
from a more viscous polymer suspension, the pristine PMMA particles may prevent the 
diffusion of drug molecules out of the chitospheres. Drug loss may be attributed to leaching 
of indomethacin out of the chitospheres and into the surrounding solution by a passive 
diffusion process across a high-to-low concentration gradient. However, the percentage of 
indomethacin retained within the chitospheres was relatively high for all chitospheres ranging 
from 97-99%. 
 
Table 3.5: Drug loss and %DEE for the various formulations of indomethacin-loaded 
chitospheres (n=6). 
 
Chitosan:PMMA Formulation Ratio % DEE 
Control (No pristine PMMA particles) 97.75 ±0.028 
2:1 98.10 ±0.0307 
1:1 98.61 ±0.026 
1:2 98.74 ±0.041 
 
 
3.3.4. Analysis of PEC formation within PMMA-loaded chitospheres upon hydration in 
PBS pH 7.4 
FTIR spectra of 24-hour hydrated chitosan-only multiparticulates and chitospheres were 
obtained to determine the molecular composition and crosslinking degree of the 
chitospheres as shown Figure 3.4. Crosslinking is evident from the  P=O vibrations occurring 
at 1150cm-1 as this indicates the  quantity of bound STPP ions which form interchain links 
between the –NH3+ protonated groups of chitosan (Mi et al., 1999). The molecular integrity of 
the native polymer compounds, chitosan and PMMA (Eudragit® S100), can be discerned in 
the FTIR spectra of the PMMA-loaded chitospheres. Chitosan maintains its OH stretching at 
3200cm-1 and the peak at 1630cm-1 is indicative of its amino ( ̶ NH2) bending vibration. The 
presence of PMMA is indicated by the C=O vibrations of the esterified carboxyl groups 
characterised by the strong peaks at 1700cm-1. The broad peak of chitosan at 3600cm-1 and 
the peak representing the amine bending at 1630cm-1 are evident in all of the formulations 
however with increase in the concentration of PMMA the intensity of these peaks decrease. 
On the contrary, the carboxylic acid peak of PMMA at 1700cm-1 is strongly detected in 
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formulations 1:1 and 1:2, as those chitospheres contained the highest quantity of pristine 
PMMA particles, whereas the signal produced in the 2:1 formulation was very weak but 
evident. Chitospheres containing pristine PMMA particles showed the appearance of a new 
peak at 1540cm-1. This is peak is not evident in the Control formulation; however, it 
increases in intensity as the concentration of pristine PMMA particles increase indicating 
increased formation of this particular bond representing PEC.  
 
Figure 3.4: Spectra showing the FTIR analysis of the various chitospheres formulations, 
after 24 hours of hydration in PBS pH 7.4, categorised according to the %w/v of STPP used. 
 
 
3.3.5. Changes in thermodynamic properties upon PMMA addition to chitospheres 
The DSC curves (Figure 3.5) show that chitospheres cured in stronger STPP solutions 
required more heat to initiate melting. The melting points of the chitospheres increased when 
a 2:1 ratio of chitosan:PMMA was used. However, a further increase in the PMMA 
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concentration caused a decrease in the melting points with the exception of chitospheres 
prepared in a 1% w/v STPP solution. PMMA (Eudragit® S100) has a melting point of 200˚C 
whereas chitosan exhibits the onset of melting at about 270˚C corresponding to values 
reported in literature (Ruiz-Caro and Veiga-Ochchoa, 2009; Ramachandra and 
Nandhakumar, 2011). When the concentration of PMMA exceeds that of chitosan, the onset 
of melting decreases since PMMA is abundantly present in the chitosphere matrix. 
Regardless of the concentration of STPP used, 1:2 chitospheres exhibited similar melting 
points.  
 
 
Figure 3.5: Profile depicting the influence of pristine PMMA particles concentration on the 
melting point of the chitospheres (n=2). 
 
The TGA thermograms showed the degradation of chitospheres in 3 steps, whereas the 
degradation of the Control multiparticulates occurred in 2 steps. Between 264.45˚C and 
900˚C chitosan exhibited a decrease in weight from 11.02% to 90% with 10% of the weight 
remaining at 900˚C. The degradation of PMMA started at 284˚C where 94.035% of the 
sample remained but this quickly declined to 7.984% at 448.08˚C, and at 540˚C complete 
degradation took place. The first step in the thermal degradation of the chitospheres, ranging 
from 100-190˚C, was probably due to the loss of residual water as only a 2% loss in weight 
was observed. The second stage of degradation was noted in the temperature range of 266-
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380˚C where 30-40% weight loss was noted. This may be due to the decomposition of 
chitosan in the matrix, whereas a combination of chitosan and PMMA decomposition may 
have occurred in matrices comprising pristine PMMA particles. The final stage of 
degradation occurring after 450˚C pertains only to the pristine particle-loaded chitospheres 
and demonstrates a further weight loss of 50-60% of the initial weight. This most likely 
indicated the decomposition of PMMA particles as a decrease in weight was particularly 
noted in samples containing higher ratios of pristine PMMA particles to chitosan. At each 
thermal degradation stage outlined, an increase in STPP crosslinker enhanced the thermal 
stability of the chitospheres. This can be seen in Figure 3.6, which shows the % weight 
remaining at 900˚C, signifying the end of the run. The chitosan-only multiparticulates 
demonstrated the least loss in weight denoting that it has a higher thermal stability compared 
to those chitospheres containing pristine PMMA particles which apparently weaken the 
matrices’ thermal stability and accelerates its heat degradation.   
 
Figure 3.6: Graphic representation of the % weight remaining after thermal degradation of 
the various chitosphere formulations and Controls at a temperature of 900˚C.  
 
The decline in the properties of thermal stability corresponds to the data obtained from DSC 
studies which show decreased melting points of chitosan matrices containing a higher 
PMMA content. Similarly, as noted in both TGA and DSC, the amount of crosslinker 
influences the thermal stability via its effects in the degree of the matrix density and the 
strength of the polymer inter-chain linkages formed between the polymer and crosslinking 
ions. Chitospheres containing high ratios of pristine polymer particles have lower thermal 
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stability as the native PMMA polymer itself is easily melted in addition to the insufficient ionic 
linkages between the crosslinker and chitosan and the absence of such bonds between the 
crosslinker and pristine PMMA particles. 
 
3.3.6. Gravimetric water-uptake and matrix erosion of PMMA-loaded chitospheres 
Determining the degree of hydration and swelling is essential for understanding the transport 
of drug molecules through the polymer matrix. Likewise, studying the pattern of erosion is 
important in determining the drug release mechanisms since the release of entrapped drug 
from a polymer matrix often occurs via more than one mechanism (Varma et al., 2004). 
Factors such as water-uptake, swelling and erosion play a role in influencing the diffusion, 
cleavage and ultimate release of the drug molecule from within the polymer chains to the 
surrounding dissolution media (Varma et al., 2004; Alexis, 2005). In addition to this, swelling 
and erosion studies provide insight into the effect of the different pristine PMMA particle 
concentrations on crosslinking density and drug release.  
 
Analysis of the % Swelling Ratio (%SR) and % Volume Ratio (%VR) showed that increasing 
the concentration of pristine PMMA particles within the chitosan matrices resulted in 
decreased water-uptake and hence less changes in the volume of the chitospheres with the 
exception of formulation 2:1. Chitospheres formulated with a 2:1 ratio of chitosan:PMMA 
particles showed the highest degree of swelling, which exceeded the swelling propensity of 
the Control when crosslinked in a 1%w/v solution of STPP (Figure 3.7a-c). As the percentage 
of the crosslinking solution increased to 3%w/v the swelling ratio of formulation 2:1 
approached similar values to that of the control formulation. Formulation 1:2 exhibited the 
least swelling and change in volume. The change in volume indicated by %VR showed that 
the Control and 2:1 chitospheres exhibited swelling to such an extent that the %VR was 4.5 
and 4.8 times higher than that of the 1:2 chitospheres, respectively. 
 
On the contrary, degradation data showed a somewhat reversed trend compared to the 
observations noted in the swelling studies (Figure 3.7d-f). Regardless of the strength of 
STPP crosslinker used, the Control multiparticulates degraded the fastest over the 30-day 
study period. Chitospheres containing the highest PMMA particle content degraded faster 
than those made from a lower PMMA particle concentration. Chitospheres made from a 2:1 
suspension of chitosan:PMMA pristine particles underwent the least loss of bulk mass, 
however, when a 3%w/v crosslinking solution is utilized the 1:1 formulation exhibited the 
slowest and steadiest degradation pattern. The 2:1 formulation degraded the least, hence, 
suggesting that increasing pristine PMMA particle concentration hastens the degradation 
rate of the matrix. Increasing the pristine particles concentration suggests an increase in the 
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number of pores created by the pH-responsive dissolution of PMMA out of the chitosan 
matrix in a time-dependent manner. Chitospheres with a higher PMMA content were 
observed to undergo a substantial loss of mass as compared to the matrices without PMMA 
particles. This may be due to the pristine polymer particles, which form the bulk of the 
chitospheres weight, dissolving and leaching out of the chitosan matrix upon exposure to 
PBS of pH 7.4 which leaves behind an array of porous microenvironments along the surface 
of the polymer matrix remnants. Furthermore, such chitospheres presented with reduced 
swelling as there was less chitosan content for the absorption of water into its 
polysaccharide chains. Figure 3.8 depicts the concentration of pristine PMMA particles and 
its effect on the number of pores created. However, as mentioned elsewhere in this 
investigation, the formation of pores is possibly a surface phenomenon only as seen in the 
SEM images of the degradation samples in Figure 3.2. During the first 2 days the mass loss 
of the chitospheres were less for the 1:1 and the 1:2 chitospheres, but as the penetration of 
water proceeded, these chitospheres underwent a rapid incline in degradation. 
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Figure 3.7: Profiles depicting % SR (a-c) a) 1% w/v STPP  b) 2% w/v STPP c) 3% w/v STPP 
and % degradation (d-f) d) 1% w/v STPP e) 2% w/v STPP f) 3% w/v STPP of the different  
chitosphere formulations according to crosslinking percentage (n=3). 
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Figure 3.8: Representation of the effect of the concentration of pristine PMMA particles on 
the mass loss with regards to the quantity of chitosan left after PMMA particle dissolution. 
 
3.3.7. Elucidation of mechanical properties of chitospheres  
Textural analysis on chitospheres exposed to PBS provides insight into understanding the 
mechanism of swelling, degradation and drug release. Upon absorption of water, the 
chitosan matrices undergo various changes in mechanical properties depending on the 
concentration of crosslinker used and the total content of PMMA particles dispersed 
throughout the matrix. The penetration of water into the chitospheres matrix initiates 
disentanglement of the chitosan polysaccharide chains resulting in polymer relaxation. 
Polymer disentanglement and chain relaxation allows the further influx of water into the core 
of the matrix. The movement of water in and out of the matrix allows the dissolution of the 
pristine PMMA particles thus creating a series of pore structures via an in situ leaching out 
process. 
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MR refers to the ability of an object to recover to its original state after application of a force. 
It is also used as an indication of the presence of a porous matrix structure where the pores 
confer a sponge-like attribute to the matrix thereby allowing it easily return to its original 
shape. Porous matrix structures have a higher MR compared to less porous and more 
compact matrices. The term ‘compact’ refers to a densely packed matrix network where 
minimal spaces are left between the polymer chains. Densely packed matrices are often 
brittle in nature and generally display low MR and high deformability moduli (DF) (matrix 
rigidity and flexibility) as they tend to resist any applied mechanical stress as opposed to 
dissipating the energy throughout the matrix to undergo deformation as with pliable matrix 
systems (Singh, 2007; Bawa et al., 2011). 
 
The MR and DF values, as represented in Figure 3.9, show that as the concentration of 
pristine PMMA particles increase it produces chitospheres of higher MR and lower DF. This 
shows that matrices containing pristine PMMA particles are more resilient due to the 
formation of a porous matrix network hence its ability to recover after application of stress 
and undergo plastic deformation indicated by the low DF values. This increase in MR due to 
pore formation is validated by the SEM imaging and the porositometric analysis. 
Chitospheres containing more PMMA particles presented with larger pores of a greater 
cumulative pore surface area and improved MR. Such a matrix, being more flexible, is able 
to absorb energy to undergo deformation and hence require more energy to rupture the 
chitospheres as opposed to compact less resilient matrices which resists the force applied 
until it breaks as indicated by the fracture energy (FE). FE was obtained as the amount of 
work done to initiate fracture of an object when a compressive stress is applied (Tanaka et 
al., 2005). The chitosan-only matrices exhibiting low a MR and high DF suggest that these 
multiparticulates are brittle. The FE, equating to the amount of energy in Joules required to 
rupture a hydrated chitosphere, showed that the 1:1 chitospheres displayed superior 
strength however a trend was noted where an increase in PMMA content improved FE with 
such chitospheres requiring more energy than the Controls to rupture the matrix. FE 
decreases as the chitosphere matrix undergoes degradation over time. 
 
Initially, during the first 2-5 days, the Controls and 2:1 chitospheres exhibited the highest MR 
compared to the 1:1 and 1:2 chitospheres, however, upon further exposure to PBS MR 
rapidly increases whereas that of the Control and 2:1 chitospheres gradually decreases. This 
increase in MR corresponds to the proposed theory of pristine PMMA particles leaching 
resulting in the formation of pores which enhance the resilience of the chitospheres matrix. 
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Figure 3.9: Textural analysis profiles featuring the %MR (a-c), DF (d-f) and FE (g-i) of the 
respective chitosphere formulations (n=3). 
 
3.3.8. The influence of PMMA pristine particles on in vitro drug release studies 
The different chitospheres formulations were able to provide complete and sustained release 
of indomethacin in a linear manner. From the release profiles depicted in Figure 3.10 it is 
evident that the addition of pristine PMMA particles to the chitospheres matrices were able to 
prolong the drug release rate where increase in pristine PMMA particles concentration lead 
to a reduction in the rate of drug release. The Control matrices, formulated from only 
chitosan, provided release up till only 72 hours whereas chitospheres containing pristine 
PMMA particles exhibited release profiles extending over 144 hours where the former was 
observed for chitospheres crosslinked in a 2%w/v STPP solution. Although increase in the 
concentration of crosslinking solution used demonstrated a decrease in the release rates, 
the difference in this reduction was very little as the plotted drug release curves were often 
superimposable. Burst release has been defined as the immediate and large release of drug 
molecules from a delivery system within 24 hours of exposure to dissolution medium (Huang 
and Brazel, 2001).  Significant burst release was not noted during the first sampling point 
however, after 24 hours, chitospheres released less drug compared to the Control 
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formulation which released between 55-64% of the incorporated drug within the first 24 
hours. As the concentration of PMMA increased the total amount of drug released at 24 
hours considerably decreased with the 2:1 chitospheres releasing 42-56%, the 1:1  
chitospheres releasing 31-40%, and the 1:2 chitospheres releasing only 25-39% of the total 
encapsulated drug. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 89 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10: Drug-release profiles of the various chitospheres formulations indicating the 
effect of pristine PMMA particles concentration on the drug-release rate a) 1% w/v STPP b) 
2% w/v STPP c) 3% w/v STPP (n=3). 
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Mathematical modelling of the release kinetics was performed using the zero-order, first-
order, Higuchi, Korsmeyer-Peppas and Hixson-Crowell models as described by Shoaib and 
co-workers (2006). From Table 3.6, it is seen that the drug-release profiles of the 
chitospheres can be described by a combination of 2 models. The best-fit of 2 models were 
used since the R2 values were of insignificant difference and hence could not be ignored. 
The Control followed the Hixson-Crowell and Korsmeyer-Peppas models, however, in the 
case of PMMA-loaded chitospheres the release profiles followed the Korsmeyer-Peppas and 
Higuchi models. Increase in the concentration of PMMA particles and the resultant increase 
of mesopore formation suggests the predominance of the Higuchi model in describing the 
release of drug. A review by Wang (2009) mentions that drug release from mesoporous 
materials is often described using the Higuchi relationship.  The release exponent obtained 
from the n-value of the Korsmeyer-Peppas model showed that majority of the chitospheres 
exhibited values greater than 0.89 which is indicative of super case II transport whereas 
those with n-values of 0.45-0.89 demonstrate non-Fickian release or anomalous transport 
(Dash et al., 2010; Singhvi and Singh, 2011). Both super case II and anomalous transport 
indicate that more than one mechanism is involved in the release of drug from the 
chitospheres which generally involves a combination of polymer chain erosion and diffusion 
of drug out of the matrix (Singh et al., 2012; Maity and Sa, 2014). Furthermore, F1 and F2 
values indicating the %difference and %similarity, respectively, between the Control 
formulations and the PMMA-containing chitospheres show that increasing the PMMA 
concentration produces a distinct variation in the dissolution profiles. The data in Table 3.7 
shows that when the PMMA concentration increases the F1 values increase and the F2 
values gradually decrease showing greater difference and less similarity between the two 
dissolution profiles. These values correspond to the deviation of the curves noted in the drug 
release profiles between the Controls and the chitosphere formulations with the 1:2 
dissolution curve lying furthest away from that of the Control. The 1:2 formulation prepared 
with 2%w/v STPP crosslinking showed the greatest %difference of 53.90% and the lowest 
%similarity of 57.86%. 
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Table 3.6: Kinetic modelling of indomethacin release from the Controls and PMMA-loaded chitospheres. 
Formulation Zero-Order First-Order Higuchi Korsmeyer-Peppas Hixson-Crowell First best-fit model 
Second 
best-fit 
model 
  r² k₀(h⁻¹) r² k₁(h⁻¹) r² kH(h⁻½) r² n  KKP(h⁻ⁿ) r² kHC(h⁻¹ˊ³)     
C 1% 0.9912 1.4884 0.9883 0.0652 0.9822 14.1440 0.9904 1.0497 2.7040 0.9979 -0.0643 Hixson-Crowell Zero-Order 
C 2% 0.9019 1.4645 0.9903 0.0636 0.9825 14.0190 0.9960 0.9671 3.4538 0.9971 -0.0632 Hixson-Crowell 
Korsmeyer-
Peppas 
C 3% 0.9335 1.4692 0.9784 0.0631 0.9856 13.8450 0.9956 0.9149 3.4269 0.9902 -0.0629 Korsmeyer-Peppas 
Hixson-
Crowell 
              
2-1 1% 0.9506 1.1458 0.9584 0.0486 0.9852 12.1470 0.9919 1.0740 1.6036 0.9851 -0.0471 Korsmeyer-Peppas Higuchi 
2-1 2% 0.9694 1.4266 0.9189 0.0573 0.9905 13.2250 0.9934 0.8927 3.0839 0.9527 -0.0590 Korsmeyer-Peppas Higuchi 
2-1 3% 0.9538 1.4328 0.9391 0.0583 0.9892 13.3820 0.9874 0.7860 4.1918 0.9664 -0.0597 Higuchi Korsmeyer-Peppas 
              
1-1 1% 0.9606 0.9145 0.9516 0.0362 0.9874 10.6690 0.9943 0.9988 1.4598 0.9760 -0.0358 Korsmeyer-Peppas Higuchi 
1-1 2% 0.9436 0.9095 0.9590 0.0371 0.9914 10.7280 0.9928 1.0127 1.5940 0.9835 -0.0362 Korsmeyer-Peppas Higuchi 
1-1 3% 0.9778 0.8329 0.8164 0.0295 0.9670 9.5269 0.9876 0.9794 1.1519 0.8693 -0.0309 Korsmeyer-Peppas Zero-Order 
              
1-2 1% 0.9455 0.7199 0.9352 0.0286 0.9971 9.2433 0.9708 0.9332 2.1548 0.9633 -0.0281 Higuchi Korsmeyer-Peppas 
1-2 2% 0.9755 0.6464 0.7910 0.0302 0.9862 8.7289 0.9908 0.8766 1.5150 0.9456 -0.0257 Korsmeyer-Peppas Higuchi 
1-2 3% 0.9608 0.7185 0.9125 0.0265 0.9977 9.1553 0.9931 0.8519 2.3211 0.9442 -0.0270 Higuchi Korsmeyer-Peppas 
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Table 3.7: The percentage difference (F1) and similarity (F2) factors for the various 
chitosphere formulations in comparison to the Controls. 
% Crosslinking Formulation F1 value (%) F2 value (%) 
1% 2:1 22.16 76.43 
1:1 35.86 66.94 
1:2 33.27 65.93 
    
2% 2:1 14.14 84.19 
1:1 31.95 69.69 
1:2 53.90 57,86 
    
3% 2:1 6.91 99.73 
1:1 45.71 62.71 
1:2 36.77 65.71 
 
3.4. Discussion 
The following section explains the mechanisms by which the pristine PMMA particles interact 
with chitosan leading to the observed effects on the swelling, erosion and drug release 
attributes of the chitosphere formulations. 
 
The spherically shaped chitosan matrices are proposed to undergo water penetration and 
hydration in concentric layers as depicted in Figure 3.11. Upon splitting slightly swelled 
chitospheres in half, a hydrated slightly opaque outer layer and an unhydrated solid core can 
be seen as water moves from the outside of the chitospheres inwards. This mechanism of 
hydration may be further evidenced by the fluctuating peaks noted in the texture analysis 
profiles of MR and DF (Figure 3.9).  Increases in MR may indicate the presence of the 
swollen peripheral layer of the chitospheres. As evidenced by SEM (Figure 3.2), after the 
outmost layer has reached its swelling capacity it ruptures and eventually sloughs off 
revealing the next solid drug-loaded layer to be hydrated via water-uptake hence, producing 
a decline in MR. Hydration of this fresh layer induces release of some of the drug molecules 
from the surface via diffusion (Maity and Sa, 2014). The sloughing of the previously hydrated 
layer suggests the mechanism by which erosion takes place. When the rate of penetration of 
water into the chitospheres matrix is less than the rate of mass loss of the chitospheres, 
surface erosion is considered to take place (Alexis, 2005; Yao et al., 2011).  
 
The surface erosion mechanism occurs particularly with chitospheres containing pristine 
PMMA particles whereas the chitosan-only multiparticulates may erode via bulk degradation 
since it displayed rapid loss of mass and increased swelling behaviour. The Control 
matrices, as visualised by SEM, had numerous cracks on its surface compared to 
chitospheres containing pristine PMMA particles. As indicated by the low MR and high DF 
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values these chitosan multiparticluates were brittle and depending on the depth of the 
cracks, water could easily penetrate the matrix hydrating the core and causing the sphere to 
rupture from within. Furthermore, cracks and chips on the sphere surface increase the 
surface area available for moisture hydration and as a result this allows the entry of large 
quantities of water and increases the escape of drug molecules via diffusion hence the rapid 
release of drug within 72 hours. Variation in drug release rates produced by changes in 
surface area is evidenced by the BET total surface areas where the Control with a surface 
area of 25.5898m2/g released drug faster than the chitospheres which featured smaller BET 
surface areas of 7.5959-12.6663m2/g and slower drug release rates. Although the 2:1 
chitospheres swelled the most and underwent the greatest change in volume compared to 
the Control, it was able to release drug slower than the Control due to its mechanism of 
surface erosion and the subsequent peeling of hydrated layers as noted in the SEM images 
pertaining to Day 2 of degradation samples.  
 
 
Figure 3.11: Schematic representing the hydration and erosion of chitospheres loaded with 
pristine PMMA particles occurring in concentric layers. 
 
Drug release occurs by three primary mechanisms as described by Yao and associates 
(2011): 1) diffusion-controlled, 2) swelling-controlled and 3) chemically-controlled. The 
chemically-controlled drug release mechanism encompasses surface erosion, bulk 
 94 
 
degradation and other interactions or processes taking place within the polymer matrix. It 
may be possible that one or more of these release mechanisms could be occurring 
simultaneously within a matrix system or one may be the dominant mechanism at certain 
stages of matrix hydration and erosion. 
 
All the chitosphere formulations  and the Control initially release drug via diffusion as the 
drug molecules located on the peripheral layers of the sphere hydrate and dissolute through 
the swelling gel layer into the surrounding media via a concentration gradient. A burst 
release of drug was not observed and was possibly due to washing of the spheres in 1M 
acetic acid to remove surface drug and unreacted polymer. As the chitospheres continue to 
hydrate from the outside towards the inner core, the polymer matrix undergoes a transition 
from a glassy to a rubbery state (Figure 3.11b) (Yao et al., 2011). Drug molecules in the 
hydrated rubbery layer of the chitospheres are free to dissociate from the matrix and diffuse 
out whereas molecules located in the unhydrated glassy core remain static. A combination of 
erosion, swelling and chemically-based release may occur with chitospheres containing 
pristine PMMA particles. Chitospheres are proposed to release drug by an in situ leaching 
process where the pristine PMMA particles act as the porogen. PMMA, being a pH-
responsive polymer, dissolves at pHs higher than 7.0. When the chitospheres are exposed 
to PBS of pH 7.4, the same pH-responsive dissolution is considered to take place leaving 
behind porous structures in its place.  
 
Furthermore, since PMMA dissolves in the PBS, it may be possible that some of the 
dissolved matter remains in the chitosan matrix thereby initiating the formation of a PEC 
between the cationic chitosan the dissolved molecules of the pristine PMMA particles (Figure 
3.12). Since chitosan is a cationic polymer and PMMA an anionic polymer it is likely that 
some electrostatic interactions may have arisen resulting in the formation of a PEC with 
binding occurring between the positively charged amine and negatively charged carboxyl 
groups of chitosan and PMMA, respectively, leading to the synthesis of a carboxylate 
functional group indicated by the new peak formed at 1540cm-1 as depicted in the FTIR 
spectra in Figure 4 (Li and Huang, 2012). However, since the unreacted amine and 
carboxylic acid functional groups corresponding to the native polymers of chitosan and 
PMMA, respectively, are still present it suggests that only a certain ratio of these molecules 
reacted to form a new bond. It may be possible that parts of the PMMA particle may still be 
residing in a partially empty pore while the surface around this particle forms a PEC. Since 
the intensity of the new peak at 1540cm-1 is far less than the native peaks it may suggest 
that the PEC is present small quantities. It is noted that unhydrated chitospheres also display 
this new peak although a very weak signal is produced; particularly when the crosslinker 
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concentration is increased, this peak becomes hardly evident. However, after hydration of 
the matrices in PBS pH 7.4, the intensity of the peak significantly increases. This presence 
of this peak in the unhydrated spheres is due to the alkaline pH of the crosslinking solution. 
In weak STPP solutions, diffusion of the crosslinking ions can easily occur from the outside 
to the centre of the sphere and its alkalinity causes a small degree of PMMA particle 
dissolution which readily forms a PEC with chitosan. In stronger STPP solutions, a hard 
crosslinked outer layer is rapidly formed which acts as a barrier and hinders the further entry 
of crosslinking ions towards the core, hence less diffusion of the crosslinker ions is able to 
take place, less solution enters the matrix and the dissolution of PMMA does not occur.  This 
issue can simply be addressed by adjusting the pH of the crosslinking solution with dilute 
acid. However, the increase in the intensity of the 1540cm-1 peak from the unhydrated to the 
hydrated chitosphere matrices, as observed in FTIR, proves the spontaneous, largely in situ 
synthesis, of a PEC between these oppositely charge polymers. Furthermore, the weak 
thermal stability of unhydrated chitospheres suggests the presence of unreacted PMMA 
particles validating that PEC synthesis takes place only upon hydration. This formation of a 
PEC may explain the reduced swelling and the prolonged and slowed drug release rates. 
Moreover, the retention and entanglement of drug in the PEC regions further retard drug 
release. 
 
The swelling behaviour of chitosan is dependent on the number of available amino groups 
for protonation however, with crosslinking interactions and PEC formation, the number of 
free amino groups for protonation is reduced due to complexation of STPP ions and PMMA 
anions with the amino groups of chitosan (Yao et al., 1994; Berger et al., 2004). This 
explains the low water-uptake and swelling ratios observed in the chitospheres loaded with 
PMMA pristine particles coupled with the resulting smaller surface areas which reduce the 
contact surface available for interaction with water molecules. 
 
As visualized by SEM such chitospheres were able to maintain their structural integrity and 
also exhibited superior FE as indicated by textural profiling denoting that they possess 
improved mechanical strength requiring more energy to cause breakage of the chitospheres. 
Such PECs between chitosan and polymethacrylate copolymers are possible and have been 
previously confirmed where polymethacrylates were used as surface coating agents for pH-
controlled release (Lorenzo-Lamosa et al., 1998; Moustafine et al., 2008; Hamman, 2010). 
To our knowledge, this is the first report of in situ polyelectrolyte synthesis in addition to in 
situ porogen leaching. 
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We postulate that the mechanism governing the release of drug from chitospheres 
containing pristine PMMA particles occurs primarily via an in situ PEC formation in addition 
to in situ leaching and surface porous microenvironment formation. The chitospheres first 
undergo hydration of its peripheral layers. When the matrix has absorbed sufficient water the 
pristine PMMA particles become hydrated. Adequate moisture-uptake is required to instigate 
the dissolution of the pristine PMMA particles resulting in its final discharge into the 
surrounding media. Hence, the complete dissolution of the pristine PMMA particles occurs 
only on the surface of the chitosphere for creation of pores and not throughout the entire 
matrix system. Chitospheres prepared in higher concentrations of STPP crosslinking 
solutions impeded the penetration of water therefore swelling minimally. In this case, the rate 
of water permeation into the polymer matrix becomes the rate-determining step in drug 
release as the rate of water penetration influences the rate of pristine PMMA particles 
dissolution and pore formation. The 1:2 chitospheres, containing the highest concentration of 
pristine PMMA particles, swelled the least suggesting only slight water-uptake therefore the 
pristine PMMA particles were not sufficiently hydrated to dissolve out of the matrix. 
Furthermore, the presence of more PMMA suggested the formation of more PEC regions. 
This, together with the slower rate of pore formation resulted in a slower release of the drug. 
From the SEM photographs, it is noted that 1:2 chitospheres display the least amount of 
pores on its surface compared to the 1:1 chitospheres which contain a greater number of 
porous structures on the outer surface.  Furthermore, the formation of a PEC meant that 
drug molecules would be entrapped in the matrix for a longer time thereby prolonging the 
release of drug. This is confirmed by FTIR as the intensity of the peak at 1540cm-1 was 
greatest for chitospheres  prepared with higher concentrations of PMMA suggesting that 
more regions of PEC was formed when more PMMA is available. Moreover, it was noted 
that 3% crosslinked 1:1 chitospheres featured the slowest release of indomethacin, however, 
it also exhibited the highest peak intensity corresponding to the polyelectrolyte formation and 
hence this may explain its prolonged release. The mechanism of surface erosion of the 
hydrated layer indicated that drug is released in concentric layers until the core is reached. 
This way, bulk fluid does not move into the centre of the chitosphere causing the premature 
release of drug molecules as with the Controls. The in vitro dissolution of the pristine PMMA 
particles and the potential formation of a PEC combined with processes of surface erosion 
can be considered as chemically-controlled drug mechanisms as interactions take place 
between the PMMA and chitosan molecules. Release of entrapped drug from the PEC 
regions occurs via erosion of the PEC when the amino groups of chitosan become 
deionized. Upon deionization of the amino groups, the binding affinity between the two 
electrostatically interacting molecules, -NH2 of chitosan and -COOH of PMMA, becomes 
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weaker resulting in increased water penetration into the polymer network and ultimate 
disintegration of the PEC (Berger et al., 2004; Li et al., 2012). 
 
Mathematical modelling of the release kinetics reveals that the release exponent (n) 
decreases with increases in crosslinking and PMMA particles. This may suggest that 
increasing the quantity of crosslinker and PMMA particles, creates a shift in the release 
mechanism from a predominantly erosion-based (where n>1) release towards a coupled 
polymer-relaxation, erosion and diffusion-oriented release termed as super case II transport 
(where 0.45<n<0.89) (Maity and Sa, 2014; Nayak et al., 2014). Since indomethacin is a 
poorly water soluble drug (Inada et al., 2013), its release may occur mainly by surface 
erosion (Contreras et al., 2012) of the chitospheres as depicted in the SEM images in Figure 
3.2 in addition to diffusion occurring from the peripherally hydrated layers of the chitospheres 
and via the porous surface left by the dissolution of surface pristine PMMA particles and 
erosion of the PEC. The shift in the release mechanism of the chitospheres imparted by the 
addition of pristine PMMA particles corresponds to the F1 and F2 values showing 
dissimilarity of the drug release profiles as the concentration of PMMA particles is increased. 
Although F2 values exceeding 50 indicate similarity of the dissolution profiles (Shah et al., 
1998), the drug release profiles of the Controls and the chitosphere formulations may be 
deemed similar by the fact that they both release drug in a linear first-order manner. The 
large F1 values >15 may be a result of the prolonged mechanism of drug release via PEC 
and pore formation which were absent in the Controls. Thus, the key factor differentiating the 
dissolution profiles is attributed to the spontaneous in situ PEC and pore formation. 
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Figure 3.12: Depiction of the formation of surface pores and a PEC between pristine PMMA 
particle surfaces and the chitosan matrix. 
 
3.5. Concluding Remarks 
Chitospheres were prepared to use as a model matrix system for the investigation of the 1) 
in situ PEC synthesis and 2) in situ leaching and surface pore-formation effects of pristine 
PMMA particles validated by SEM imaging and porositometric characterization. Comparison 
of the chitosan-only multiparticulates and chitospheres containing pristine PMMA particles 
showed that the dispersion of pristine PMMA particles throughout a polymer matrix is 
capable of prolonging drug release in addition to enhancing mechanical strength of the 
matrix and shape of the chitospheres. Multiparticulates without pristine PMMA particles 
could control the release of indomethacin over 72 hours only whereas those containing 
pristine PMMA particles offered controlled release extending over 144 hours via super case 
II transport. The dissolution of pristine PMMA particles into the surrounding chitosan matrix 
resulting in the spontaneous formation of a PEC, confirmed by FTIR, indicates the variations 
in the outcomes of drug release between the different pristine PMMA particle ratios, swelling 
and erosion based on polymer selection. Although PMMA-loaded chitospheres exhibited 
superior textural properties and mechanical strength, they lacked ideal properties of thermal 
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stability in their unhydrated form compared to multiparticulates prepared from chitosan 
alone. The density of crosslinking of chitosan determines the rate of moisture permeation 
into the chitospheres thereby influencing the degree of hydration and consequential escape 
of the pristine PMMA particles out of the matrix leaving behind an impression of the space it 
occupied (artefact). However, the STPP crosslinking concentrations utilised in this study 
produced insignificant differences in the various characterisation studies between 
formulations of the same polymeric constituents, thus the pertinent alterations in 
characteristics and observed release profiles is largely attributed to the formation of a PEC 
due to the presence of PMMA particles. Such a matrix, modified by the inclusion of pristine 
polymer particles, may be of interest in the development of long-term controlled-release 
systems for the administration of potent small molecular weight therapeutic drugs. The 
enhanced matrix resilience, strength, porosity and minimal swelling may be attractive for the 
design of drug-releasing implantable tissue-engineering scaffolds such as those required for 
drug-delivery to the brain and other parts of the nervous system where tissue healing may 
be slow necessitating the need for an adequate scaffold. 
 
The proof-of-concept study described in this chapter was essential to confirm the proposed 
action of pristine polymer particle intercalation on extending drug release rates and inducing 
porosity for microenvironment formation and modulation of matrix resilience properties 
before further progression. Following the validation of the particle-intercalation strategy, this 
technique can then be applied to the design of a novel hydrophilic polymeric matrix that is 
better suited for nerve repair, in terms of fabrication and processing and tissue 
biocompatibility. Such a design is discussed in Chapter 4 where a Box-Behnken 
experimental design is employed for the intent of further formulation optimization. 
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CHAPTER 4 
DESIGN, FORMULATION AND STATISTICAL OPTIMIZATION OF AN 
INTERCALATED INTERPENETRATING POLYSACCHARIDE HYDROGEL 
CONDUIT FOR THE DUAL DELIVERY OF PROTEIN AND ANTI-INFLAMMATORY 
DRUG 
 
 
Abstract 
The purpose of this study was to develop novel, porous neurodurable interpenetrating 
networks of gellan-xanthan hydrogel conduits intercalated with pristine polymethyl 
methacrylate (PMMA) particles for the sustained and concurrent release of two model 
compounds: bovine serum albumin (BSA) and diclofenac sodium. Hydrogel conduits were 
synthesised using a thermal-ionic crosslinking mechanism with direct incorporation of 
PMMA. The 15 formulations, generated using a Box-Behnken experimental design, were 
analysed for drug release, swelling, erosion, and textural properties. The 15 formulations 
provided a near zero-order release of BSA (37-75% fractional release) and diclofenac 
sodium (14-22% fractional release) over 20 and 30 days, respectively, modulated via a 
combination of pH-responsive (pH 7.4) dissolution of the intercalated pristine polymer 
particles and the unique gelling and erosion properties imparted by the graded addition of 
xanthan gum to the hydrogel blend. The concentration-dependent intercalation of PMMA 
extended drug release rates and enhanced matrix resilience from 31% to 56%. The gellan-
xanthan ratio variability and the pore-inducing effects of intercalated PMMA yielded a means 
for fine tuning the mechanical attributes of the hydrogel matrices, particularly matrix rigidity 
and flexibility, offering an appealing strategy for the design and development of synthetic 
bioactive-releasing peripheral nerve repair conduits. 
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4.1. Introduction 
Although the gold standard of peripheral nerve repair remains the autologous nerve graft 
and direct end-to-end tensionless suturing in the case of short gap nerve injuries, the 
drawback of donor tissue harvesting and resulting deformities associated with the nerve 
autograft potentiates the need for alternative treatment strategies (Strauch and Strauch, 
2013). A number of artificial polymeric-constructed nerve guides are commercially available 
for clinical use and have proven to be beneficial in the regeneration of transected peripheral 
nerves, however, their efficacy in attaining satisfactory levels of functional recovery are 
considered substandard compared to the autograft (Kehoe et al., 2012; Dinis et al., 2015). 
This particularly pertains to the drug release mechanisms and resulting release kinetics as 
outlined in our review (Ramburrun et al., 2014). 
 
The inclusion of neurotrophic factors (NTFs) within nerve conduits has produced remarkable 
effects on peripheral nerve regeneration and functional recovery. NTFs enhance peripheral 
nerve regeneration by promotion of neuronal survival, Schwann cell migration and axonal 
regeneration (Thoenen and Sendtner, 2002; Catrina et al., 2013). This research study 
utilized Bovine serum albumin (BSA) and diclofenac sodium (anti-inflammatory and 
analgesic) as the model protein and small molecular weight drug, respectively. 
 
In order to obtain optimum levels of functional recovery in the treatment of peripheral nerve 
injuries, comparable to the nerve autograft, the following aspects of the tissue scaffold 
require particular focus: 1) the release kinetics relating to suboptimal and overdosing of 
bioactives, particularly during the initial stages of nerve regeneration; and 2) the mechanical 
properties in terms of the maintenance of structural integrity post-implantation, the ability to 
withstand compressive forces from surrounding tissues, flexibility and permeability for 
uninterrupted gas and nutrient exchange to regenerating tissues (Dalton et al., 2008; Bian et 
al., 2009; Cunha et al., 2011; Kehoe et al., 2012; Madduri and Gander, 2012). 
 
Naturally-derived polymers are gaining attractiveness for the development of tissue repair 
scaffolds and ingestible drug delivery systems, particularly the large molecular weight 
polysaccharide-based polymers such as chitosan, starch, alginates, hyaluronan, dextran and 
gellan gum. The non-toxic, biocompatible, hemocompatible and biodegradable properties of 
this polymer class have popularised its use in scaffold-based materials for tissue engineering 
applications and drug delivery systems (Coviello et al., 2006; Malafaya et al., 2007). 
 
Gellan gum, an anionic bacterial exopolysaccharide, consisting of repeating tetrasaccharide 
units of two glucose, one glucuronic acid and one rhamnose molecule, readily undergoes 
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ionotropic gelation to form physically crosslinked gels, hence its wide applications relating to 
the manufacture of in situ gelling ophthalmic preparations for enhanced drug delivery and 
bioavailability (Coutinho et al., 2010). Similarly, xanthan gum is a high molecular weight 
anionic bacterial heteropolysaccharide. Due to its hydrophilic, inert and biocompatible 
nature, it has further been proved to retard drug release thereby providing time dependent 
release kinetics (Pongjanyakul and Puttipipatkhachorn, 2007; Singh et al., 2011). However, 
its weak gelling properties following physical crosslinking is unsuitable for use in the 
development of long-term tissue implants and scaffolds. 
 
Polymethyl methacrylates (PMMA) are anionic pH-responsive synthetic acrylate copolymers 
comprising varying ratios of methacrylic acid and methyl methacrylate. Eudragit S100 
consisting of poly(methacylic acid-co-methyl methacrylate) in a 1:2 ratio undergoes 
dissolution at a pH > 7,0. Therefore, intercalation of such particles into a gel matrix results in 
the in situ formation of pores, via particulate leaching, for controlled delivery of bioactives 
and improvement of scaffold resilience properties as established in the previously conducted 
proof-of-concept study described in Chapter 3. 
 
The present study uses a dual heat and calcium crosslinked gellan and xanthan gum 
combination for the fabrication of hydrogel nerve conduits. Further modification of the 
hydrogel matrix was achieved via the intercalation of pristine polymethylmethacrylate 
(PMMA) particles to modulate drug release and attune scaffold resilience properties via 
particulate leaching for the in situ formation of pores, as established in our previously 
conducted proof-of-concept study (Ramburrun et al., 2015). The resulting hydrogels were 
polymethlmethacrylate pristine polymer particle intercalated gellan-xanthan interpenetrating 
networks P4[Gel-Xan]IPNs. The conduits were analysed for drug release, swelling, erosion, 
thermal behaviour, chemical transitions and mechanical properties upon utilization of varying 
polymer, crosslinker and pristine polymer particles concentrations. 
 
4.2. Materials and Methods 
4.2.1. Materials 
Gellan gum (low acyl GelzanTM CM), Xanthan gum, Diclofenac sodium and Bovine serum 
albumin (BSA) were purchased from Sigma Aldrich, Steinham, Germany. Polymethyl 
methacrylate (PMMA) (Eudragit S100) was purchased from Evonik, Midrand, Johannesburg, 
South Africa and was used without further modifications. Propylene glycol was purchased 
from Merck, Darmstadt, Germany and calcium chloride anhydrous was purchased from 
Rochelle Chemicals, Johannesburg, South Africa. 
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4.2.2. Determination of the upper and lower variable limits for formulation synthesis 
and Box-Behnken design generation 
A 3-factor Box-Behnken experimental design was utilized for the establishment of an 
optimized formulation. For the construction of the Box-Behnken design, a set of independent 
variable and their upper and lower limits had to be identified. Following the selection of 
appropriate polymers, preliminary investigations assisted in determining the formulation 
variables and the required limits. The gellan and xanthan gum ratios, CaCl2 crosslinker 
concentration and pristine polymer particle concentration were identified as the variables for 
input into the Box-Behnken design. From the proof-of-concept study, detailed in Chapter 3, it 
is evident that the degree of crosslinking and the concentration of pristine polymer particle 
intercalation influences important matrix characteristics of swelling, erosion, bioactive 
release and mechanical properties. The upper and lower limits of the identified variables 
were determined, predominantly, based on the prospect of reproducible and effortless 
conduit fabrication via a mould casting technique. The following criteria, pertaining to 
formulation synthesis, were considered during establishment of the variable limits: 
 The blended gel solution should facilitate easy pouring and moulding for the 
fabrication of seamless hollow conduits. 
 Upon mould casting, the gel solution should snap set in minimal time to avoid settling 
of the suspended pristine polymer particles. 
 The gelation temperature should be appropriate (37˚C or less) to allow magnetic 
agitation for the homogenous incorporation of thermo-labile protein and peptide-
based bioactives. 
 
Table 4.1 lists the preliminary trial formulations prepared and the effects observed on conduit 
formation for the identification of the independent variables and their limits. Pristine polymer 
particle intercalation was obtained by the addition of PMMA in grams per gram of dry gum 
powders. Formulations were mould-cast and film-cast to assess conduit formation. Certain 
formulations were subjected to 14-day dissolution trials in PBS pH 7.4 to observe swelling 
characteristics and maintenance of a solid gel structure upon hydration. 
 
Table 4.1: Composition and observations of preliminary trial formulations 
Trial Formulation Composition Observation 
1 1%w/v XG, 20%w/v PG 
1%w/v XG, 10%w/v PG 
1%w/v XG, 5%w/v PG 
1%w/v XG, 2%w/v PG 
1%w/v XG, 5%w/v PG, 0.125%w/v CaCl2 
1%w/v XG, 5%w/v PG, 0.1%w/v CaCl2 
 
Xanthan gum alone was unable to 
maintain a solid architecture and 
dissolved into a liquid gel state after 
12 days dissolution in PBS pH 7.4. 
Excessive PG would leach out of 
matrices after drying of scaffolds. 
Increase in crosslinker concentration 
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resulted only in increased viscosity of 
the gel but no formation of solid gel 
structure. 
 
2 1%w/v GG, 5%w/v PG 
1%w/v GG, 5%w/v PG, 0.05%w/v CaCl2 
1%w/v GG, 5%w/v PG, 0.1%w/v CaCl2 
1%w/v GG, 5%w/v PG, 0.3%w/v CaCl2 
 
Gellan gum alone produced well-
formed solid gels with rapid swelling 
propensity in PBS pH 7.4 where 
increased crosslinker resulted in the 
formation of harder and brittle gels 
undergoing immediate snap-setting 
upon decrease in temperature. 
Matrices maintained rigid form and 
shape upon swelling. 
 
3 1%w/v GG:XG 50:50, 5%w/v PG, 0.05%w/v 
CaCl2 
1%w/v GG:XG 70:30, 5%w/v PG, 0.05%w/v 
CaCl2, PMMA 1g/g 
1%w/v GG:XG 80:20, 5%w/v PG, 0.05%w/v 
CaCl2 
 
Combinations of gellan and xanthan 
provided a means to adjust matrix 
rigidity and swelling characteristics. 
Increased gellan produced brittle gels 
that were difficult to mould whereas 
increased xanthan produced weak 
gels that would collapse after 
removal from moulds. 
 
4 1%w/v GG:XG 60:40, 5%w/v PG, 0.15%w/v 
CaCl2, PMMA 1g/g 
1%w/v GG:XG 60:40, 5%w/v PG, 0.05%w/v 
CaCl2, PMMA 0.25g/g 
 
1%w/v GG:XG 80:20, 5%w/v PG, 0.15%w/v 
CaCl2, PMMA 1g/g 
 
 
 
 
1%w/v GG:XG 80:20, 5%w/v PG, 0.1%w/v 
CaCl2, PMMA 1g/g 
 
 
 
1%w/v GG:XG 80:20, 5%w/v PG, 0.05%w/v 
CaCl2, PMMA 0.25g/g 
Produced solidified gel scaffolds of 
sufficient strength upon removal from 
moulds.  
 
 
Gel solutions solidified rapidly 
forming cracks and were unable to 
form conduits. Gelation temperature 
was 42˚C   ̶  cause thermal 
degradation of protein bioactives. 
 
Gelation temperature was 38˚C upon 
cooling of solution. 
PMMA concentration produced 
clumping of particles. 
 
Gelation temperature was 35˚C upon 
cooling of solution. 
 
The preliminary trial formulations mentioned above, allowed the identification of the 
independent formulation variables and the upper and lower limits for successful fabrication of 
conduits and loading of thermo-labile protein-based bioactives. Table 4.2 lists the identified 
variable upper and lower limits and the effects on conduit formulation. 
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Table 4.2: The identified variables and the upper and lower limits for generation of a Box-
Behnken experimental design 
Variable  Effect 
Gellan:Xanthan Lower limit: 60:40 Formulations composed of an equal or greater 
concentration of xanthan gum resulted in the 
formation of high-swelling, soft and rapid-
dissolving matrices in PBS pH 7.4. 
Due to formation of a weak and insufficiently 
rigid gel, removal from the moulds upon 
setting resulted in frequent collapse of the 
scaffold. 
 
 Upper limit 80:20 Formulations composed of greater gellan gum 
concentrations result in rigid and brittle gels 
with increased propensity of cracking during 
removal from moulds. 
 
PMMA particles Lower limit: 0.25g/g Concentrations <0.25g/g produced insufficient 
particle intercalation as per microscope 
observations. Low particle intercalation would 
produce negligible changes in mechanical 
properties and bioactive release rates. 
 
 Upper limit: 0.75g/g Concentrations exceeding 0.75g/g and of 
equal gum concentration produced scaffolds 
of deformed surface morphology as per 
microscope imaging and increased potential 
of scaffold breakage during removal from 
moulds. 
Higher concentrations produced clumping of 
particles. 
 
CaCl2 Lower limit: 0.05%w/w Concentrations <0.05w/w provided insufficient 
crosslinking producing weak liquid-like gels 
resulting in collapse of the scaffold. 
 Upper limit: 0.1%w/w Concentrations >0.1%w/w resulted in the 
formation of rigid and brittle gels exhibiting 
immediate snap-setting and hardening at 
temperatures >38˚C with reduced pourability 
for moulding purposes. 
   
Propylene glycol Fixed: 5%w/v Concentrations >0.5%w/v resulted in 
inadequate drying of conduits and leaching 
out of excessive plasticiser forming oily 
matrices.  
 
4.2.3. Synthesis of hydrogel nerve conduits 
4.2.3.1. Preparation of the gel blend and pristine polymer particle suspension 
Gellan gum and xanthan gum powders of varying ratios were combined and added to 
deionised water to form a 1%w/v gel solution. After solubilisation of the gum powders, 
propylene glycol and calcium chloride were added as the plasticiser and crosslinker in 
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concentrations of 5%w/v and 0.05% w/v -0.1%w/v, respectively.  The gel blend was then heated 
to 100˚C and maintained at that temperature for 10 minutes. Addition of polymethyl 
methacrylate (PMMA) nano-sized particles was introduced into the gel blend, in 
concentrations of 0.25g (low), 0.5g (intermediate) and 0.75g (high) per gram of dry 
polysaccharide powder blend, after cooling the solution to 60˚C. The gel-polymer particle 
suspension was slowly cooled to temperatures between 35-37˚C to accommodate the 
incorporation of drug and model protein (diclofenac sodium and bovine serum albumin, 
respectively). Cylindrical moulds (Figure 4.1), measuring 50mm in length and 12mm in 
diameter, were constructed. A removable glass rod of 1.88mm diameter was inserted into 
the centre of the mould to form the lumen of the conduit. The polymer gel suspension was 
carefully syringed into pre-lubricated cylindrical moulds and allowed to set at room 
temperature for 20 minutes before being removed and left to air-dry, while on the glass rods, 
in a fumehood for 24 hours. A series of 15 experimental gellan-xanthan gum-pristine 
polymer particle intercalated formulations were synthesised employing a 3-factor Box-
Behnken design utilizing Minitab® statistical software (V15, Minitab Inc., PA, USA)  as listed 
in Table 4.3. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Schematic depicting the synthesis of the Gel-Xan conduits and formation of an 
IPN hydrogel. 
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Table 4.3: Formulations obtained via the Box-Behnken design 
Formulation Gellan:Xanthan CaCl2 (%w/v) PMMA (g)1 
1 60:40 0.1 0.5 
2 70:30 0.075 0.5 
3 80:20 0.1 0.5 
4 70:30 0.05 0.75 
5 70:30 0.1 0.75 
6 70:30 0.075 0.5 
7 80:20 0.05 0.5 
8 80:20 0.075 0.25 
9 60:40 0.075 0.75 
10 70:30 0.05 0.25 
11 60:40 0.075 0.25 
12 60:40 0.05 0.5 
13 70:30 0.075 0.5 
14 80:20 0.075 0.75 
15 70:30 0.1    0.25 
1 Amount of PMMA (g) per 1 gram of dry polysaccharide powder blend. 
 
4.2.4. Response surface analysis as per the Box-Behnken design 
Response surface analysis of the 15 design formulations were carried out employing 
Minitab® statistical software (V15, Minitab Inc., PA, USA). The in vitro performance and 
design optimization of the experimental formulations were evaluated in terms of drug 
release, swelling, erosion and textural properties (matrix resilience, deformation and 
fracture) to elucidate the influence of polymer ratios, crosslinker and pristine particle 
concentration on the studied response outcomes. 
 
4.2.5. Characterization of the pristine polymer particle intercalated gel conduits 
4.2.5.1. Detection of vibrational molecular changes of the nerve conduits 
To confirm the chemical structures and detect molecular transitions thereof, samples of the 
conduits (listed in Table 1) were analysed for the presence of crosslinking and interactions 
between the native polymers (gellan, xanthan and PMMA). Samples were analysed over an 
FTIR spectra of wavelengths between 4000-600cm-1 using a PerkinElmer Spectrum 2000 
ATR-FTIR (PerkinElmer 100, Llantrisant, Wales, UK) spectrometer fitted with a single-
reflection diamond MIRTGS detector. 
 
4.2.5.2. Thermophysical characterization of nerve conduits 
The thermodynamic properties of the conduits were determined using a Temperature 
Modulated Differential Scanning Calorimeter (TMDSC) (Mettler Toledo, DSC, STARe 
System, Swchwerzenback, ZH, Switzerland). Samples of 15mg were sealed in aluminium 
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crucibles and heated over a temperature range between 0-300˚C at a heating rate of 
10˚C/min. DSC curves were obtained by plots of sample weight over sample temperature. 
Differences in the heat flow and phase transitions of the formulations provided insight into 
the effects of polymer blending and crosslinking. The determination of change in sample 
weight as a function of temperature was performed using a Thermogravimetric analyser 
(TGA) (PerkinElmer, TGA 4000, Llantrisant, Wales, UK). Samples were heated at a rate of 
10˚C/min from 30-900˚C under continuous nitrogen purging. Thermograms were generated 
as percentage weight vs. temperature and analysed using the PyrisTM software. Correlation 
of DSC and TGA data assists in determining the effect of crosslinking in relation to polymer 
thermal degradation properties. 
 
4.2.5.3. Porositometric analysis 
The surface area and pore size of 24-hour hydrated hydrogel conduits in PBS pH 7.4 were 
evaluated using a Porositometric Analyzer (Micromeritics ASAP 2020, Norcross, GA, USA). 
Samples were frozen at -85˚C and lyophilized (Freezone 12, Labcono, Kansas City, USA) 
before degassing samples for elimination of residual moisture and contaminants. A glass 
filler rod inserted into the sample tube reduced the total free space volume in the tube thus 
hastening the degassing stage involving an evacuation and heating phase. Thereafter, the 
sample tube was transferred to the analysis port for determination of surface area, pore size 
and pore volume in accordance with the BET and BJH models. An evacuation rate of 
50.0mmHg/s with a temperature ramp rate of 10˚C/min, target temperature of 40˚C and a 
hold temperature of 30˚C for 900min was used. The BET linear equation (Equation 4.1) was 
used to determine the monolayer capacity. 
 
p/na(p0-p) = 1/nam ˟ C + (C – 1)p/nam ˟ Cp0                            Equation 4.1 
 
Where, na refers to the quantity of N2 adsorbed at the relative pressure p/p0, nam was the 
monolayer capacity and C was exponentially related to the enthalpy of adsorption in the first 
adsorbed layer. 
 
Using the molecular cross-sectional value am, the surface area was determined from the 
monolayer capacity employing Equations 4.2 and 4.3. 
 
As(BET) = nam ˟ L ˟ am                                                                                           Equation 4.2 
as(BET) = As(BET)/m                                                                                            Equation 4.3 
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Where As(BET) and as(BET) are the total and specific surface areas, respectively, of the 
adsorbent of mass m and L is the Avogadro constant. 
 
4.2.5.4. Scanning Electron Microscopy for visualisation of surface morphology 
For evaluation of the surface morphology, lyophilized hydrogel samples, post 24 hours 
dissolution in PBS pH 7.4, were fixed to aluminium stubs using double-sided adhesive 
carbon tape and then sputter coated with carbon and gold-palladium for 120 seconds (SPI 
ModuleTM Sputter-Coater and Control Unit, West Chester, PA, USA). Samples were viewed 
using an FEI Nova NanoLab 600TM Scanning Electron Microscope (SEM) (FEI Company, 
Hillsboro, OR, USA) under different magnifications and images were taken of the matrix 
surface architecture. 
 
4.2.5.5. Swelling and erosion studies 
Swelling and erosion studies were performed in triplicate by immersing 10mm conduit 
samples in 2mL of PBS pH 7.4 in an orbital shaking incubator (LM-530-2, MRC Laboratory 
Instruments Ltd., Hahistadrut, Holon, Israel) maintained at 37˚C and set at 50rpm for sample 
agitation. Samples were removed at predetermined time intervals and the change in mass 
were measured for the determination of swelling ratio after carefully blotting the hydrated 
samples with tissue paper for the  removal of excess water. The mean wall thickness of the 
hydrated conduits at each sampling point was measured at four different angles using a 
digital Vernier calliper (Krafft, DV150GW, Schoellerstr Düren, Germany). The conduit 
samples were then dried at 40˚C for 72 hours to ensure complete removal of residual 
moisture before being weighed for the determination of the eroded mass. Equations 4.4 and 
4.5 were employed for the determination of swelling ratio and erosion, respectively. 
 
% Swelling ratio = Ws-Wi
 Wi
 ×100              Equation 4.4 
% Erosion = Wf-Wi
Wi
 ×100               Equation 4.5 
 
Where Wi is the intial weight of the conduits, Ws is the weight of conduits after hydration and 
Wf is the weight of eroded conduits.  
 
4.2.5.6. Textural profiling of hydrated conduits 
Textural analysis characterization using a Texture Analyser (TAXTplus Stable Microsystems, 
Surrey, UK) fitted with a 10mm diameter delrin probe was undertaken on hydrated conduit 
samples at pre-determined sampling points. The Matrix Resilience (MR), Deformability 
Modulus (DF) and Fracture Energy (FE) were determined. MR (N.sec) was determined by 
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the ratio of the areas under the compression and decompression curves generated by 
Force-Time textural profiles. This represented the ability of the hydrogel conduit to recover to 
its original form after application of an external deforming stress. The Area under the Curve 
(AUC) from the Force-Distance textural profile allowed the determination of the FE (N.mm) 
which equates to the energy in joules required to cause rupture of or a break in the matrix of 
the hydrated swollen conduits. The DM (N/mm) is an indication of the hydrogel matrix 
flexibility and was computed from the gradient of the Force-Distance profile from zero to the 
point of the peak force.  The textural analysis parameters utilized include a pre-test and post-
test speed of 1.00mm/sec, a test speed of 0.5mm/sec, a trigger force of 0.5N and a load cell 
of 5kg with a target mode of 10% strain. 
 
4.2.5.7. In vitro release studies and kinetic modelling 
In vitro release studies were performed using 10mm samples of conduit each loaded with 
3mg BSA and diclofenac sodium. Samples were placed in glass vials containing 1mL PBS 
pH 7.4 and stored in an orbital shaking incubator.  At pre-determined time intervals, 0.3ml of 
dissolution media was removed for drug content analysis and replaced with an equal fresh 
volume of media to maintain sink conditions. Samples were analysed for the quantity of BSA 
and diclofenac sodium by UV-spectrophotometry set at 595nm and 276nm, respectively, 
using a Bradford protein assay and an absorbance multi-plate reader (BioTek, USA). Further 
insight into the drug-release mechanisms was obtained via kinetic modelling of the drug-
release profiles using the models listed in Table 4.4. 
 
Table 4.4: Models and parameters employed for kinetic modelling of drug release profiles 
Model Name Parameters Reference 
Zero-order: 
C = K0t 
K0 = zero-order rate constant 
t = time 
 
Dash et al., 2010 
First-order: 
LogC = LogC0 - kt/2.303 
C0 = initial concentration of drug 
K = first-order constant 
 
Dash et al., 2010 
Higuchi: 
Q = Kt1/2 
Q = % drug release 
K = design variable of the system 
t = time 
 
Dash et al., 2010 
Siepmann and Peppas, 2012 
Hixson-Crowell: 
Q01/3 - Qt1/3 = KHCt 
Q0 = initial amount of drug loaded 
Qt = amount of drug released in 
time t 
KHC = rate constant 
t = time 
 
Dash et al., 2010 
Hopfenberg: 
Mt/M ͚ = 1 - (1 - K1t)n 
 
Mt / M ͚= fractional drug release at 
time t 
K = rate constant 
Dash et al., 2010 
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t = time 
n = 1, 2 or 3 for slab, cylinder or 
sphere geometries, respectively 
 
Korsmeyer-
Peppas/Power Law: 
Mt/M ͚ = Ktn 
Mt / M ͚= fractional drug release at 
time t 
K = rate constant 
t = time 
n = release exponent 
 
Siepmann and Peppas, 2012 
Maity and Sa, 2014 
Peppas-Sahlin: 
Mt/M ͚ = K1tm + K2t2m 
Mt / M ͚= fractional drug release at 
time t 
K1 = Fickian diffusional contribution 
(F) 
K2 = Case-II relaxational 
contribution (R) 
t = time 
m = constant 
Siepmann and Peppas, 2012 
Mady, 2013 
 
4.3. Results and Discussion 
4.3.1. Vibrational molecular transitions and thermodynamic analyses validating 
crosslinking and formation of an IPN hydrogel network 
FTIR spectroscopy was used to identify the similarities and differences in the chemical 
structures of the crosslinked gellan-xanthan hydrogel blends. Spectroscopy of the native 
polymers served as a comparison for the detection of polymer-polymer and polymer-
crosslinker interactions thus providing validation of and the degree of crosslinking achieved. 
The FTIR spectra of both the pure forms of gellan and xanthan gum are very similar and 
correspond to the typical chemical structure of polysaccharides. Both polymers exhibited a 
broad band at 3316cm-1 and 3281cm-1 indicative of –OH stretching of gellan and xanthan 
gum, respectively. Stretching vibrations of the –CH2 groups occurred at wavelengths of 
2884cm-1 for gellan gum. Xanthan gum produced a peak at 2901cm-1 corresponding to the 
C-H strectching of the CH3 alkyl groups (Faria et al., 2011). Bands appearing at 1600cm-1 
and 1400cm-1 are due to the asymmetric and symmetric stretching of COO- groups in both 
polymers, respectively (Faria et al., 2011). Defined bands occurring towards the end of the 
spectra at wavenumbers of 1018-1017cm-1 are characteristic of C–O stretching in both 
gellan and xanthan gum. The strong peak produced at 1722cm-1 distinguishes xanthan from 
gellan gum and is indicative of the C=O vibrations of the carboxylate anion whereas further 
peaks at 1370cm-1 and 1246cm-1 present the C-H bending of methyl groups and the 
presence of o-acetyl esters (Faria et al., 2011). The presence of PMMA is identified by its 
esterified carboxylic acids peaking at 1722cm-1, however, when combined within the gel 
formulations this peak overlaps with that corresponding to the carbonyls of xanthan gum 
resulting in increased intensity of this peak.  
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The PMMA intercalated gellan-xanthan gum formulations maintained the characteristic 
chemical compositions of the parent polymers as shown in Figure 4.2a. The broad band of –
OH stretching shifts to higher wavenumbers (3370-3390cm-1) becoming narrower and 
decreasing in intensity thus suggesting interaction of hydroxyls with Ca2+ during 
intramolecular and intermolecular hydrogen-bonding. The peak corresponding to stretching 
of methyl (CH3) and methylene (CH2) groups of gellan and xanthan, respectively, shifts to 
higher wavenumbers increasing in intensity and slightly broadening before splitting into two 
peaks at 2920cm-1 and 2870cm-1. The change in stretching vibration of these groups can be 
attributed to the interaction and bonding of Ca2+ ions with the carboxylate groups on the 
glucoronate and pyruvate moieties present in the polysaccharide polymers thereby affecting 
the nearby CH2 and CH3 groups. The peak corresponding to the carboxylate ion of xanthan 
becomes narrower with a slight increase in intensity due to the addition and overlapping of 
the PMMA carboxylate peak appearing at the same wavenumber, however shifting of the 
peak to a higher wavenumber of 1730cm-1 is noted. Formulations where polymer 
composition and PMMA particle concentration was constant, differing only in crosslinker 
concentration, were selected for clarified comparison {60:40: F1 (0.1%w/v) and F12 
(0.05%w/v); 70:30: F15 (0.1%w/v) and F10 (0.05%w/v); 80:20: F3 (0.1%w/v) and F7 (0.05%w/v)}. 
Formulations containing higher concentrations of calcium crosslinker exhibited carboxylate 
peaks of decreased intensity suggesting either the interaction of COO- groups of Xanthan 
gum with Ca2+ or its participation in hydrogen-bonding (Pongjanyakul and 
Puttipipatkhachorn, 2007) (Figure 4.2b). The peaks at 1600cm-1 and 1400cm-1 indicative of 
COO- asymmetric and symmetric stretching, respectively, shifts to higher wavenumbers of 
1615cm-1 and 1435cm-1 undergoing a significant decrease in intensity, particularly the 
asymmetric stretching peak. This indicates the disappearance of the carboxylate anions as it 
interacts with Ca2+ cations leading to the formation of a calcium carboxylate salt (Verma and 
Pandit, 2012; Yang et al., 2013). As described in another study (Elmowafy et al., 2008), the 
peaks occurring between 1017-1018cm-1 associated with the C-O stretching in both gellan 
and xanthan native polymers undergoes a substantial change in the respective formulations 
upon ionic interaction with calcium ions. This peak significantly increases in intensity towards 
higher wavenumbers forming a broad peak and then splitting into a 1065cm-1 and 1031cm-1 
peak indicating Ca2+ bonding to the COO- groups of gellan and xanthan, respectively, 
thereby changing the C-O stretching vibration via stearic hindrance on the carbonyl 
functional group. This interaction may further explain the formation of the new peak at 
946cm-1 shouldering off the broad 1065-1031cm-1 peak.  
 
In addition, the FTIR spectra show that PMMA particles are merely present in its pristine 
form in the hydrogel formulations and do not partake in the crosslinking mechanism between 
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the divalent salt and the polysaccharides. This is plausible considering that during the 
hydrogel synthesis the PMMA particles were incorporated into the aqueous gel solution in its 
non-dissolved solid state after the addition of CaCl2 and initiation of gelation. 
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Figure 4.2: FTIR Spectra a) showing the vibrational changes between constituent polymers 
and F4 upon crosslinking with CaCl2 b) validation and comparison of crosslinking degree via 
carboxylate-calcium interactions between F1 and F12 (60:40 with intermediate PMMA 
intercalation). 
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DSC and TGA were employed in addition to FTIR spectroscopy to further validate the 
formation of crosslinks resulting in a gellan-xanthan hydrogel IPN by measuring the changes 
in energy transfers and mass polymer decomposition. The first endothermic peak in the DSC 
thermograms appearing around 100˚C is probably the presence of crystalline water 
entrapped between the polymer chains. No defined melting peaks were observed in both the 
native polysaccharides and the formulations. Gellan gum displays its exothermic peak at 
253˚C whereas Xanthan gum exhibits an exothermic peak at 282˚C indicating its superior 
thermal stability compared to gellan. The DSC thermogram of PMMA shows two 
endothermic peaks: a weak peak at 93˚C which may be attributed to the evaporation of 
moisture residues and a prominent peak at 220˚C were melting is initiated. The broad 
exothermic peak occurring towards the end of the experimental run around 270˚C indicates 
polymer decomposition; however this peak exhibited significant changes in intensity with 
varying concentrations of crosslinker and thus provides validation and determination of the 
degree of crosslinking. It was noted that increase in CaCl2 concentration generally resulted 
in decreased height and area of the exothermic peak suggesting calcium-polymer bond 
formation resulting from the Ca2+ cation chelation of anionic carboxylates thus improving 
thermal stability of the formulations via formation of a more rigid matrix network. The energy 
associated with this phase of degradation provides an indication of the ease of bond-
breaking and hence the crosslinking degree. Highly crosslinked matrices require greater 
temperatures for the initiation of thermal decomposition thereby giving off less energy due to 
a smaller number of bond-breakage at that specific temperature. Increase in CaCl2 
concentration from 0.05%w/v to 0.1%w/v across the three different gum ratios increased the 
temperature at which the exothermic peak appeared hence increasing the temperature of 
the onset of degradation (Figure 4.3). Moreover, this decomposition stage resulted in the 
release of less energy, at that particular temperature range, which equates to less bond-
breakage ensuing in the polymer matrix during thermal degradation. The improved thermal 
stability arises from ionic bonds between calcium cations and carboxylate anions present in 
gellan and xanthan gum. Comparing the parent polymers, although the temperature 
corresponding to the onset of degradation remained similar, the enthalpy change during 
polymer disintegration decreased from 1684mJ and 1240mJ for gellan and xanthan gum, 
respectively, to values in the range of 91-192mJ in the various hydrogel formulations where 
increased concentration of crosslinker decreased the change in energy transferred. This 
indicates that the unmodified polymer powders underwent extensive thermal degradation 
due to absence of crosslinks compared to the crosslinked hydrogel IPNs. 
 
In addition, the glass transition temperature (Tg) may be used to provide an indication of 
crosslinking, crystallinity and homogeneity of the constituent polymer components. The 
 123 
 
presence of only one Tg including a single exothermic peak indicates the formation of a 
homogenous crosslinked IPN matrix whereas basic polymer blends would result in the 
emergence of multiple distinct glass transition temperatures each corresponding to the 
individual constituent polymers (Elmowafy et al., 2008). Increase in crystallinity is reflected 
by a larger and broader glass transition whereas increase in crosslinking shifts the Tg to 
higher temperatures. The Tg of gellan and xanthan gum were not evident in the experimental 
run and may possibly occur at temperatures lower than zero. However, well-defined glass 
transitions, peaking at around 20˚C (Figure 4.3), of the crosslinked formulations were evident 
on the thermograms indicating the presence of crosslinks and the formation of a partly rigid 
matrix structure. Furthermore, a slight endothermic dip noted in the thermograms between 
220-230˚C prior to the onset of polymer decomposition may be indicative of PMMA melting 
as formulations containing higher PMMA concentrations ranging from 0.5g-0.75g/g present 
with a slightly pronounced endothermic slope. 
 
The TGA thermograms in conjunction with the derivatisation curves were correlated to the 
results obtained from DSC. As noted in DSC, all TGA thermograms presented with an initial 
minimal decomposition step which corresponded to the dehydration process of entrapped 
crystalline water molecules. Pure gellan and xanthan gum underwent the greatest loss in 
weight at temperatures of 270˚C and 295˚C, respectively, corresponding to the polymer 
decomposition indicated by the exothermic peak in DSC with complete decomposition 
occurring at 615˚C for gellan whereas an 8% mass of xanthan remained at the end of the 
900˚C run. According to the derivatisation curves, a further decomposition step occurred 
peaking at 606˚C and 634˚C for gellan and xanthan, respectively. PMMA exhibited two 
decomposition steps: at 237˚C where less than 5% weight loss occurred indicative of 
polymer melting and at 395˚C which was indicative of polymer decomposition with complete 
sample degradation occurring at 434˚C. CaCl2 exhibited the first decomposition peak at 
190˚C pertaining to the decomposition of chloride with a steady 39% remaining mass 
towards the end temperature of 900˚C. According to literature, calcium only melts at 840˚C 
(Kaye and Laby, 1995) explaining the flat linear portion of the thermogram starting from 
280˚C onwards indicating only slight changes in sample weight. 
 
TGA thermograms of the experimental formulations exhibited decomposition in 4 steps: Step 
1 occurring between 80-100˚C corresponds to the loss of residual moisture from the 
samples; Step 2 occurring between 250-260˚C and ending at 350˚C was attributed to 
polysaccharide degradation where the major loss of sample weight was observed; Step 3 
initiating at approximately 395-399˚C and ending at 436˚C was due to the decomposition of 
the pristine polymer particles; Step 4 was assigned to the final stage of polymer degradation 
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and occurred in the range of 570-580˚C. Analysis of the derivatisation curves revealed that 
the most significant change in weight of the samples occurred at Step 2 and Step 4. The 
peak corresponding to Step 3 fluctuated in intensity in response to increases and decreases 
in the concentration of PMMA particles. From the derivative curve, it was further noted that 
highly crosslinked formulations, F1, F3, and F15 containing 0.1%w/v CaCl2 and F8 and F11 
containing 0.075%w/v CaCl2 presented with a new peak at 319˚C shouldering off the Step 2 
decomposition peak. This may indicate the decomposition of calcium carboxylate salt in the 
form of carboxylate-Ca-carboxylate crosslinks. 
 
The results indicate that an IPN is indeed formed where the two polymer components are 
simultaneously crosslinked via two crosslinking mechanisms. FTIR indicates the types of 
bonding that may have occurred to form crosslinks between polymers whereas thermal 
analysis indicates that the constituent polysaccharides are in fact crosslinked and not merely 
present as a blend. 
  
Crosslinking in the hydrogel matrices could occur via two mechanisms: thermo-induced 
physical crosslinking and ionotropic crosslinking with bivalent calcium ions. Upon heating 
above 80˚C and subsequent cooling of the gel solutions, gellan and xanthan gum are known 
to undergo a change in structural conformation of the polymer chains from random coils to 
ordered helical structures (Tang et al., 2001; Bergmann et al., 2008). The double helix 
structures in gellan gum creating junction zones are further reinforced and stabilised via Ca2+ 
chelation, specifically between two carboxyl anions on opposite chains. This leads to the 
formation of 3D physical solid gels. Similarly, xanthan gum undergoes conformational 
change forming either double or single helices via calcium chelation where the presence of 
cations result in the reduction of electrostatic repulsion (Baumgartner et al., 2008) between 
the negative carboxyls leading to wrapping of the side chains around the polymer backbone 
via hydrogen bonding thereby forming a helical rod. Ionotropic crosslinking and gelation may 
occur via a combination of intramolecular and intermolecular crosslinks.  
 
Intramolecular interactions may occur via hydrogen-bonding amongst single chains and the 
polymer backbone and additionally between hydrogens and carboxylates on the terminal 
ends of a single chain resulting in chain contraction (Dário et al., 2011). Likewise, an 
intramolecular crosslink may occur between a single calcium cation and the terminal ends of 
two carboxylate side chains, present on the pyruvate and glucoronate moieties, along a 
single main polymer chain (Bergmann et al., 2008; Dário et al., 2011; Bueno et al., 2013) 
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Intermolecular crosslinking may occur via hydrogen-bonding between formed helical 
structures and between hydroxyls and carboxylates of xanthan and gellan, respectively and 
vice versa (Chandrasekaran and Radha, 1997; Pongjanyakul and Puttipipatkhachorn, 2007). 
 
Intermolecular cation chelation arises from electrostatic interaction between a central Ca2+ 
ion and two carboxyl anions on separate chains of gellan-gellan, xanthan-xanthan or gellan-
xanthan resulting in the formation of a rigid structure attributed to the stabilization of junction 
zones by Ca2+ and the resulting reduction in electrostatic repulsion between negatively 
charged side chains, specifically the pyruvate and glucoronate (Dário et al., 2011) functional 
moieties of xanthan gum. The above intra- and intermolecular interactions and the resulting 
structural conformations may occur randomly in any ratio as the reaction during thermal 
treatment proceeds.  
 
As depicted in Figure 4.3, this method of non-covalent crosslinking and the potential 
existence of various crosslink-types within a single matrix may yield the formation of an 
interpenetrating hydrogel network where two crosslinked polymer networks are partially 
interlaced on a molecular scale but not covalently bonded to each other and where the 
constituent polymers can only be separated upon breaking of chemical bonds (Matricardi et 
al., 2013; Aminabhavi et al., 2015). 
 
  
 
 
 
 126 
 
 
Figure 4.3: DSC thermograms of formulations varying in gellan-xanthan ratios with the 
following CaCl2 crosslinker concentrations 60:40 a) F1-0.1%w/v and b) F12-0.05%w/v; 70:30 
c) F10-0.05%w/v and d) F15-0.1%w/v; 80:20 e) F3-0.1%w/v and f) F7-0.05%w/v. 
 
4.3.2. Analysis of pH-responsive in situ particulate leaching of intercalated PMMA 
particles for formation of porous microenvironment structures 
We have previously reported elsewhere the mechanism of pH-responsive particulate 
leaching of the intercalated pristine PMMA particles via dissolution at pH 7.4 leading to the 
formation of a pore-like microenvironment network (Ramburrun et al., 2015). We postulated 
that the intercalation of pristine polymer particles of nano-size distribution within a hydrophilic 
polymer matrix would result in pore formation in the form of a core microenvironment array. 
Increase in PMMA particle concentration would lead to an increased number of core 
microenvironment structures. Similar to the previous proof-of-concept study in chitospheres, 
the gellan-xanthan IPN hydrogels exhibited an increase in the quantity of pores formed with 
increasing PMMA particle concentration where such particles elicited the induction of pores 
by serving as a pH-responsive porogen in situ. Matrix resilience and porositometric analyses 
validated the formation of such microporous environments within the hydrogel matrix post-in 
vitro dissolution.  
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Matrix resilience may be used to indicate the presence of porous structures within a polymer 
matrix. Loose, empty voids within a polymer matrix allows the matrix to undergo a transient 
change in shape upon compression to a certain extent before reverting to its original form 
and shape after removal of the compressive force. The matrix resilience profiles in Figure 
4.4 show marked increased resilience in formulations containing larger quantities of pristine 
PMMA particles. This is particularly observed with F5 and F15, F9 and F11 and F14 and F8 
where polymer and crosslinker compositions are identical but differ only in PMMA particle 
concentration. As the dissolution media penetrates the matrix initiating the dissolution of the 
PMMA particles, porous microenvironment structures are continuously formed until complete 
leaching of the particles hence explaining the progressive increase in %matrix resilience. 
 
It was further noted that formulations containing higher concentrations of particles displayed 
superior matrix resilience, particularly F4, F5 and F14 containing 0.75g/g of pristine particles 
and F7 and F12 synthesised with 0.5g/g of PMMA particles. At the end of the study period, 
these formulations exhibited resilience values between 45-56% compared to formulations 
containing 0.25g/g of PMMA particles displaying resilience values between 31-40%. The 
observed increase in matrix resilience conferred by the pH-responsive particulate leaching of 
the PMMA particles for the formation of pores corresponds to the loss in weight of the 
conduits.  
 
Porositometric analysis performed in accordance to the BET and BJH models, using 
nitrogen as the adsorptive gas, was used to ascertain the pore size, pore surface area and 
shape by assessing the shape of the isotherm and resulting hysteresis loop. Presence of 
hysteresis indicates the presence of pores whereas its shape may assist in determining pore 
shape. Formulations, after 24 hours of dissolution, containing higher concentrations of 
PMMA particles presented with greater BET surface and micropore areas as a result of 
multiple empty impressions left behind after the in situ porogen leaching effect of the 
intercalated particles (Table 4.5). The pores formed by the dissolution of the PMMA particles 
measure between 2-3.6nm indicating a pore size distribution within the mesopore range 
(Sing, 1984; Groen et al., 2003). In addition, such formulations exhibited slightly larger pore 
volumes and pore diameters compared to formulations containing less PMMA particles. 
Type II and IV isotherms were noted for formulations comprising 70:30 and 60:40 gum 
ratios, respectively, whereas F14 composed of an 80:20 polymer ratio and 0.75g/g PMMA 
particles featured a Type II isotherm while 0.25g/g PMMA particle intercalation presented a 
Type IV isotherm. The presentation of H3 and H4 hysteresis may suggest a varying slit-like 
ranging to a conical-like shape of the pores. 
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Figure 4.4: (A) Textural profiling matrix resilience analysis of the experimental formulations 
conducted over 30 days of dissolution in PBS pH 7.4 and (B) SEM cross-section imaging, at 
200x magnification, of selected P4[Gel-Xan]IPN formulations for visualisation of 
morphological properties: 60:40 a) F9 and b) F11; 70:30 c) F5 and d) F15; 80:20 e) F14 and 
f) F8.  
 
SEM cross-section morphology, shown in Figure 4.4, reveals the appearance of large 
honeycomb-like macroporous structures post-dissolution and lyophilisation of the hydrated 
conduits. The presence of this large porous network further enhances the resilience of the 
hydrogels and improves its water holding capacity. 
 
The induction of porous structures is not only critical for optimal mechanical properties but 
moreover functions as reservoirs for the temporary accumulation of bioactive molecules in 
achieving controlled drug release. A porous matrix further allows the uninterrupted 
A B 
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physiological exchange of nutrient and waste products between the regenerating tissues 
confined within the interior environment of the implant (Garg and Goyal, 2014). Porosity 
enhances resilience which allows the scaffold to maintain its former architectural integrity 
when subjected to alternating compressive and decompressive forces acting on the scaffold 
from the movement of surrounding tissues at the implantation site, thereby making highly 
porous hydrogel scaffolds a favourable characteristic for tissue regeneration applications 
(Mastropietro et al., 2012). 
 
Table 4.5: Porosity analysis of 60:40 (F9 and F11); 70:30 (F5 and F15) and 80:20 (F14 and 
F8) P4[Gel-Xan]IPNs after 24 hours dissolution in PBS pH 7.4 
 
4.3.3. Response surface and statistical analysis of the Box-Behnken experimental 
design 
Response analysis was performed of the following selected response outcomes after a 30-
day period of in vitro studies: %swelling, %erosion, textural properties comprising %matrix 
resilience, deformation and fracture and drug release of BSA and diclofenac sodium based 
on mean dissolution time (MDT).  
 
Increases in xanthan gum and CaCl2 concentrations results in potentiated swelling via 
increased water-uptake whereas higher concentrations of gellan gum and PMMA particles 
results in an opposing effect on swelling ability of the conduits (Figure 4.5). Lower CaCl2 
concentrations in the range of 0.05-0.075%w/v may assist in producing ideal swelling 
capacities with the consequential increase in mass being maintained between 500-1000%, 
after water absorption into the matrix.  As shown in Figure 4.6, the investigated CaCl2 
concentrations between 0.05-0.1%w/v result in steady erosion rates of the scaffolds with 67-
70% of the conduit eroding at the end of 30 days. Similarly, the three polymer blend ratios 
produce steady erosion rates; however, gellan has a slight hindering effect on erosion with 
less than 65% matrix loss occurring after a 30-day period. The pH-responsive particulate 
leaching of the intercalated PMMA pristine particles leads to substantial increase in erosion. 
Porositometric Parameters 0.75g/g PMMA Particles 0.25g/g PMMA 
Particles 
 F9 F5 F14 F11 F15 F8 
BET Surface Area (m2/g) 4137.046 41.233 30.474 92.086 - 44.677 
Micropore Area (m2/g) 4073.272 2.127 - 32.987 - - 
BET adsorption average pore 
width (4V/A) (nm) 
3.600 2.722 3.554 1.542 - 2.998 
BJH adsorption average pore 
diameter (4V/A) (nm)  
4.690 5.340 5.230 4.670 4.478 5.016 
BJH desorption average pore 
diameter (4V/A) (nm) 
3.627 3.840 4.168 4.016 3.932 3.676 
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The main affecters of matrix resilience, shown in Figure 4.7, were increasing PMMA particle 
and decreasing CaCl2 concentrations. PMMA and CaCl2 concentrations of 0.4g/g and 
0.05%w/v, respectively, are likely to produce scaffolds of at least 50% in resilience behaviour. 
Increase in CaCl2 concentration from 0.05%w/v to 0.1%w/v results in a linear decline in 
resilience from 50% to 30%, attributed to formation of rigid polymer chains upon crosslinking. 
The maximum gellan gum concentration in the polymer blend, 80%w/w, produces a slight 
enhancement in resilience by only 5%. Altering the ratios of gellan xanthan gum allows 
adjustment of the matrix to produce ideal deformation characteristics in the range of 1.2-
1.5N/mm. Gellan and CaCl2 concentrations between 70-80%w/w and 0.05%w/v, respectively, 
result in stiffer matrices, ascribed to decreased water-uptake and swelling, with deformation 
moduli exceeding 1.4N/mm after 30 days of dissolution (Figure 4.8). Increased CaCl2 and 
decreased PMMA particle concentrations results in enhanced fracture energies (Figure 4.9) 
of the conduits signifying the requirement of higher amounts of energy for rupturing of the 
hydrated matrices. 
 
The effects of the experimental variables on the release of BSA and diclofenac sodium 
varied in comparison to each other. Response analysis in Figure 4.10 showed that CaCl2 
concentrations hasten the release of BSA and diclofenac sodium whereas increases in 
xanthan gum and PMMA particle concentration promote slowed release of the model protein 
and drug. Although higher xanthan ratios were indicative of slowed diclofenac sodium 
release, analyses depict that combined lower CaCl2 concentrations (0.05%w/v) and an 
optimal PMMA concentration of 0.4g/g suggest a further enhanced reduction in the release 
rates, specifically of diclofenac sodium (Figure 4.11). 
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Figure 4.5: (a) Response surface, (b) contour and (c) main effects plots depicting the effects 
of gellan-xanthan ratios, CaCl2 and PMMA concentrations on %swelling. 
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Figure 4.6: a) Response surface, b) contour and c) main effects plots depicting the effects of 
gellan-xanthan ratios, CaCl2 and PMMA concentrations on %erosion. 
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Figure 4.7: a) Response surface, b) contour and c) main effects plots depicting the effects of 
gellan-xanthan ratios, CaCl2 and PMMA concentrations on %matrix resilience. 
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Figure 4.8: a) Response surface, b) contour and c) main effects plots depicting the effects of 
gellan-xanthan ratios, CaCl2 and PMMA concentrations on the deformation modulus. 
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Figure 4.9: a) Response surface, b) contour and c) main effects plots depicting the effects of 
gellan-xanthan ratios, CaCl2 and PMMA concentrations on the fracture energy. 
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Figure 4.10: a) Response surface, b) contour and c) main effects plots depicting the effects 
of gellan-xanthan ratios, CaCl2 and PMMA concentrations on BSA MDT. 
 137 
 
7
8
60:40 70:30 80:20
9
0,100
0,075
0,050
CaCl2 (%w/v)*Gellan gum: Xanthan gum
80:2070:3060:40
0,100
0,075
0,050
8,0
8,5
9,0
60:40 70:30 80:20
9,5
20
60
40
7
8
9
0,050 0,075 0,100
10
60
40
20
Eudragit S100 (%w/w)*Gellan gum: Xanthan gum
80:2070:3060:40
70
60
50
40
30
Eudragit S100 (%w/w)*CaCl2 (%w/v)
0,1000,0750,050
70
60
50
40
30
Diclofenac
8 -  9
9 -  10
>  
MDT
10
<  7
7 -  8
Gellan:Xanthan
CaCl2%w/v
M
D
T
Gellan:Xanthan
PMMA %w/w
CaCl2%w/v
PMMA %w/w
Ca
Cl
2%
w
/ v
Gellan:Xanthan
Gellan:Xanthan
CaCl2%w/v
PM
M
A 
%
w
/ w
M
D
T
M
D
T
PM
M
A 
%
w
/ w
M
ea
n 
of
 D
ic
lo
fe
na
c 
M
D
T
80:2070:3060:40
9,5
9,0
8,5
8,0
7,5
0.1000.0750.050
755025
9,5
9,0
8,5
8,0
7,5
Gellan gum: Xanthan gum CaCl2 (%w/v)
Eudragit S100 (%w/w)
a) b)
c)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11: a) Response surface, b) contour and c) main effects plots depicting the effects 
of gellan-xanthan ratios, CaCl2 and PMMA concentrations on diclofenac sodium MDT. 
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A complete ANOVA analysis (presented in Table 4.6) was further conducted on the selected 
experimental response outcomes of %swelling, %erosion, %matrix resilience, deformation 
moduli, fracture energies and bioactive release represented as BSA and diclofenac MDTs to 
determine the correlation between the response variables and the predictor variables. A p-
value ≤ 0.05 indicates a significant effect between a response factor and the corresponding 
variable. The p-values highlighted in Table 4.6 indicate a significant effect of CaCl2 and 
PMMA concentrations on %swelling (CaCl2*PMMA, p = 0.014) and %matrix resilience 
(CaCl2, p = 0.043; PMMA, p = 0.021; PMMA*PMMA, p = 0.016; CaCl2*PMMA, p = 0.044) 
whereas CaCl2, solely, had a significant effect on deformation moduli (CaCl2, p = 0.013; 
CaCl2*CaCl2, p = 0.015) of the hydrogel formulations. The collective concentrations of 
gellan, xanthan and CaCl2 exhibited notable effects on the fracture energies 
(Gellan*Xanthan*CaCl2, p = 0.028) of the formulations. The response factors of %erosion, 
BSA MDT and diclofenac sodium MDT presented no significant effects with regards to the 
selected variable factors.  
 
Additional statistical evaluation of the experimental model was acquired via the analysis of 
residual plots (Figure 4.12) where uniformity and distribution of the obtained data points 
were assessed. The normal probability plots of the residuals concerning the %swelling, 
%erosion, %matrix resilience, deformation modulus, BSA MDT and diclofenac sodium MDT 
present strong linear  arrangement of the points indicating normal distribution whereas that 
of fracture energy deviated from the line with clustering of the points towards a linear 
arrangement thus indicating the potential influence of an external unaccounted variable. The 
residuals versus fitted plots of the 7 aforementioned response variables present random 
scattering of the lack of clustering of the points on either side of the zero line therefore 
suggesting the absence of trends. The histograms pertaining to the effects of BSA MDT, 
deformation modulus and %matrix resilience depict bimodal and symmetrical distribution of 
the residuals thus indicating probability of a uniform distribution of the acquired dataset with 
non-random error as noted from the evenly distributed points in the plots representative of 
the relationship between the residual and observation order. The histograms relating to 
%swelling, %erosion, fracture energy and diclofenac sodium MDT lacked symmetrical 
distribution denoting the occurrence of a random error of the dataset as further indicated by 
the declined even distribution of the data points along the zero line of the observation order 
plots. 
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Table 4.6: ANOVA analysis for the measured responses. 
    p-values    
Response Variables %Swelling %Erosion %Matrix 
Resilience 
Deformation 
Modulus 
Fracture 
Energy 
BSA 
MDT 
Diclofenac 
Sodium 
MDT 
Constant 0.579 0.000 0.011 0.044 0.061 0.433 0.507 
Gellan:Xanthan 0.627 0.767 0.253 0.334 0.206 0.675 0.383 
CaCl2 0.215 0.112 0.043 0.013 0.373 0.338 0.284 
PMMA 0.511 0.680 0.021 0.865 0.650 0.088 0.065 
Gellan:Xanthan* 
Gellan:Xanthan 
0.915 0.100 0.405 0.649 0.569 0.375 0.387 
CaCl2*CaCl2 0.334 0.384 0.144 0.015 0.633 0.855 0.322 
PMMA*PMMA 0.424 0.967 0.016 0.810 0.923 0.068 0.134 
Gellan:Xanthan*CaCl2 0.298 0.060 0.854 0.610 0.028 0.095 0.388 
Gellan:Xanthan*PMMA 0.713 0.135 0.638 0.708 0.385 0.699 0.379 
CaCl2*PMMA 0.014 0.547 0.044 0.544 1.000 0.626 0.306 
 
The complete regression equations regenerated for the responses of %swelling, %erosion, 
%matrix resilience, deformation modulus, fracture energy, BSA MDT and diclofenac sodium 
MDT are presented as follows: 
 
%Swelling = 559 – 73.1[Gellan:Xanthan] + 13836[CaCl2] – 9.32 [PMMA] 
  Equation 4.6 
 
% Erosion = 70.3 – 0.112[Gellan:Xanthan] – 85.7[CaCl2] + 0.108[PMMA] 
Equation 4.7 
 
%Matrix Resilience = 40.7 + 2.55[Gellan:Xanthan] – 207[ CaCl2] + 0.209[PMMA] 
Equation 4.8 
 
Deformation Modulus (N/mm) = 1.20 + 0.135[Gellan:Xanthan] – 15.2[CaCl2] + 
0.00466[PMMA] 
Equation 4.9 
 
Fracture Energy (N.mm) = 0.126 + 0.00040[Gellan:Xanthan] + 0.305[CaCl2] – 
0.000415[PMMA] 
Equation 4.10 
 
BSA (MDT) = 9.86 + 0.809[Gellan:Xanthan] + 14.1[CaCl2]  - 0,0672[PMMA] 
Equation 4.11 
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Diclofenac Sodium (MDT) = 6.26 + 0.139[Gellan:Xanthan] + 31.2[CaCl2] – 0.0050[PMMA] 
Equation 4.12 
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Figure 4.12: Residual plots for the responses a) %swelling b) %erosion c) %matrix 
resilience d) deformability modulus e) fracture energy f) BSA MDT and g) diclofenac sodium 
MDT. 
 
4.3.4. The effect of hydrogel polymer composition on the hydrodynamic and 
mechanical properties of the matrix in vitro 
Swelling and erosion studies provide insight into the dominant drug release mechanism and 
the resultant changes in mechanical properties by determining the degree of water-uptake 
into the matrix network. The overall change in size of the system (Figure 4.13 ) induced by 
swelling is an important factor to consider for implantable scaffolds, including its erosion 
properties, as these characteristics affect the mechanical strength of the implant and the in 
vivo performance. The presented data in Figure 4.13 shows the percentage swelling and 
erosion over a period of time for the different gellan-xanthan gum hydrogel formulations 
containing varying quantities of pristine PMMA particles and crosslinker. All polysaccharide 
polymers are hydrophilic materials with great propensity for swelling via their water-
absorbing properties (Coviello et al., 2006). The gradual absorption of water leads to various 
changes in the polymer network encompassing processes of hydration, conversion of the 
matrix from glassy to rubbery states, polymer chain relaxation and disentanglement 
eventually leading to disintegration. These intrinsic factors and the accumulation of water 
molecules amid the polymer chains create changes in the mechanical properties of the 
matrices over time. From the textural profiles obtained, it is noted that the ratios of 
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gellan:xanthan gum and the crosslinker concentration influence mainly deformation and 
fracture energy of the hydrogel matrices whereas pristine PMMA particle concentration 
largely affected matrix resilience properties. The concentrations of gellan, xanthan, PMMA 
particles and CaCl2 affects the water-absorptive capacity of the hydrogel networks due to the 
various types of crosslinks formed and the unique gelling properties of the polysaccharide 
gums. Increase in pristine PMMA particle content reduces the swelling capacity of the 
polymer matrix due to the formation of pores leading to the potential continuous inflow and 
outflow of water through the pores. Swelling was enhanced with increased concentrations of 
CaCl2 crosslinker in the gellan-xanthan formulations, which further increased the size of the 
hydrated conduit in terms wall thickness. The intermolecular and intramolecular calcium-
carboxylate complexes formed between gellan-xanthan, gellan-gellan and xanthan-xanthan 
chains upon crosslinking promote enhanced holding of the network thereby increasing the 
hydrogel’s water-holding capacity. Upon in vitro swelling and gap enlargement between the 
polymer chains forming the matrix network, the previously crosslinked bivalent calcium ions 
may escape being replaced with the weaker monovalent ions, potassium and sodium, from 
the dissolution media thereby unrestricting its water-uptake ability due to weak electrostatic 
shielding causing greater repulsion between the anionic carboxylates on the polymer side 
chains. Furthermore, it may be possible that an excessive concentration of CaCl2 disrupts 
the structured conformation of specifically gellan gum leading to a comprised network 
structure (Tang et al., 2001) thus permitting unhindered water penetration.  
 
Likewise, formulations containing higher xanthan gum ratios underwent greater swelling with 
less erosion occurring over time. This is due to the inherent swelling and erosion 
characteristics of the individual polymers. Although some xanthan chains may be partially 
interlaced with those of gellan forming intermolecular gellan-xanthan crosslinks, the xanthan 
chains forming weak intramolecular xanthan-xanthan crosslinks dissociate and absorb water 
to initiate swelling. The hydrogen-bond dissociation and slippage of small calcium ions from 
xanthan chains may lead to the lack of electrostatic shielding causing increased repulsion 
between negatively charged pyruvate and glucoronate moieties resulting in polymer chain 
expansion as water-uptake increases.  
 
It is noted that the enhanced swelling associated with increase in CaCl2 concentration and 
the xanthan gum ratio produced hydrogels of lower resilience and deformation but with 
higher fracture energies as shown in Figure 4.14. This suggests that increased water-uptake 
and swelling resulting from accumulation of entrapped water within the matrix decreases 
matrix resilience and deformation while increasing fracture energies. This may be attributed 
to the changes occurring in mainly xanthan gum during water-absorption and swelling. 
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Xanthan gum does not form rigid 3D gels as gellan gum does, instead it undergoes changes 
in viscosity modulated by temperature and ionic strength of the gel solution. Increasing 
crosslinker concentrations only thicken the gel solution inhibiting its flow properties. Further 
penetration of water and potential loss of calcium ions from the single xanthan helices and 
chains initiates the change of the gel from a viscous to a more fluid state. As a result, matrix 
resilience is lowered due to filling of pores with xanthan gel and excess entrapped water. 
The hydrogel network in its swollen state is more flexible due to the viscous gel-sol state of 
xanthan gum according to the lowered deformation values, however, since xanthan gum is 
pseudoplastic (Pongjanyakul and Puttipipatkhachorn, 2007; Dário et al., 2011) in nature it 
flows upon application of stress via a transient decrease in viscosity thus requiring higher 
energies to slightly deform in order to flow but not actually causing rupturing of the gel 
system. In contrast, increased gellan gum ratios inhibited water-uptake and swelling in 
addition to improving resilience properties. However, such formulations were stiff as 
presented by the higher deformation values due to the instantaneous formation of a solid 
gel-structure via establishment of junction zones when crosslinked with mono- and divalent 
ions at temperatures above 90˚C. Compared to xanthan, gellan required less energy to 
initiate change in shape but it easily reverts to its original shape upon compression and 
decompression forces reflected by its enhanced resilience. However, it contributed towards 
the formation of a stiffer and less flexible system producing brittle matrices that were easily 
broken as indicated by the low fracture energies required to initiate rupture. 
 
It was further noted that formulations containing higher ratios of gellan gum and calcium 
chloride, 4 parts gellan to 1 part xanthan and 0.1%w/v crosslinker, displayed high fracture 
energies and low matrix flexibility due to the formation of a rigid gel network following 
conformation of an orderly molecular structure upon crosslinking. Increased gellan and 
calcium quantities produce brittle hydrogel matrices which crack upon application of a force 
due to resistance of the force rather than distributing the applied energy throughout the 
matrix to undergo plastic deformation. Formulations 1 and 15 undergoing the greatest 
degree of swelling (absorbing a maximum of 0.312mL and 0.428mL of water, respectively) 
were least resilient and the deformation modulus and fracture energies indicated a brittle 
matrix, particularly F15 which was observed to crack during compression from the textural 
probe. F1 was least prone to cracking compared to F15 due to its higher ratio of xanthan 
gum however; both formulations contained the maximum crosslinker concentration. Xanthan 
modifies the hardness of the hydrogel matrix offering a method for achieving a fine balance 
between flexibility and rigidity.  
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Figure 4.13: Water-uptake properties of Gel-Xan IPNs showing %swelling (top), wall 
thickness of the conduits (middle) and %erosion (bottom) over a study period of 30 days in 
PBS pH 7.4. 
 
Erosion of the polymer matrix decreases with increased CaCl2 crosslinker concentrations 
due to the formation of rigid crosslinks in certain areas of the hydrogel however the inclusion 
of pristine polymer particles had opposing effects on the erosion properties of matrices. The 
erosion rates of the gellan-xanthan gum matrices appeared steady; however, higher pristine 
polymer particle content increased the initial and final stages of erosion. The observed 
erosion characteristics may be attributed to the differences in ionic charge of the individual 
polymers and the ionic interactions taking place between the polysaccharide matrix and the 
intercalated pristine PMMA particles at pH 7.4. With both the gellan-xanthan combination 
and PMMA being anionic polymers, ionic attraction interactions are not possible and 
repulsion occurs between the similarly charged compounds. The actions of repulsion and 
further influx of water into the gellan-xanthan matrices results in the dissolution and 
subsequent release of a large number of PMMA particles thereby contributing to the 
hastened erosion rate signified by mass loss of the matrix. F4, F5, F12 and F14 exhibited 
the highest erosion rates and resilience due to the loss of PMMA particles from the matrix 
resulting in less polymer material remaining at the various sampling points.  Subsequent to 
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erosion and loss of polymer mass, the lessened quantity of polymer matrix remaining is 
unable to absorb further water and undergo swelling compared to the slower eroding blends 
containing less PMMA particles, hence the stabilizing swelling profiles. As erosion continues, 
deformation and fracture energy decrease as the matrix loses bulk weight and weakens, 
thus indicating loss of rigidity of the network. A weakening matrix network requires less 
energy to cause a break in the system hence the declining fracture energies. 
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Figure 4.14: Texture analysis depicting fracture energy (left) and deformation (right) of the 
experimental formulations performed at various time-points post-dissolution in PBS pH 7.4. 
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4.3.5. Pristine polymer particle intercalation, hydrogel water-absorption analysis and 
formation of gelled-core microenvironment   
The crosslinked gellan-xanthan gum hydrogel formulations were able to sustain the release 
of the model protein, BSA (Figure 4.15), up until 15-20 days. Thereafter, no further BSA was 
detectable. Formulations 2, 4, 5, 6 and 9 released between 45-50% of the total incorporated 
protein whereas F1, F3, and F13 released more than 50% and F7, F8, F10, F11 and F14 
releasing between 60-67% of the total protein. At the end of 15 days, F12 released the 
lowest amount of protein, 37%, and F15 released the highest amount of 75%. Formulation 
15, releasing the highest amount of BSA also exhibited the fastest release rate which 
corresponds to its high degree of water-uptake and swelling. Formulation 12 displayed the 
slowest release rate conferred by the equally slowed rate of water penetration and swelling. 
Similar release kinetics were observed with the release of diclofenac sodium however, the 
release of diclofenac sodium from all the formulations was significantly retarded with only 14-
20% of the total drug being released over 30 days as shown in Figure 4.15.  
 
Drug release from controlled-release systems occurs primarily via three mechanisms: 
diffusion-controlled, swelling-controlled and chemically-controlled (Fu and Kao, 2010; 
Siepmann and Peppas, 2011). The inclusion of pristine PMMA particles assisted in reducing 
the drug release rates for both BSA and diclofenac sodium. The slowed release rates 
imparted by the intercalation of pristine PMMA particles are seen particularly in F4 and F9 
where drug release is dependent on water penetration into the matrix, hydration of the 
PMMA particles and subsequent dissolution of PMMA out of the matrix. The release rate of 
F4 corresponds to the reduced water-uptake and swelling. Formulations 1, 3, 5 and 15 
containing the highest concentration of crosslinker displayed faster release rates which were 
mostly due to the enhanced swelling of the matrix, particularly F1 and F15 which underwent 
the greatest swelling and size change. Faster dug release rates in the presence of increased 
CaCl2 concentrations may attributed to the formation of intramolecular complexes between 
calcium ions and the pyruvate moiety of xanthan gum leading to collapse of the sidechains 
into the polymer backbone thereby decreasing the hydrodynamic volume of the polymer 
chains  when a rigid orderly conformation is adopted. This intramolecular interaction and 
chain conformation results in the formation of large network pores which facilitate water and 
drug diffusion through the matrix (Jaipal et al., 2013). Moreover, the exchange of excess 
calcium ions with weaker monovalent ions present in the dissolution medium and the 
pronounced electrostatic repulsion between anionic side chains of the polymers may have 
resulted in uncontrolled swelling thus allowing the escape of drug molecules via diffusion 
through the enlarging meshwork between the polymer chains of the gel matrix as swelling 
and network expansion continued (Baumgartner et al., 2008; Jaipal et al., 2013). The 
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erosion associated with the inclusion of pristine polymer particles did not affect the drug 
release rates, since upon the dissolution of the particles drug molecules remained within the 
gel matrix and slowly diffused out through the pores as the hydration interface expanded. 
Decreased drug release rates were noted with formulations containing higher ratios of 
xanthan gum. In these cases, the viscosity change of xanthan gum associated with its water-
uptake and swelling combined with the pH-responsive particulate leaching contributed to the 
formation of gelled-filled channels and pore structures. These gel-filled spaces retarded the 
diffusion-driven movement of drug molecules out of the matrix thus retaining the drug 
particles in a gel-suspension within these voids. 
 
Mathematical modelling was performed to assist the ascertainment of the drug release 
mechanism and its correlation to the observed swelling and erosion utilizing bioactive 
release as a function of time. Mathematical modelling results shown in Tables 4.7 and 4.8 for 
BSA and diclofenac sodium, respectively, show that the drug release kinetics of the 
incorporated model drugs is best described by the Higuchi equation. This indicates that the 
prevailing drug transport mechanism is diffusion-based where a rate limiting boundary layer 
may further influence drug release rates. The chemical composition of F15, however, 
ascribed its release of BSA to the First-Order model. 
 
The diffusional exponent, derived from n of the Korsmeyer-Peppas equation, determines the 
type of diffusional release whereas the Peppas-Sahlin model identifies the contribution of 
Fickian diffusion (F) and Case-II relaxational (R) release of the system by calculation of the 
R/F ratios. The release of BSA presented with various changes in the n-values across 
different formulations of varying polymer compositions whereas that of diclofenac sodium 
release was maintained between the ranges of 0.32-0.44. This indicates that variances in 
polymer and crosslinker composition produced no significant change in the drug transport 
mechanism of diclofenac sodium which is considered a purely Fickian diffusional release. 
The fairly constant R/F ratios in the 0.011-0.014 range and the negligible K2 values of 0.0001 
compared to the K1 values (0.006-0.010), listed in Table 4.8 for diclofenac sodium release, 
derived from the Peppas-Sahlin equation confirms Fickian diffusional release. 
  
Regarding the release of BSA, of the 15 experimental formulations, 11 formulations 
presented with n-values below 0.45 indicating Fickian diffusion. Formulations presenting 
smaller n-values, particularly F2 (0.1464), F4 (0.1345), F5 (0.1718), F9 (0.2243) and F14 
(0.2755) contained higher concentrations of pristine PMMA particles (0.5-0.75g/g) correlating 
to diffusion of drug molecules from an increasing series of porous microenvironment 
structures and expansion of the surrounding matrix attributed to swelling. The temporary 
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storage and release of drug molecules from within these gel-filled porous reservoirs 
produced near zero-order release profiles from Day 5 onwards. Similar n-values were noted 
for formulations comprising higher xanthan ratios and intermediate crosslinker and pristine 
particle concentration signifying the effect of water-uptake, swelling and viscosity change 
associated with xanthan gum on the diffusion-based transport of drug molecules. In contrast, 
formulations comprising increased ratios of gellan gum with intermediate calcium 
concentrations and low (0.25g/g) pristine PMMA particle intercalation exhibited higher n-
values within the 0.45<n<0.89 range. This was specifically noted with formulations F8, F10, 
F11 and F15 with n-values of 0.5897, 0.6263, 0.5084 and 0.7592, respectively. This 
suggests that decreasing PMMA particle concentrations and increasing gellan and calcium 
concentrations lead to a gradual shift in the drug release mechanism from an 
anomalous/non-Fickian transport towards Case-II transport encompassing predominantly 
polymer relaxation ensuing erosion as compared to the former anomalous transport 
featuring a coupled diffusion-polymer relaxation mechanism of drug transport (Fu and Kao, 
2010). This dual mechanism translates to the processes of polymer chain disentanglement 
and subsequent relaxation following the decrease in electrostatic shielding between 
carboxylate groups as water penetration into the matrix enhances thereby leading to gelling 
of particularly xanthan gum whereas gellan gum undergoes erosion of the matrix. The 
Peppas-Sahlin model validates the shift in the drug release mechanism brought about by 
decreased PMMA-particle intercalation and increased gellan and calcium concentrations as 
presented by the R/F ratio, K1 and K2 values in Table 4. Overall, K1 values were greater than 
K2 values therefore, indicating Fickian diffusional release as the predominant drug release 
mechanism. The R/F ratio varied among the different formulations for BSA release where 
higher R/F values indicate increased contribution of the Case-II relaxational release 
mechanism. As noted earlier, formulations F1, F8, F10, F11 and F15 comprising a lower 
degree of PMMA-particle intercalation (0.25g/g) and higher calcium concentrations 
presented with R/F ratios in the 0.040-0.042 range. Formulations F3, F6, F7, F12 and F13 
comprising 0.5g/g PMMA particles exhibited slightly lower R/F values between 0.031-0.036 
and formulation F4 and F5 containing 0.75g/g PMMA displayed the lowest value of 0.028 
and 0.016, respectively. The gradual decrease in R/F ratios upon increasing PMMA particle 
concentration promotes the dominance of Fickian diffusional release over Case-II 
relaxational release. 
 
Additionally, it was noted that although pristine polymer particle intercalation indeed slowed 
drug release rates, this effect was minute for the release of diclofenac sodium compared to 
the differences observed with the BSA release. This phenomenon could be ascribed to the 
difference in the aqueous solubility of BSA (≈40mg/mL) and diclofenac sodium (≈20mg/mL). 
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Therefore, diclofenac sodium may be subject to a dissolution-controlled drug release which 
is typically attributed to the low solubility of drugs in the matrix environment. In this instance, 
the release of diclofenac sodium is dependent on its local dissolution of drug particles within 
the matrix before diffusion of dissolved drug molecules out of the matrix occurs. In essence, 
drug dissolution within the matrix should be rapid compared to drug diffusion out of the 
matrix. Furthermore, the significantly smaller molecular size of diclofenac sodium, compared 
to that of BSA, leads to an increased likelihood of its occupation and entrapment within the 
microenvironment spaces, thereby delaying its release out of the matrix. It can be 
ascertained that the control of drug release from the pristine polymer intercalated gellan-
xanthan IPNs occurs via two steps: 1) the initial dissolution of intercalated particles which 
make way for drug molecules in the matrix to pass via diffusion 2) the resulting formation of 
gelled macroporous network which temporarily store drug molecules and inhibits its 
movement out of the matrix. Likewise, the diffusion-driven movement of drug molecules 
through the matrix occurs along a concentration gradient via a two-step process: 1) the 
movement of drug from the matrix into the empty large porous structures 2) the movement of 
drug out of these structures and into the surrounding media.  
 
4.3.6. Optimization of Box-Behnken experimental design and assessment of in vitro 
response outcomes 
Minitab® V15 statistical software was employed to generate the optimal variables and 
response outcomes based on the results of the Box-Behnken experimental design. As 
shown in Figure 4.16a, it was predicted that a gellan:xanthan ratio of 73:27, CaCl2 
concentration of 0.05w/v and low PMMA particle intercalation of 0.25g would produce the 
optimal P4[Gel-Xan]IPN formulation featuring ideal BSA fractional release, diclofenac MDT, 
swelling, erosion and compatible mechanical properties at the end of the 30-day study 
period. The optimised P4[Gel-Xan]IPN hydrogel was similar in composition to F10, with 
65.93% BSA and 19.51% diclofenac sodium released over 20 and 30 days, respectively 
(Figure 4.16b). At the end of the study, a swelling ratio of 677.04% and erosion of 68.79% 
with 42.01% resilience were noted whereas ideal deformation of 1.26N/mm and fracture 
energy of 0.173N.mm were obtained (Figure 4.16c-d). This demonstrated the ability of the 
optimised P4[Gel-Xan]IPN hydrogel in providing an attuned system for combined desirable 
drug release kinetics and durable textural properties, thereby conforming to the predicted 
response outcomes. 
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Figure 4.15: In vitro drug release profiles of BSA (left) and diclofenac sodium (right) in PBS 
pH 7.4.
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Table 4.7: Kinetic modelling results of BSA release from the PMMA-intercalated IPN gellan-xanthan hydrogel conduits. 
 
Formulation Zero-Order First-Order Higuchi 
Korsmeyer-
Peppas 
Peppas-
Sahlin 
Hopfenberg 
Hixson-
Crowell 
Best-fit 
model 
  R² R² R² R² n R² K1 K2 
R/F 
Ratio 
R² R²   
1 0.508 0.555 0.663 0.774 0.209 0.828 0.060 0.0025 0.042 0.532 0.539 Higuchi 
2 0.632 0.680 0.743 0.805 0.146 0.747 0.021 0.0006 0.029 0.656 0.664 Higuchi 
3 0.734 0.790 0.852 0.917 0.217 0.874 0.047 0.0017 0.036 0.762 0.772 Higuchi 
4 0.440 0.478 0.526 0.601 0.135 0.488 0.014 0.0004 0.028 0.459 0.465 Higuchi 
5 0.490 0.530 0.550 0.604 0.172 0.501 0.013 0.0002 0.016 0.510 0.517 Higuchi 
6 0.510 0.570 0.643 0.715 0.208 0.701 0.035 0.0011 0.032 0.540 0.550 Higuchi 
7 0.868 0.923 0.943 0.953 0.345 0.950 0.068 0.0022 0.032 0.898 0.907 Higuchi 
8 0.587 0.698 0.735 0.927 0.590 0.852 0.104 0.0042 0.040 0.643 0.661 Higuchi 
9 0.682 0.722 0.816 0.903 0.224 0.895 0.052 0.0042 0.081 0.702 0.709 Higuchi 
10 0.674 0.787 0.814 0.970 0.626 0.901 0.106 0.0042 0.040 0.731 0.750 Higuchi 
11 0.484 0.586 0.635 0.665 0.508 0.778 0.119 0.0050 0.042 0.534 0.551 Higuchi 
12 0.875 0.896 0.948 0.974 0.250 0.943 0.029 0.0009 0.031 0.886 0.889 Higuchi 
13 0.437 0.499 0.580 0.657 0.280 0.682 0.050 0.0017 0.034 0.468 0.478 Higuchi 
14 0.600 0.684 0.738 0.822 0.276 0.770 0.050 0.0016 0.032 0.642 0.656 Higuchi 
15 0.646 0.801 0.786 0.961 0.759 0.861 0.116 0.0046 0.040 0.725 0.751 First-Order 
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Table 4.8: Kinetic modelling results of diclofenac sodium release from the PMMA-intercalated IPN gellan-xanthan hydrogel conduits. 
 
Formulation 
Zero-
Order 
First-Order Higuchi 
Korsmeyer-
Peppas 
Peppas-Sahlin Hopfenberg 
Hixson-
Crowell 
Best-fit 
model 
  R² R² R² R² n R² K₁ K₂ 
R/F 
Ratio 
R² R²   
1 0.901 0.913 0.952 0.960 0.342 0.928 0.007 0.0001 0.014 0.907 0.909 Higuchi 
2 0.881 0.892 0.931 0.941 0.333 0.902 0.007 0.0001 0.013 0.887 0.889 Higuchi 
3 0.879 0.891 0.944 0.952 0.389 0.924 0.008 0.0001 0.013 0.885 0.887 Higuchi 
4 0.899 0.909 0.957 0.958 0.401 0.935 0.007 0.0001 0.014 0.904 0.906 Higuchi 
5 0.883 0.897 0.947 0.954 0.349 0.920 0.008 0.0001 0.012 0.890 0.893 Higuchi 
6 0.906 0.915 0.964 0.969 0.357 0.950 0.007 0.0001 0.014 0.910 0.912 Higuchi 
7 0.923 0.930 0.973 0.981 0.324 0.951 0.006 0.0001 0.014 0.927 0.928 Higuchi 
8 0.897 0.909 0.966 0.972 0.355 0.953 0.009 0.0001 0.012 0.903 0.905 Higuchi 
9 0.879 0.891 0.951 0.960 0.402 0.939 0.009 0.0001 0.011 0.885 0.887 Higuchi 
10 0.833 0.848 0.919 0.931 0.377 0.901 0.010 0.0002 0.020 0.841 0.843 Higuchi 
11 0.837 0.851 0.917 0.933 0.349 0.894 0.008 0.0001 0.012 0.844 0.846 Higuchi 
12 0.927 0.933 0.958 0.959 0.443 0.942 0.006 0.0001 0.011 0.930 0.931 Higuchi 
13 0.909 0.921 0.956 0.960 0.350 0.932 0.008 0.0001 0.013 0.915 0.917 Higuchi 
14 0.892 0.906 0.946 0.955 0.330 0.916 0.008 0.0001 0.013 0.899 0.902 Higuchi 
15 0.857 0.871 0.920 0.930 0.333 0.889 0.008 0.0001 0.013 0.864 0.867 Higuchi 
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Figure 4.16: Statistical optimization and response parameter outcomes of the P4[Gel-
Xan]IPNs: a) desirability plots depicting the variables required for the optimised formulation 
and response outcomes for the optimised Gel-Xan IPN hydrogel b) in vitro drug release 
profiles c) %swelling, %erosion and  %matrix resilience and d) textural analysis depicting 
deformation and fracture energy conducted over 30 days of dissolution in PBS pH 7.4. 
 
4.4. Concluding Remarks 
Utilizing heat for the transformation of polysaccharide gums from random coils to ordered 
helical structures combined with divalent metal ions for the physical crosslinking of xanthan 
moieties to that of gellan, via targeting of the carboxylate functional group, yields the 
successful formation of an IPN through a series of intramolecular and intermolecular 
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crosslinking mechanisms with metal ion chelation being the primary crosslinking method. 
Incorporating the technique of pristine polymer particle intercalation, using an appropriate 
pH-responsive polymer, is capable of producing zero-order release kinetics of protein and 
small molecular weight compounds via a tuneable combination of Fickian diffusional and 
Case-II relaxational release, dependent on the level of particle intercalation and 
hydrodynamic properties of the matrix. The in situ particulate leaching mechanism preceding 
the pH-responsive dissolution of the intercalated particles results in the formation of a porous 
microchannel network allowing for improved matrix resilience via formation of void space 
and controlled drug release modulated by the intermediate step of particle dissolution. 
Furthermore, integrating the concept of particle intercalation with an IPN swellable system 
provides a strategy for the simultaneous manipulation of matrix resilience properties 
whereas crosslinking of a weak gelling agent with a rigid gelling gum assists in adjusting 
scaffold pliability and stiffness for enhanced tissue compatibility of various soft and 
connective tissue types in addition to extending drug release rates for long-term drug 
delivery via resistance to diffusion-driven transport of drug molecules. 
 
The study involving the intercalation of pristine polymer PMMA particles within the anionic 
crosslinked gellan-xanthan gum polysaccharide matrices shows the advantages of 
decreased swelling, prolonged drug release and enhanced mechanical properties 
specifically matrix resilience and flexibility imparted by the pH-responsive dissolution of the 
particles leading to the formation of a porous network and channels. Furthermore, the tuning 
of matrix rigidity and flexibility was attainable via variation of xanthan gum composition in the 
hydrogel formulation. In addition, the ionic crosslinking of the hydrogel blends forming an 
interpenetrating network, as validated by FTIR spectrometry, provides the appropriate 
attributes of a tissue repair material offering a matrix network of suitable mechanical 
properties for tissue compatibility and the concurrent sustained release of proteins and small 
molecular weight drug molecules. The variables and responses investigated in this study 
necessitate an extended phase of formulation optimisation, based on the current findings, 
utilizing appropriate neurotrophic factors and subsequent analysis of the conduit’s 
regenerative potential in an in vivo peripheral nerve injury model. The results of the study 
show promise for the development of drug-delivering long-term tissue repair implantable 
scaffolds for the restoration of damaged tubular organ structures such as nerves, blood 
vessels and intestinal tissues. 
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CHAPTER 5 
DESIGN, FORMULATION AND STATISTICAL OPTIMIZATION OF 
ELECTROSPUN NEURAL GUIDANCE CUE SCAFFOLDS 
 
 
5.1. Introduction 
The technique of electrospinning for the design and fabrication of nanofibrous scaffolds for 
drug delivery and tissue engineering applications has acquired swift popularity over the 
years. Its maintained appeal for the fabrication of tissue regeneration scaffolds emanates 
from its ability to produce highly porous fibrous meshes of high surface-area-to-volume ratio 
and improved resemblance to the architectural properties of native extracellular matrix 
(ECM) in addition to its ability to encapsulate a diverse range of pharmaceutical drug 
molecules for the design of site-specific and controlled-release drug delivery strategies 
(Chew et al., 2007; Masaeli et al., 2013 and Souza et al., 2014).  
 
The electrospinning process consists of the basic setup, as depicted in Figure 5.1. A metal 
nozzle is connected to high voltage source and a syringe pump loaded with the polymer 
solution. The application of a high voltage current is required to surpass a specific critical 
value of the resulting electric field. When the electrostatic force exceeds the surface tension 
of the polymer solution, a fine jet of the polymer solution is emitted from the nozzle tip 
towards a grounded collector. Evaporation of the solvent from the polymer jet results in the 
deposition of fibers onto the collector. A cylindrical rotating collector is generally used for the 
acquirement of aligned fibers whereas a static collector leads to the formation of randomly-
orientated nonwoven fibers (Pan et al., 2006). 
 
The polymer utilized for the electrospinning of fibrous films in this study was Poly(3-
hydroxybutyric acid-co-3-hydroxyvaleric acid) (PHBV). PHBV is a polyhydroxyalkanoate 
(PHA) belonging to the class of naturally-derived biodegradable polyesters since it is bio-
synthesized by microorganisms that use it as an intracellular energy source (Masaeli et al., 
2013). The most commonly utilized PHAs are poly(3-hydroxybutyrate) and poly(3-
hydroxyvalerate) which are often blended together in various ratios for modification of the 
physicochemical and physicomechanical properties of the resulting PHBV copolymer. 
Although various studies have demonstrated its promising potential as non-cytotoxic 
scaffolds for neural, skin and bone tissue engineering; its high crystallinity, rigidity and 
brittleness further narrows its process-ability qualities for techniques such as film and 
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injection moulding, extrusion, blown-film manufacturing and fibre spinning (Masaeli et al., 
2013 and Wei et al., 2015).  
 
 
Figure 5.1: Schematic representation of the electrospinning setup and process for the 
collection of aligned fibers.  
 
PHBV, being hydrophobic, requires modification and blending with other constituents to 
enhance its limited cell adhesion and proliferation properties (Pompe et al., 2007 and 
Masaeli et al., 2013). Therefore magnesium, oleic acid and N-acetyl-L-cysteine (NAC) were 
incorporated to function as therapeutic and chemical cues for the design of neuronal 
guidance scaffolds for improved neuronal biocompatibility. 
 
The presence of magnesium ions may have potential for improving functional recovery after 
peripheral nerve injury via its neuroprotective properties. It was shown that increased 
consumption of magnesium as a dietary mineral improved functional recovery after sciatic 
nerve crush injuries (Pan et al., 2011). Vennemeyer et al., 2014a, demonstrated the benefit 
of magnesium salts in improving cell proliferation and neurite extension in primary mouse 
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neuronal stem cell cultures. In addition to its neuroprotective effects, the inclusion of 
magnesium could provide an electrical stimulus cue to assist nerve regeneration and muscle 
innervation (Vennemeyer et al., 2014b). An interesting study investigating the biodegradation 
and regeneration potential of magnesium wire filaments across the rat sciatic nerve gap 
injury model, reported adequate biocompatibility with mild inflammation and improved tissue 
regeneration while possibly slowing the rate of muscle atrophy (Vennemeyer et al., 2014b). 
 
To decrease the extent of inflammation in response to implantation of a foreign solid material 
and to assist with formulation preparation and elimination of chemical incompatibilities, 
magnesium ions were introduced into the scaffold system as a magnesium-oleate (MgOl) 
salt utilizing oleic acid. Oleic acid, known by the systematic name of octadecanoic acid, 
forms a large percentage weight composition of the sciatic nerve lipids (45% weight in the rat 
sciatic nerve) and myelin fatty acids (Berry et al., 1965; Norton and Cammer, 1984 and 
Sastry, 1985). Furthermore, it has been investigated for its role as a neurotrophic factor in 
the central nervous system (Velasco et al., 2003). 
 
Similarly, NAC has shown potential as a neuroprotective and growth-promoting agent in 
peripheral nerve injuries and as an adjunct therapy to pain management strategies in nerve 
injuries and neuropathies (Hart et al., 2004; Welin et al., 2009; Karalija et al., 2012; Panesar, 
2012 and Scheib and Höke, 2013). It has further, shown prospect as an effective enhancer 
of neuronal differentiation via increased expression of N-cadherin and activation of Akt (Noh 
et al., 2012). 
 
The present study utilizes the technique of electrospinning for the fabrication of PHBV 
aligned fibrous films for application as potential neuronal guidance scaffolds in peripheral 
nerve injuries. The blending of MgOl and NAC were further employed as modifiers of 
chemical, physical and mechanical properties of the electrospun PHBV fibers whilst 
contributing to the dual function as therapeutic and chemical cues of the scaffold. Figure 5.2 
depicts the 3 ways in which the electrospun fibrous sheets can be implemented for the 
design or improvement of nerve repair devices. The resulting fibrous films were analysed for 
chemical, thermal and crystallinity transitions, mechanical properties, erosion, bioactive 
release and neuronal proliferative effects in response to variations in MgOl and NAC 
concentrations. 
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Figure 5.2: Representation of the different ways of implantation of the NAC loaded PHBV-
MgOl electrospun fibrous films: a) utilized as a wraps or dressings with a tissue glue sealant 
for the protection of crush injuries where the nerve is unbroken b) electrospun sheets can be 
rolled and thermos-sealed into multi-ply hollow conduits of various sizes for the repair of 
transected nerve injuries c) electrospun sheets can be cut into various sizes to be used as 
liners or fillers in an existing hollow conduit for the introduction of physical neuronal guidance 
cues. 
 
5.2. Materials and Methods 
5.2.1. Materials 
Poly(3-hydroxybutyric acid-co-3-hydroxyvaleric acid) (PHBV) (PHV content 12mol%) natural 
origin, N-Acetyl-L-cysteine (NAC) (≥99% TLC), 2,2,2-Trifluoroethanol (≥99% GC) and 
dialysis tubing cellulose membrane (molecular weight cut-off = 14000Da) were purchased 
from Sigma Aldrich, Steinham, Germany. Sodium hydroxide pellets, chloroform, oleic acid 
vegetable (extra pure) and Span 80 were purchased from Merck, Darmstadt, Germany. 
Magnesium sulphate heptahydrate CP (MgSO4.7H2O), methanol and acetone were 
purchased from Associated Chemical Enterprises, Southdale, Johannesburg, South Africa. 
Ethanol (99% absolute) was purchased from LabChem, Edenvale, Johannesburg, South 
Africa. Milipore water was used for washing of preparations. Dulbecco’s Modified Eagle 
Medium (DMEM), Donor Equine Serum (DES) and Fetal Bovine Serum (FBS) were procured 
from Hyclone, Separations, South Africa. Pencillin/Streptomycin/Amphotericin B (P/S/AB) 
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solution and the Roche Cell Proliferation Kit I was purchased from Lonza, USA and Sigma-
Aldrich, USA, respectively. 
 
5.2.2. Determination of the upper and lower variable limits for construction of a Box-
Behnken experimental design 
For investigations into formulation optimization, a 3-factor Box-Behnken experimental design 
was constructed utilizing independent variables for fibre fabrication and the corresponding 
upper and lower limits for successful electrospinning processes. Electrospinning of 
preliminary formulations, varying in the chemical constituent concentrations, allowed the 
identification of the formulation variables and limits and optimization of the electrospinning 
parameters: flowrate, distance, rotation speed and voltage. Preliminary investigations 
revealed that PHBV polymer concentration and concentrations of MgOl (as grams per gram 
of PHBV) and NAC incorporation influenced the quality outcome of the electrospinning 
process. Although NAC was used as a bioactive and therapeutic agent, its incorporation into 
the fibrous films affected the mechanical properties, thus, its effects had to be considered for 
obtaining films of adequate strength. The electrospinning potential of the trial formulations, 
listed in Table 5.1, was used to determine the upper and lower variable limits. The aim was 
to keep the variable limits within the set electrospinning parameters. Therefore, the detected 
ideal electrospinning parameters were kept constant for the fabrication of fibers from the 
entire Box-Behnken experimental solutions. This was done as to prevent variations in 
formulation properties ascribed by alteration of the electrospinning parameters. The following 
electrospinning and design criteria were adhered to during determination of the variable 
limits and optimisation of the electrospinning parameters: 
 Physical and chemical stability of the formulation constituents in solution over the 
duration of electrospinning. 
 Tensile strength and flexibility of the electrospun films. 
 Smooth and unproblematic removal of the electrospun film from the collecting sheet. 
 Elimination of solution sputtering and nozzle blockage. 
 Minimisation of the deposition frequency of randomly orientated fibers. 
 
Table 5.1: List of preliminary formulation compositions and electrospinning parameters 
Formulation Composition Electrospinning Parameters 
(Flowrate; Distance; Voltage; Rotation) 
5%w/v PHBV, 0.5g/g MgOl in chloroform 3mL/hour; 155mm; 24.0kV; 850rpm 
 3mL/hour; 130mm; 24.0kV; 1000rpm 
 3mL/hour; 155mm; 24.0kV; 1200rpm 
 
10%w/v PHBV, 1g/g MgOl in chloroform 2mL/hour; 135mm; 24.0kV; 1000rpm 
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5%w/v PHBV, 0.2g/g MgOl in chloroform 
10%w/v PHBV, 0.5g/g MgOl in chloroform 
 
2mL/hour; 130mm; 24.0kV; 1000rpm 
 
5%w/v PHBV, 0.1g/g MgOl, 4%w/v NAC 
5%w/v PHBV, 0.6g/g MgOl, 4%w/v NAC 
5%w/v PHBV, 0.6g/g MgOl, 2%w/v NAC  
All in 3:2 chloroform:trifluroethanol 
2mL/hour; 150mm; 25.0kV; 1200rpm 
 
The trial formulations above assisted in the determination of the upper and lower variable 
limits as well as the detection of ideal electrospinning parameters suited for the various 
formulations lying within the range of the identified limits. Table 5.2 lists the variables, the 
identified limits and the effect on electrospinning of the samples utilizing fixed 
electrospinning parameters of: 2mL/hour flowrate, 150mm distance, 25.0kV voltage and 
1200rpm rotation speed. 
 
Table 5.2: The identified variables and the upper and lower limits for generation of a Box-
Behnken experimental design 
Variable  Effect 
PHBV Lower limit: 5%w/v Concentrations <5%w/v produced sparse 
fibers with thin and fragile film formation. 
 
 Upper limit: 10%w/v Concentrations >10%w/v resulted in 
increased viscosity of the polymer solution 
leading to overflowing at the nozzle tip and 
reduced electrospinning potential. 
 
MgOl Lower limit: 0.1g/g Concentrations <0.1g/g produced brittle 
and friable fibrous films that could not be 
removed from the collecting sheet without 
tearing. 
 
 Upper limit: 0.6g/g Concentrations >0.6g/g conferred poor 
electrospinning properties to the solution, 
often separating out and collecting at the 
nozzle tip causing blockages thus resulting 
in sputtering and spraying of the solution 
rather than spinning of fibers. 
Anything higher would precipitate out of 
solution as 0.6g/g was the solubility limit. 
 
Bioactive Loading   
NAC Lower limit: 0%w/v NAC-free formulations imparted increased 
tensile strength of the fibrous films. 
  
 Upper limit: 4%w/v Concentrations >4%w/v resulted in solution 
stability issues and precipitation of MgOl in 
addition to decrease in tensile strength of 
the films. 
However, NAC-loading enhanced 
conductivity and electrospinning of the 
 168 
 
solution. 
 
5.2.3. Fabrication of aligned guidance cues 
5.2.3.1. Synthesis of magnesium-oleate complex 
The magnesium-oleate (MgOleate) complex was synthesised using a method adapted from 
Ghosh et al., 2013, for metal-oleate preparation using oleic acid and methanol. Briefly, 4.93g 
of MgSO4.7H2O and 12.7mL of oleic acid were dissolved in 100ml methanol. After 30 
minutes of magnetic stirring, 100mL of a 0.4mol/L sodium hydroxide solution was slowly 
added (to avoid unwanted magnesium hydroxide precipitation) and stirred for a further 3 
hours for reaction completion to yield an oily white layer containing the MgOleate complex. 
The oily liquid was separated from the solvent, placed into dialysis tubing and dialysed 
against deionized water for 3 days followed by 3 washings with ethanol and acetone for the 
removal of any unreacted constituents. The resulting MgOleate precipitate, a yellow wax-like 
solid, was obtained by overnight drying in a vacuum oven at 100˚C and then stored in an 
airtight glass container until further use. 
 
5.2.3.2.. Electrospinning procedure for fibre fabrication 
The polymer solutions for electrospinning were prepared by dissolving PHBV pellets in a 
solvent mixture of chloroform and trifluoroethanol (for NAC solubilisation) in a 3:2 ratio under 
continuous magnetic stirring at 60˚C to prepare 5-10%w/v concentration solutions followed by 
the addition of MgOleate in the range of 0.1-0.6g/g PHBV and NAC in concentrations of 0-
4%w/v of polymer solution. For fabrication of the films, 5mL of the PHBV-MgOleate solutions 
with or without NAC were loaded into a syringe for electrospinning (NanoSpinner24, 
Inovenso, Turkey) onto Span 80-coated aluminium sheets (to facilitate effortless film-
removal) attached to a rotating drum set at 1200rpm, using a voltage of 25kV, a flowrate of 
2mL/hour and a nozzle distance of 150mm. The resulting films measured 8cm×30cm and 
were cut into 0.5cm×3cm strips for further analysis. A total of 15 experimental formulations, 
varying in PHBV, MgOleate and NAC concentrations, were synthesised employing a 3-factor 
Box-Behnken design utilizing Minitab® statistical software (V15, Minitab Inc., PA, USA)  as 
listed in Table 5.3. 
 
Table 5.3: Formulations obtained via the Box-Behnken experimental design 
Formulation PHBV (%w/v) MgOleate (g/g PHBV) NAC (%w/v) 
1 5 0.35 4 
2 10 0.35 4 
3 7.5 0.35 2 
4 7.5 0.35 2 
5 5 0.6 2 
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6 5 0.35 0 
7 5 0.1 2 
8 7.5 0.35 2 
9 7.5 0.6 4 
10 10 0.1 2 
11 7.5 0.1 4 
12 7.5 0.6 0 
13 10 0.35 0 
14 10 0.6 2 
15 7.5 0.1 0 
 
5.2.4. Response surface analysis as per Box-Behnken design and formulation 
optimization 
Response surface analysis of the 15 design formulations were carried out employing 
Minitab® statistical software (V15, Minitab Inc., PA, USA). The in vitro performance of the 
experimental formulations were evaluated according to the response outcomes of water-
uptake, erosion and tensile strength to elucidate the influence of polymer concentration, 
metal-oleate content and bioactive loading on the structural integrity of the electrospun films. 
Statistical optimization of the results obtained from the Box-Behnken experimental design 
predicted the optimal quantities of each chemical component required to obtain the ideal 
formulation based on the responses. 
 
5.2.5. Characterization of the electrospun aligned films 
5.2.5.1. Detection of vibrational molecular changes of the chemical constituents and 
electrospun fibers 
FTIR spectroscopy was used to confirm the synthesis of MgOleate and detect the molecular 
transitions and changes in crystallinity indices, of the experimental formulations, arising from 
interactions between PHBV, MgOleate, NAC and the overall electrospinning process. 
Samples were analysed over an FTIR spectra of wavelengths between 4000-600cm-1 using 
a PerkinElmer Spectrum 2000 ATR-FTIR (PerkinElmer 100, Llantrisant, Wales, UK) 
spectrometer fitted with a single-reflection diamond MIRTGS detector. 
 
5.2.5.2.. Thermophysical characterization of the electrospun fibers 
The thermal transitions upon heating and cooling of the electrospun fibers were determined 
using a Temperature Modulated Differential Scanning Calorimeter (TMDSC) (Mettler Toledo, 
DSC, STARe System, Swchwerzenback, ZH, Switzerland). Samples of 8mg were sealed in 
aluminium crucibles and heated or cooled over a temperature range of 0-300˚C and 200-
0˚C, respectively, at a temperature change rate of 10˚C/min. DSC curves were obtained by 
plots of sample weight over sample temperature. Differences in the heat flow, phase 
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transitions and crystallization temperatures of the formulations provided insight into the 
effects of polymer/metal-oleate interaction and electrospinning. A measure of crystallinity 
was determined using Equation 5.1.  
 
%Crystallinity = [ΔHm – ΔHc]/ΔHm˚              Equation 5.1 
 
Where the heats of melting, ΔHm, and cold crystallization, ΔHc, are in terms of J/g and 
ΔHm˚ is the heat of melting of the 100% crystalline reference polymer. 
 
The determination of change in sample weight as a function of temperature was performed 
using a Thermogravimetric analyser (TGA) (PerkinElmer, TGA 4000, Llantrisant, Wales, 
UK). Samples were heated at a rate of 10˚C/min from 30-900˚C under continuous nitrogen 
purging. Thermograms were generated as percentage weight vs. temperature and analysed 
using the PyrisTM software. Correlation of DSC and TGA data assists in determining the 
effect of MgOleate incorporation in relation to polymer thermal degradation properties. 
 
5.2.5.3. X-ray diffraction analysis 
Sample crystallinity and PHBV crystallite size were determined using X-ray diffraction 
measurements (Rigaku MiniFlex 600, Tokyo, Japan) computed into the %Crystallinity Index 
equation (Equation 5.2) and the Scherrer equation (Equation 5.3), respectively. 
 
CrI = I16/ITotal × 100                Equation 5.2 
  
Where CrI reflects the %crystallinity index of the sample, I16 is the intensity of the peak close 
to 2θ = 16˚ and ITotal is the sum of the intensities of all the crystalline peaks of PHBV. 
 
Π = Kλ/β cosθ                 Equation 5.3 
 
Where π is the particle size of single crystallites, K is the shape factor of value 0.9 for 
spherical particles, λ is the X-ray wavelength of 1.54 for CuKα X-ray source, β is the line 
broadening width (FWHM) at half maximum intensity measured in radians and cosθ is the 
Bragg angle. 
 
5.2.5.4. Tensile strength analysis 
Determination of the mechanical properties of the fibrous films before and after dissolution, 
at pre-determined sampling points was conducted using a Texture Analyser (TAXT.plus 
Stable Microsystems, Surrey, UK) fitted with two clamps and a 5kg load cell. A 0.5cm×3cm 
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film strip was fixed at a distance of 10mm between the two clamps and a pre-test, test and 
post-test speed of 0.5mm/s with a 0.5N trigger force was applied to the sample over a 
distance of 20mm. The force (N) at breaking point of the film sample was computed via 
generation of a Force-Distance textural profile. For the determination of tensile strength 
(MPa), Equation 5.4 was employed, where film dimensions of length, width and thickness 
were measured using a digital Vernier calliper (Krafft, DV150GW, Schoellerstr Düren, 
Germany). The deformability modulus (DM) (MPa) was determined from the slope of the 
generated Force-Distance curve whereas toughness of the sample (N.mm) was calculated 
from the area under the curve. 
 
Tensile Strength = Force at break point
 Cross-sectional area of sample
             Equation 5.4 
 
5.2.5.5. Scanning Electron Microscopy for visualisation of fibre morphology and size 
and Energy Dispersive X-ray Spectroscopy for elemental analysis 
Evaluation of surface morphology, fibre alignment, measurement of fibre size and image 
capturing was performed under different magnifications using an FEI Nova NanoLab 600TM 
Scanning Electron Microscope (SEM) (FEI Company, Hillsboro, OR, USA). The samples 
were further analysed for elemental composition using SEM-Energy Dispersive X-ray 
Spectroscopy (EDS). 
 
5.2.5.6. Water-uptake and erosion studies 
Water-uptake and erosion studies were performed by submersing 0.5cm×3cm film samples 
in 1mL of PBS pH 7.4 contained in glass vials. An orbital shaking incubator (LM-530-2, MRC 
Laboratory Instruments Ltd., Hahistadrut, Holon, Israel) maintained at 37˚C and set at 50rpm 
was used for sample agitation. Samples were removed at predetermined time intervals, 
excess moisture was carefully removed by blotting with tissue paper and the change in mass 
was measured for determination of moisture absorption. After 72 hours of drying time at 
40˚C, for complete removal of residual moisture, the film samples were weighed for 
determination of the eroded mass. Equations 5.5 and 5.6 were employed for the calculation 
of water-uptake and erosion, respectively. 
 
% Water-uptake = Wh-Wi
 Wi
 ×100              Equation 5.5 
% Erosion = Wf-Wi
Wi
 ×100               Equation 5.6 
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Where Wi is the intial weight of the film samples, Wh is the weight of the samples after 
hydration and Wf is the weight of the final eroded samples.  
 
5.2.5.7. In vitro release studies and kinetic modelling 
In vitro release studies of NAC from the electrospun films were performed using 0.5cm×3cm 
samples containing either 0.5mg or 1mg NAC. Samples were placed in glass vials 
containing 1mL PBS pH 7.4 and stored in an orbital shaking incubator.  At pre-determined 
time intervals, 0.5mL of dissolution media was removed for sample analysis and replaced 
with an equal fresh volume of media for maintenance of sink conditions. Samples were 
analysed for the quantity of NAC released using UV-spectrophotometry set at λmax = 212nm 
(Specord40, Analytik Jena, AG, Germany). The results were analysed using WinASPECT® 
Spectroanalytical Software (Analytik Jena AG, Jena). Further insight into the drug-release 
mechanisms was obtained via kinetic modelling of the drug-release profiles using the Zero-
order, First-order, Higuchi, Hixson-Crowell, Korsmeyer-Peppas and Peppas-Sahlin models 
as described in Chapter 4 Table 4.4. 
 
5.2.5.8. PC12 Cell culture and MTT proliferation assay 
Rat adrenal gland pheochromocytoma PC12 mixed adherent/suspension cell line from 
Cellonex (Separations, South Africa) was cultured in tissue culture treated (TPP) T-75 flasks 
using DMEM supplemented with 10%v/v DES, 5%v/v FBS and 1%v/v P/S/AB solution in a 
humid 5% CO2 atmosphere at 37˚C. The culture medium was replaced at 75% every 2 days. 
 
For the detection of cell proliferation and cyto-compatibility of the electrospun fibers, the 
MTT-based Roche Cell Proliferation Kit I was utilised. Electrospun film samples of size 
1cm×1cm were sterilized under UV light for 12 hours before overnight incubation in 400μL 
culture medium containing 10%v/v DES, 5%v/v FBS and 1%v/v P/S/AB in a 48-well plate 
maintained at 37˚C at 5% CO2. PC12 cells were seeded onto the film samples at a density of 
2×104 cells/well and incubated for 72 hours. Thereafter, 40μL MTT solution was added to 
each well followed by a further 4-hour incubation period after which 400μL solubilising agent 
was added to dissolve the formazan crystals. The entire well contents were aspirated off, 
placed into 2mL Eppendorf tubes and centrifuged at 2000rpm for 5 minutes to separate 
suspended cells. The resulting supernatant was transferred into a 96-well plate and 
measured for absorbance at 550nm, with a background subtraction at 690nm, using a multi-
plate reader (BioTek, USA). 
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5.3. Results and Discussion 
5.3.1. Validation of MgOleate complex synthesis 
FTIR spectroscopy (Figure 5.3a) of the primary reagents, oleic acid and MgSO4.7H2O, were 
studied to elucidate the transitional vibrational shifts corresponding to the molecular 
composition of the resulting metal-oleate salt. Oleic acid presented with bands at 3004cm-1, 
2922cm-1 and 2853cm-1 corresponding to =CH stretching in the C=CH group,  ̶ CH2 
asymmetrical and symmetrical stretching, respectively. The carbonyl =COOH groups of oleic 
acid presented with peaks at 1709cm-1, 1463cm-1 and 1284cm-1 relating to C=O carbonyl 
stretching, O-H band and C-O stretching, respectively. Bands at 1412cm-1, 935cm-1 and 
723cm-1 were indicative of CH3 groups, out-of-plane O-H stretching and CH2 rocking, 
respectively (Xu and Hu, 2012). Peaks indicating water of crystallisation in the heptahydrate 
region of MgSO4.7H2O appeared at 3202cm-1 and 2343cm-1 representing O-H vibrational 
stretching whereas O-H bending emerged at 1670cm-1. Asymmetrical and symmetrical 
stretching vibrations of sulphate produced peaks at 1056cm-1 and 982cm-1, respectively 
(Zhao et al., 2006; Ovalles et al., 2009). The FTIR spectrum (Figure 5.3a) of the synthesised 
MgOl complex revealed that the metal-oleate salt formed as a result of Mg2+ ions binding to 
the free carbonyl groups of oleic acid as indicated by the formation of new peaks occurring 
at 1561cm-1 and 1452cm-1 representing carboxylate asymmetrical and symmetrical 
stretching, respectively, and the shift of a weakened C-O stretching peak to1308cm-1 (Ross 
and Lemay, 1985; Labidi and Iddou, 2007). The numerical difference between the 
carboxylate asymmetrical and symmetrical peak wavenumbers suggest the formation of a 
bidentate ligand between Mg2+ ions and COO- groups in MgOl as described by Bronstein et 
al., 2007.  
 
TGA analysis further confirmed the formation of the MgOl complex by studying the thermal 
degradation patterns of oleic acid and MgSO4.7H2O as sown in Figure 5.3b. Oleic acid 
presented with 2 phases of degradation: the first ranging from 310.91-326.72˚C 
corresponding to the thermal decomposition of carboxylates and the second phase  
occurring from 400-800˚C indicating thermal cracking of the hydrocarbon chains (Manzi-
Nshuti et al., 2009). The thermal degradation of MgSO4.7H2O occurred in 4 stages: the first 
stage at 97.88˚C indicative of water loss and the second (147.08˚C) and third (287.82˚C) 
stages attributed to the decomposition of the organic sulphate region of the compound. The 
fourth stage occurring between 300-800˚C presented with no change in weight loss and thus 
indicated the inorganic magnesium component forming 50% of the sample mass. Likewise, 
the thermal decomposition of the organic and inorganic constituents of MgOl occurred in 3 
steps (Figure 5.3b): the first step occurring over 342.63-375.63C˚C was indicative of 
carboxylate decomposition and the second step at 452.59˚C suggested thermal cracking of 
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hydrocarbons. A shift to higher temperatures is noted in the first step corresponding to 
carboxylate degradation which could be attributed to the formation of ionic complexation with 
Mg2+ ions thereby increasing thermal stability (Figure 5.3b). The first 2 steps involved 
organic decomposition of the compound whereas the last step, 550-850˚C, presenting with 
minimal change in weight indicated the inorganic magnesium residue at 9.1% of the total 
sample mass. DSC analysis established the melting point of MgOl as 128.34˚C with the 
onset of thermal degradation at 270.58˚C. The high thermal stability of MgOl indicates the 
presence of elemental magnesium. 
 
Both FTIR and TGA analysis confirm the synthesis of a magnesium-oleate salt complex 
where unreacted reagents and sulphate or sodium residues are undetectable. Samples 
subject to EDS analysis further revealed the presence of only magnesium in the electrospun 
PHBV-MgOl fibers. 
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Figure 5.3: Validation of MgOl synthesis a) FTIR spectra showing the composition of the 
reagents used to synthesize MgOl and the mechanism of ionic bidentate complexation and 
b) TGA thermograms showing the presence and increased thermal stability of the 
synthesized MgOl compared to its primary constituents. 
 
5.3.2. Assessment of vibrational molecular and thermophysical transitions of PHBV 
fibers upon MgOl and NAC incorporation 
FTIR spectroscopy of the experimental design formulations validated the PHBV-MgOl blend 
where the molecular composition of the electrospun fibers remained similar to that of the 
parent constituents, PHBV, MgOl and NAC (Figure 5.4). Formulations containing NAC 
presented with a broad band at 3370cm-1 indicative of N-H stretching and weak bands at 
2547cm-1 and 1916cm-1 where the former is attributed to S-H stretching (Picquart et al., 
1998). Bands at 2927cm-1 were indicative of PHBV symmetrical –CH2 stretching and MgOl 
asymmetrical stretching whereas the weak peak at 2854cm-1 represented MgOl –CH2 
symmetrical stretching vibrations (Ross and Lemay, 1985; Labidi and Iddon, 2007; Cheng et 
al., 2009). Peaks at 1378cm-1 were attributed to CH2-CO vibrations of PHBV (Cheng et al., 
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2009). Asymmetrical and symmetrical stretching of the magnesium-carboxylates groups of 
MgOl are assigned to peaks at 1564cm-1 and 1454cm-1 where the latter could represent 
scissoring vibration of –CH2 groups of PHBV as well (Ross and Lemay, 1985; Labidi and 
Iddon, 2007; Cheng et al., 2009). The high intensity peak at 1720cm-1 is attributed to the 
C=O vibration of the carboxylic groups of PHBV and reflects the highly crystalline 
composition of the polymer (Cheng et al., 2009). It was noted that the intensity of this 
crystalline peak decreased upon increased MgOl addition compared to formulations 
containing less MgOl, as shown in Figure 4: F5 and F7, thus suggesting a change in the 
crystalline nature of the polymer. 
 
Figure 5.4: FTIR spectra of pristine PHBV and NAC and F5 and F7 showing molecular 
compositions and transitions upon blending of PHBV with MgOl and NAC. 
 
The blending of MgOl with and incorporation of NAC in the PHBV polymer base did not 
induce any notable structural molecular changes in the final electrospun film fibers. 
However, DSC and TGA analysis revealed thermophysical transitions relating to melting 
points, onset of degradation and overall thermal decomposition when upon the addition of 
MgOl and NAC. 
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TGA thermograms depicted the mass degradation of the experimental formulations 
occurring in 2 major steps. The first step occurring at 230˚C suggested the degradation of 
NAC and appeared only in formulations containing NAC since F6, F12 (shown in Figure 5.5), 
F13 and F15 free of NAC were absent of this peak. It was further noted that F14 containing 
the maximum variable concentrations of PHBV and MgOl and only 1%w/w NAC did not 
present this peak. Similarly, F3, F4 and F5 containing 1%w/w NAC presented with weak 
shouldering peaks ranging from 233˚C and 236˚C. The major decomposition peak indicative 
of PHBV degradation at 298.36˚C (in pure PHBV) was significantly decreased upon MgOl 
addition, ranging from 254.82-282.53˚C. This suggested that formulations containing higher 
concentrations of MgOl possessed lower thermal stability, as seen in Figure 5.5 with F9 
(265.23˚C) and F12 (254.49˚C), attributed to the decrease in crystallinity as noted in FTIR 
analysis of the PHBV carboxylate peak (Figure 5.4) whereas stability was improved upon 
NAC addition and decrease in MgOl as noted in F11 (282.53˚C) containing 2%w/w NAC 
(Figure 5.5). These results corresponded to that obtained from DSC analysis.  
 
 
Figure 5.5: Representation of TGA curves depicting the transitions in thermal degradation 
properties of the formulations upon incorporation of MgOl and NAC-loading into the 
electrospun PHBV fibers. 
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DSC curves, shown in Figure 5.6, of the experimental formulations depicted the emergence 
of 2 distinct endothermic peaks corresponding to PHBV melting and degradation. In some 
cases, an initial weaker endothermic peak at around 120˚C was noted, which could be 
attributed to the melting of either MgOl or the hydroxyvaleric acid co-polymer in PHBV. The 
melting points (Tm) of the parent constituents were established as 154.71˚C, 128.34˚C and 
111.67˚C for PHBV, MgOl and NAC, respectively. The Tm and degradation temperature (Td) 
of pure PHBV peaking at 282.54˚C was noted to decrease after the addition of MgOl as 
indicated in the comparisons in Figure 5.6c-f of selected formulations composed of the lower 
and upper limit of MgOl. Changes in PHBV content of the film fibers presented no change in 
the Tm and Td. It was noted that for formulations composed of 5%w/v (F5 and F7) and 10%w/v 
(F14 and F10) PHBV, increase in MgOl concentration resulted in an increased Tm (151.61˚C 
and 149.59˚C; 150.14˚C and 148.22˚C, respectively) and decreased Td (244.55˚C and 
253.49˚C; 243.72˚C and 256.15˚C, respectively) whereas those composed of 7.5%w/v PHBV 
resulted in the decrease of both Tm and Td, as seen with F9 (141.59˚C and 248.98˚C, 
respectively) and F11 (146.25˚C and 261.35˚C, respectively). As shown in Figure 5.6b, 
formulations containing NAC demonstrated decreases in Tm compared to the NAC-free 
varieties (F9: 141.59˚C and F12: 142.58˚C; F11: 146.25˚C and F15: 151.57˚C; F1: 142.56˚C 
and F6: 149.59˚C; F2: 142.42˚C and F13: 151.77˚C) which could be attributed to the lower 
Tm of NAC, however, such formulations tolerated higher Td temperatures making the NAC-
loaded fibers more heat stable. The experimental formulations presented with a Tm in the 
range of 141-152˚C and a Td ranging between 206-262˚C. The blending of MgOl with PHBV 
resulted in the emergence of the glass transition temperature (Tg), as shown througout 
Figure 5.6, at approximately 3˚C whereas the Tg of PHBV in Figure 5.6a is absent due to its 
probable occurrence at temperatures lower than 0˚C. In addition to the effects of MgOl and 
NAC, it was further revealed that the electrospinning process too impacted the thermal 
properties of the formulations. A sample of pure PHBV (7.5%w/v) electrospun fibers were 
determined as having a Tm and Td of 152.90˚C and 264.82˚C, respectively, being 
considerably lower than that of neat unmodified PHBV pellets. This sample of pure 
electrospun PHBV was further utilized as a comparative to evaluate the effects of 
electrospinning on formulation crystallinity. 
 
The thermophysical transitions, in conjunction with FTIR analysis, suggest an alteration of 
the crystalline properties of the polymer rather than chemically-induced changes as indicated 
by the weakened thermal stability of the experimental formulations and the absence of major 
molecular vibrational shifts. 
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Figure 5.6: DSC thermograms of a) the parent constituents and representation of the 
changes observed with b) NAC-loading (F1) and c-f) increase in MgOl from 0.1g/g (F7, F11, 
F10 and F15) to 0.6g/g (F5, F9, F14 and F12). 
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5.3.3. The effect of MgOl, NAC and electrospinning on PHBV fibre crystallinity  
FTIR spectroscopy was used to determine the changes in crystallinity imparted by the 
addition of MgOl and NAC and the overall electrospinning process by noting the changes in 
intensity of various crystalline and amorphous peaks of PHBV. It has been established that 
the bands appearing at 1720cm-1, 1278cm-1, 1230cm-1 and 980cm-1 are characteristic of 
crystalline states of PHBV whereas amorphous bands are attributed to signals appearing at 
1740cm-1 and 1185cm-1 (Li et al., 2004; Buzarovska et al., 2009; Wei et al., 2015). The 
peaks appearing at 1382cm-1 and 1453cm-1 are considered insensitive to the composition 
and crystallinity of PHBV blends and hence are used as normalising peaks when 
determining the Crystallinity Index (CI), as an indication of the degree of crystallinity, of the 
various formulations (Li et al., 2004; Luo et al., 2007; Sridhar et al., 2013). The ratios of the 
absorbance peaks at 1382cm-1/1185cm-1 (Bloembergen et al, 1986; Li et al., 2004; Sridhar 
et al., 2013) and 1453cm-1/1185cm-1 (Luo et al., 2007) provided a measure of the 
amorphous composition of the formulations. The extent of crystalline content was 
determined by the ratios of the absorbance peaks at 1720cm-1/1740cm-1 and 1230cm-
1/1453cm-1 (Wei et al., 2015). 
 
It is noted that process of electrospinning yields changes in the crystalline state of PHBV. 
The results obtained show minimal amorphous change between PHBV pellets, in its raw 
unprocessed form, and electrospun fibrous films (Δ 0.039-0.044). However, the CIs 
determined from the 1720cm-1/1740cm-1 and 1230cm-1/1453cm-1 bands demonstrate 
increased crystallinity of the polymer upon electrospinning (3.048 and 3.614, respectively) 
compared to unprocessed PHBV (2.605 and 3.365, respectively) as shown in Figure 5.7a. 
Pure electrospun PHBV presented with the highest FTIR-derived CI in comparison to the 
experimental formulations. Likewise, it was noted that the experimental formulations 
presented with minimal CI changes with regards to the amorphous bands in contrast to the 
crystalline bands which exhibited significant variations to the addition of MgOl and NAC. 
Formulations containing NAC presented with higher CI values, corresponding to particularly 
the 1230cm-1/1453cm-1 bands, compared to those without NAC, therefore suggesting 
increased crystallinity of the formulations in response to its addition. Contrasting, the CI 
values corresponding to the 1720cm-1/1740cm-1 crystalline region of PHBV depict a 
decrease in CI with NAC addition, thus indicating decreased crystallinity. However, it is a 
possibility that these sets of bands may be subject to signal interference emanating from the 
amide group at 1220-1310cm-1 or the C=O carbonyl stretching of NAC at 1712cm-1, thereby 
resulting in opposing observations. Increased concentrations of MgOl resulted in profoundly 
decreased crystallinity, as indicated by the CI values, in both the 1720cm-1/1740cm-1 and 
1230cm-1/1453cm-1 set of bands, thereby, indicating a shift in the polymer to a more 
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amorphous state in the formulations upon MgOl incorporation. The decrease in crystallinity, 
noted from the 1720cm-1/1740cm-1 and 1230cm-1/1453cm-1 bands, respectively, resulting 
from MgOl increase was particularly noted in the formulations highlighted in Figure 5.7b-e: b) 
F7 (2.45 and 3.13) and F5 (2.18 and 2.44); c) F11 (2.28 and 3.50) and F9 (1.97 and 2.33); d) 
F10 (2.61 and 3.17) and F14 (2.10 and 2.23); e) F15 (2.85 and 3.23) and F12 (2.40 and 
2.02). 
 
 
Figure 5.7: Comparison of crystallinity transitions observed from FTIR analyses depicting 
increased CIs resulting from electrospinning a) P0 (unprocessed PHBV) and Pe (pure 
electrospun PHBV) and upon increased MgOl concentration from 0.1g/g to 0.6g/g, 
respectively b) F7 and F5, c) F11 and F9, d) F10 and F14 and e) F15 and F12. 
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DSC was employed to further study the crystallinity transitions induced by MgOl and NAC as 
established by FTIR characterisation. Although the incorporation of MgOl in the present 
study was intended to function as potential neuro-protectant for injured and regenerating 
neuronal cells, previous research has shown the ability of oleic acid and metal-oleate salts in 
the altering of mechanical properties of PHAs via its effect as nucleating agents which 
accelerate crystallization rate. Upon introduction of a nucleating agent, the increased 
nucleation density and crystallization rate of the polymer results in reduced spherulite size 
and thus may induce subsequent changes in crystallinity (Kai et al., 2005). DSC was used to 
obtain a quantitative measure of crystallinity of neat PHBV, pure electrospun PHBV and the 
PHBV-MgOl electrospun fibers with and without NAC. To evaluate changes in the 
crystallization rate, nonisothermal melt crystallization temperatures (Tmc) were recorded from 
the calorimetric curves generated from the subsequent cooling of the samples from a molten 
state. The %crystallinity was determined using the enthalpy of fusion of pure electrospun 
PHBV which was taken to be the 100% crystalline reference polymer since FTIR analysis 
established it to be more crystalline than unprocessed PHBV. This was further validated 
when DSC analysis revealed the enthalpy of fusion of electrospun PHBV as 25.5 whereas 
that of unprocessed PHBV was lower at 19.63, therefore, confirming that electrospinning 
indeed produces an increased crystalline state of the polymer. Using pure electrospun PHBV 
as the 100% crystalline reference, the %crystallinity of unprocessed PHBV was calculated to 
be 76.98% 
 
In general, the results obtained from DSC analysis, depicted in Figure 5.8, showed that 
formulations exhibiting lower Tmcs in the range of 61-75˚C presented with increased 
%crystallinity between 62-76%. Formulations characteristic of this observation were F11, 
F15 (containing 0.1g/g MgOl), F6 and F13 (containing 0.35g/g MgOl). In contrast, F1, F2, 
F3, F5 and F9 containing higher concentrations of MgOl (0.35-0.6g/g) presented with higher 
Tmcs in the 76-79˚C range and lower %crystallinities between 41-58%. It is considered that 
high Tmc temperatures are indicative of faster crystallization (Kai et al., 2005 and Qian et al., 
2007). Therefore, the results demonstrate the effects of increased crystallization rates with 
increased concentrations of MgOl as a potential nucleating agent. In addition to formulations 
containing higher MgOl concentrations exhibiting increased Tmcs and crystallization rates, 
decreased crystallinity was noted as indicated by both DSC and FTIR analyses. 
 
Furthermore, DSC results were consistent with that of FTIR concerning the effect of NAC on 
the overall formulation crystallinity. According to the findings derived from calorimetric 
studies, the addition of NAC resulted in increased Tmcs equating to faster crystallization rates 
and a subsequent decrease in crystallinity of the resulting formulations. The 4 formulations in 
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the experimental design (F6, F12, F13 and F15) free of NAC were compared to formulations 
(F1, F9, F2 and F11) equivalent in PHBV-MgOl composition but containing 4%w/w NAC, 
respectively. Formulations F6, F12, F13 and F15 presented with lower Tmc temperatures of 
71.66˚C, 63.48˚C, 61.49˚C and 67.34˚C and increased %crystallinities of 74.04%, 50.59%, 
62.67% and 76.18%, respectively. In comparison to the NAC-loaded derivatives, F1, F9, F2 
and F11 featured increased Tmc temperatures of 77.31˚C, 78.33˚C, 78.14˚C and 75.67˚C 
with significantly reduced %crystallinities of 44.35%, 41.53%, 54.35% and 71.57%, 
respectively. These results indicate that the addition of NAC, like MgOl, promotes 
acceleration of crystallization rate leading to the probable formation of smaller sized PHBV 
spherulites and an apparent consequential decrease in crystallinity thereby producing a shift 
to a more amorphous state of the polymer in the synthesized electrospun PHBV-MgOl-NAC 
composite fibers. This effect induced by NAC suggests its possible action as a nucleating 
agent. 
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Figure 5.8: DSC analysis depicting a) changes in Tmc and b) %crystallinity utilizing pure 
electrospun PHBV as the crystallinity reference. 
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To further investigate the changes in PHBV crystallite size of the experimental formulations 
in response to MgOl and NAC incorporation, XRD analysis was conducted. The 
%crystallinity derived from the XRD peak intensity of 2θ = 16˚ was correlated to that 
determined from DSC. The XRD diffractograms in Figure 5.9 depicted the occurrence of 2 
principal peaks characteristic of PHBV and the experimental formulation samples at 2θ = 13˚ 
and 16˚, which correspond to the (110) and (020) planes, respectively. The 2θ = 13˚ peak, 
varying notably in response to changes in chemical composition, was used to calculate the 
crystallite size of the various samples. 
Figure 5.9: XRD diifractograms depicting a) analyses of the parent constituents and b) the 
decrease in crystallinity of PHBV upon increase in MgOl with reference to F5 and F7. 
In
te
ns
ity
0
2000
4000
6000
8000
10000
12000
14000
16000
18000
20000
2-Theta
5 10 15 20 25 30 35
In
te
ns
ity
0
2000
4000
6000
8000
10000
12000
14000
16000
18000
PHBV
MgOl
NAC
F7: 0.1g/g MgOl
F5: 0.6g/g MgOl
Decrease in PHBV 
peak intensity with 
increase in MgOl
denotes decreased 
crystallinity
2θ = 13˚
2θ = 16˚
a)
b)
 186 
 
As listed in Table 5.4, pure electrospun PHBV presented with a slightly larger crystallites 
than neat PHBV of 4.50Å and 4.43Å, respectively. The electrospun composite fibrous films 
however, depicted generally larger crystallite sizes than that of both electrospun and neat 
PHBV with the exception of F5 (4.29Å), F9 (4.31Å) and F12 (4.30Å) all containing the 
maximum 0.6g/g MgOl concentration and exhibiting smaller sized crystallites. Formulations 
containing NAC presented with increased crystallite sizes compared to NAC-free 
formulations which could be attributed to the presence of large intact NAC crystal-like 
particles distributed throughout the PHBV-MgOl matrix and hence resulting towards the 
collective crystallite size encompassing both PHBV and NAC crystallites. Function as a 
nucleating agent, formulations containing 0.6g/g MgOl compared to those containing a 
0.1g/g concentration demonstrated decreased crystallite size when PHBV and NAC 
concentrations were kept constant. Formulations F5, F9, F14 and F12 containing 0.6g/g 
MgOl had crystallite sizes of 4.29Å, 4.31Å, 4.75Å and 4.30Å, respectively. Decreased MgOl 
content (0.1g/g) in F7, F11, F10 and F15 resulted in increased crystallite sizes of 4.75Å, 
4.99Å, 4.78Å and 4.60Å, respectively. The reduced crystallite sizes resulting from MgOl 
incorporation correlates to the increased crystallization rates elucidated from DSC 
nonisothermal melt crystallization studies. XRD analysis shown in Figure 8b depicts the 
decrease in crystallization observed, with regards to the crystalline peaks of PHBV at 2θ = 
13˚ and 16˚, when MgOl concentration is increased from 0.1g/g to 0.6g/g. 
 
Table 5.4: List of XRD-derived %crystallinity and spherulite size of the experimental design 
Formulation %Crystallinity Spherulite size (Å) 
F1 42.41 4.66 
F2 55.52 4.84 
F3 58.01 4.64 
F4 57.38 4.84 
F5 47.25 4.29 
F6 49.42 4.60 
F7 64.38 4.75 
F8 57.32 4.66 
F9 48.89 4.31 
F10 65.98 4.78 
F11 64.01 4.99 
F12 50.56 4.30 
F13 46.72 4.54 
F14 57.74 4.75 
F15 52.15 4.60 
Unprocessed PHBV 45.78 4.43 
Pure electrospun PHBV 78.12 4.50 
 
The infrared crystallinity indices and the %crystallinity calculated from the heat of fusion 
obtained from DSC both corresponded to the %crystallinity indices (%CrI) determined from 
XRD measurements. XRD %CrI, as listed in Table 5.4, indicated decreased crystallinity 
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upon increased MgOl concentrations. Reductions in crystallite size were congruent with 
decline in %crystallinity. On the contrary, The inclusion of NAC resulted in larger sized 
spherulites, however, it was noted that a combination of higher MgOl concentrations (0.35-
0.6g/g) and lower PHBV concentrations (5-7.5%w/v) with 4%w/w NAC lead to decreased %CrI 
whereas lower MgOl concentrations (0.1-0.35g/g) and higher PHBV concentrations (7.5-
10%w/v) with 4%w/w NAC produced increased crystallinity of the electrospun fibrous films. 
This observation could suggest that NAC inclusion acts synergistically with MgOl to yield an 
overall decreased crystallinity of the PHBV composite fibers, although it is not yet 
ascertained whether NAC could be undertaking a nucleating function, due the noted pattern 
of increasing crystallite size. The distribution of NAC particles throughout the polymer matrix 
however, may affect the crystallinity of PHBV via disruption of its crystalline structure upon 
recrystallization and regrowth of its spherulites. 
 
5.3.4. SEM visualisation of surface morphology and EDS analysis of PHBV-MgOl 
fibrous films 
SEM imaging of the electrospun fibrous film surface morphology reveals the formation of 
thread-like nanofibers orientated in a random to linear assembly (as indicated by the red 
arrows throughout Figure 5.10). The random orientation of some of the fibers confers a 
“branching” characteristic to the overall appearance of the fibrous films. This “branching” 
arrangement results in the formation of inter-fibre interstices (as shown throughout Figure 
5.10 by the green markings) thus creating a net-like appearance and imparting a certain 
degree of porosity to the film. The formation of a porous meshwork is favourable as it 
enhances permeability of the films for uninterrupted gaseous exchange and permeation of 
nutrients to the regenerating tissues. In the case of lining a hollow conduit with the fibrous 
films an open meshwork is necessary to allow the diffusion of bioactive agents from the 
conduit wall to the regenerating tissues. Furthermore, it allows the sprouting axons to 
traverse through the interstices and around each fibre thereby maximising axonal interaction 
with the fibers while mimicking the native architecture of fibrin deposition and ECM. The 
fairly linear orientation of the electrospun fibers could further improve directional growth of 
the axons towards the distal nerve stump and reduce the chances misdirection and 
inadequate innervation of the target tissues. Should this be adequately achieved, an 
improvement in functional recovery of the injured site is expected. 
 
It is noted that increases in PHBV polymer concentrations from 5%w/v to 10%w/v (the lower 
and upper limits, respectively) result in the formation of fibers that are slightly thicker in 
diameter as noted with F7 and F10 in Figures 5.10b and 5.10f. Likewise, increased 
concentrations of MgOl appear to increase fibre diameter and thickness. The increase in 
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fibre diameter is attributed to the increase in viscosity of the electrospinning solution in 
response to the addition of increasing concentrations of polymer and MgOl thus affecting the 
stretching duration of the polymer jet and solvent evaporation (Tong and Wang, 2011). It is 
further noted that formulations containing 0.35g/g and 0.6g/g MgOl appear to coat the fibers 
thereby slightly increasing fibre size. Moreover, the upper limit of MgOl incorporation results 
in coating of the film surface creating a reduction in the number of visible open interstices. 
Another effect of MgOl on fibre electrospinning is the deposition and arrangement of the 
fibers. From Figures 5.10, it is evident that increasing MgOl content contributes to the 
formation of a greater number of randomly orientated fibers thus decreasing the linear 
directionality of the deposited fibers. Conversely, decreases in MgOl content results in the 
deposition of tighter packed fibers aggregating towards the formation of a linear 
unidirectional arrangement. The latter arrangement of the fibers would enhance controlled 
directional guidance of the regenerating axons whereas the former is desirable for the 
generation of porosity for enhanced permeability and tissue infiltration. 
 
The incorporation of NAC is observed to affect fibre morphology and topography via 
induction of textural modification of the fibre surface. Formulations containing the maximum 
limit, 4%w/v concentration, of NAC impart a rough and spinous texture to the surface of the 
fibers whereas lower concentrations and absence of NAC contribute to the formation of 
smooth-surfaced fibers, as seen in Figure 5.10i indicated by the yellow arrows. A slightly 
roughened surface increases the total surface area available for cellular interaction and 
enhances cellular adhesion via provision of a topographical guidance cue; however, an 
excessively roughened surface with protruding jagged and sharp edges could result in 
unwanted cell damage and death. 
 
Therefore, prudent adjustments in the concentrations of MgOl and NAC could assist in the 
attainment of appropriately suited topographical textured guidance cues and morphological 
properties of the electrospun fibrous films for enhanced cellular interaction. 
 
Regarding the concentration of elemental magnesium in the electrospun fibers, via addition 
of MgOl, EDS analysis (Figure 5.11) revealed that formulations containing 0.35g/g and 
0.6g/g MgOl contained between 1.4-1.7% weight magnesium. The detected carbon and 
oxygen emanate mostly from PHBV and oleic acid whereas sulphur detection stems from 
the inclusion of NAC. The EDS analysis confirms the successful incorporation of 
magnesium, as a therapeutic cue, in the electrospun fibrous films. 
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Figure 5.10: SEM surface morphology visualisation of selected electrospun formulations 
showing the changes in fiber morphology upon variations in MgOl at 1000× and 3500× 
magnification: 0.6g/g MgOl a) F5, c) F9, e) F14 and g) F12; 0.1g/g MgOl b) F7, d) F11, f) 
F10 and h) F15; depicting the effects of NAC-loading on fiber morphology at 1000× and 
5000× magnification i) F1. 
 
 
 
 
Figure 5.11: EDS representation of the elemental composition of F2 indicating the presence 
of elemental Mg from MgOl incorporation and the emergence of sulphur from NAC-loading. 
 
 
 
Element Weight% Atomic% 
 
C K 57.29 65.33  
O K 37.94 32.48  
Mg K 1.10 0.62  
S K 3.67 1.57  
Totals 100.00   
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5.3.5. Response surface and statistical analysis of the Box-Behnken experimental 
design 
Response surface and contour plots were utilized as representations of the functional 
relationships between the experimental independent variables and the measured response 
outcomes obtained from investigatory studies of the experimental formulations. Response 
analysis of tensile strength and %erosion were conducted with data collected from Day 15 of 
dissolution studies whereas that of %water-uptake was done after 24 hours of hydration. 
 
As depicted in Figure 5.12, increase in PHBV polymer concentration with lower MgOl 
quantities produced a decrease in tensile strength after dissolution in PBS. Tensile strength 
improved upon combination with increasing quantities of MgOl due to a probable plasticising 
effect on the polymer. The effect of PHBV and NAC combinations on tensile strength 
presented a min\max bell-shaped response curve were the ideal NAC concentration for 
maximum improvement of tensile strength was 2%w/v and anything below or above that 
concentration resulted in a decrease in tensile strength. A similar effect is noted with regards 
to the relationship of MgOl and NAC combinations, where enhanced tensile strength was 
observed with progressively increasing concentrations of MgOl and an optimal concentration 
of 2%w/v of NAC. 
 
The effects of PHBV and MgOl concentrations on the erosion properties of the electrospun 
fibrous films, shown in Figure 5.13, presented an inverted bell-shaped curve depicting 2 
maxima and 1 minima point. This indicated that concentrations of PHBV and MgOl closer to 
the midpoint value of the upper and lower limits (7.5%w/v PHBV and 0.35g/g MgOl) resulted 
in the largest minimisation effect of erosion rates. The inclusion of NAC leads to increased 
erosion, in relationship to PHBV and MgOl, due to greater dissolution of NAC molecules into 
the surrounding aqueous media compared to that of PHBV and MgOl, thus increasing the 
total %weightloss of the samples. 
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Figure 5.12: a) Response surface, b) contour and c) main effects plots depicting the effects 
of PHBV, MgOl and NAC concentrations on tensile strength. 
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Figure 5.13: a) Response surface, b) contour and c) main effects plots depicting the effects 
PHBV, MgOl and NAC concentrations on %erosion. 
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Higher concentrations of PHBV and lower concentrations of MgOl equates to increased 
water-uptake of the fibrous films after 24 hours immersion in PBS, as noted in Figure 5.14. 
Decreased hydration observed with this variable combination is attributed to the water-
resistance properties of the wax-like MgOl. Concerning the effects associated with NAC-
loading in combination with PHBV and MgOl, it is noted that increasing concentrations of the 
constituents lead to decreased water-uptake. NAC-loading produces a general decrease in 
water-uptake of the films irrespective of changes in PHBV and MgOl concentrations. NAC, 
present as crystalline water-soluble particles within the fibre matrix, solubilises and dissolves 
upon contact with the dissolution media whereas PHBV and MgOl are water-insoluble and 
have a propensity to absorb a certain amount of water to initiate hydrolytic degradation. It is 
revealed that enhancement of water-uptake properties of the formulations could be achieved 
via the implementation of lower MgOl concentrations and the exclusion of NAC from the 
formulations. Although, the experimental design model was constructed to investigate the 
effects imposed by NAC addition and exclusion on the response outcomes, the complete 
elimination of NAC from the optimised formulation is unlikely due to the necessity of its 
potential chemical and therapeutic effects on neuronal regeneration. 
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Figure 5.14: a) Response surface, b) contour and c) main effects plots depicting the effects 
PHBV, MgOl and NAC concentrations on %water-uptake. 
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Additionally, a complete ANOVA analysis (presented in Table 5.5) was executed on the 
formulation response outcomes of tensile strength, %erosion and %water-uptake with the 
intend of ascertaining the relationship between the response variables and the predictor 
variables. A p-value ≤ 0.05 was considered significant with regards to the effect observed 
between the response and variable factor. Apart from the significant effect noted for the NAC 
(NAC, p = 0.001; NAC*NAC, p = 0.003) and PHBV*MgOleate (p = 0.02) factor of %water-
uptake, the other factors presented with no significant effect with regards to the selected 
formulation outputs.  
 
Further statistical evaluation of the experimental model was obtained via the analysis of 
residual plots (Figure 5.15) to determine the uniformity and distribution of the data points 
attained for the selected experimental design responses. The normal probability plots of the 
residuals, pertaining to the responses of tensile strength and %erosion, depict a linear 
arrangement of the points thus, indicating normal distribution and lack of influence from 
external variations. However, the normal probability plot of %water-uptake features 3 distinct 
and interrupted arrangements of the points as opposed to a linear distribution thereby 
indicating the probable effect of some unaccounted variable. The residuals versus fitted plots 
for the 3 design responses depicted the random scattering, and no clustering, of points on 
either side of the zero line indicating an absence of trends. The histogram for %water-uptake 
presented a unimodal and symmetrical distribution of the residuals indicating the probability 
of a uniform distribution of the data set. The histograms relating to effects of tensile strength 
and %erosion depicted a lack of symmetry suggesting the occurrence of a random error of 
the data set. Regarding the scatter plot of the residuals in relation to the observation order, 
non-random error is observed for %water-uptake whereas tensile strength and %erosion 
were indicative of a random error as identified likewise form the obtained histograms. 
 
Table 5.5: ANOVA analysis for the measured responses 
  p-values  
Response Variable Tensile Strength %Erosion %Water-Uptake 
Constant 0.563 0.045 0.251 
PHBV 0.649 0.062 0.490 
MgOleate 0.314 0.439 0.106 
NAC 0.720 0.331 0.001 
PHBV*PHBV 0.306 0.072 0.835 
MgOleate*MgOleate 0.745 0.280 0.862 
NAC*NAC 0.230 0.198 0.003 
PHBV*MgOleate 0.077 0.822 0.020 
PHBV*NAC 0.210 0.518 0.057 
MgOleate*NAC 0.941 0.538 0.368 
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The complete regression equations generated for the responses of tensile strength, 
%erosion and %water-uptake are presented as follows: 
 
Tensile Strength (MPa) = 8.04 + 5.25[MgOleate] + 0.423[PHBV] – 0.27[NAC]   Equation 5.7 
 
%Erosion = 18.17 -1.1[MgOleate] – 0.44[PHBV] + 7.76[NAC]          Equation 5.8 
 
%Water-Uptake = 119 – 67.5[MgOleate] + 2.62[PHBV] – 46.3[NAC]         Equation 5.9 
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Figure 5.15: Residual plots for the responses a) tensile strength b) %erosion and c) %water-
uptake. 
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5.3.6. The effect of MgOl and NAC induced crystallinity transitions on the mechanical 
properties of PHBV fibers 
The tensile strength of the NAC-loaded and PHBV-MgOl composite fibrous films is pertinent 
to the ability of the films to maintain its mechanical strength during physical handling, further 
processing and surgical implantation. Materials and devices intended for tissue repair should 
possess similar mechanical properties to that of the native tissue under repair for enhanced 
biocompatibility. Furthermore, such materials should be able to withstand mechanical strain 
without failure for the appropriate duration of time during which tissue healing and 
regeneration takes place. The 15 experimental formulations were assessed for tensile 
strength before dissolution and at 15 and 30 days post dissolution in PBS. 
 
Direct comparison of the results, using selected formulations containing the upper (0.6g/g) 
and lower (0.1g/g) limits of MgOl, respectively (F5 and F7; F9 and F11; F14 and F10; F12 
and F15) revealed that formulations containing less MgOl were slightly superior in tensile 
strength before and after immersion in PBS at days 15 and 30 (Figure 5.16a). It was further 
noted that, as depicted in the main effects plots in Figure 5.12, formulations composed of 
higher MgOl concentrations and zero to intermediate NAC concentrations (F10 and F14 
(2%w/v); F15 and F12 (NAC-Free) tended to possess enhanced tensile strength, compared 
to those synthesized from lower MgOl and higher NAC concentrations (F7 and F5; F11 and 
F9), in the hydrated state as noted at days 15 and 30. As shown in Figure 5.12 of the 
surface response analysis and main effects plots, decreasing MgOl concentrations with a 
high NAC concentration of 4%w/v results in compromised tensile strength of the formulations. 
Decline in tensile strength noted with increased MgOl may be attributed to the formation of a 
weakened, soft and rather amorphous matrix whereas declining mechanical strength (in 
unhydrated samples) observed with higher concentrations of NAC may be due to the result 
of a disrupted PHBV crystalline structure leading to the formation of inter-spherulitic cracks 
thereby contributing to a comprised mechanical resistance. In addition, upon hydration, NAC 
particle dissolve into the surrounding media leaving probable voids throughout the fibre 
architecture thus weakening its integrity. Nevertheless, the highly crystalline pure 
electrospun PHBV fibrous film was excessively brittle and could not be separated from the 
aluminium foil backing without coming off the foil in a powdery state. This is indicative of the 
need to attune the degree of crystalline and amorphous properties of a polymer as either 
overly crystalline or amorphous states may adversely impact desirable mechanical 
properties.  
 
It is further noted that crystallinity is directly to proportional to the deformability of the sample 
and its ability to absorb energy. A measure of deformation was taken from the slope of the 
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linear portion of the Force-Distance Curve indicating the samples’ elastic extensibility over 
the 20mm stretch before undergoing permanent plastic deformation following failure at 
breaking point. The amount of energy absorbed by the sample to undergo deformation 
(N.mm) is termed as toughness of the sample.  Samples of higher crystallinity (F4, F10, F13 
and F15) presented with increased DMs (136.9MPa, 282.4MPa, 125.8MPa and 172.6Mpa, 
respectively) indicating a rigid, inflexible material whereas those samples with increased 
MgOl content demonstrated lower DM values corresponding to enhanced elasticity and 
flexibility where the sample dissipates energy to readily undergo deformation upon 
application of stress as opposed to resistance to deformation (Figure 5.16b). Formulations of 
low stiffness demonstrating a low DM presented with increased toughness (Figure 5.16c) as 
such materials are able to absorb increasing amounts of energy to deform rather than 
resisting the applied force resulting in immediate breakage. Although the crystalline samples 
composed of lower MgOl content exhibited higher tensile strength indicating strong fibers, 
the increased resistance to deformation indicated a brittle and inflexible matrix. Increased 
MgOl concentrations produced fibrous films that were slightly weaker in strength but tough 
and more flexible compared to those of low MgOl content. Elastic deformability and rigidity of 
the sample is essential in further processing of the fibrous films into various architectures 
such as rolled conduits and microchannel tubes. Brittle films would be challenging to 
manipulate as a result of easy and frequent breakage of the sample. 
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Figure 5.16: Textural analysis depicting a) tensile strength, b) tensile modulus and c) 
toughness of the Box-Behnken experimental design formulations before hydration (Day 0) 
and 15 and 30 days post-hydration in PBS pH 7.4. 
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A study of stress and strain, conducted by Peng et al. (2012) utilizing freshly harvested 
samples of human sciatic nerve revealed that a tensile strength of 6.71MPa was the limit for 
sciatic nerve physiological stress whereas as 11.63MPa resulted in rupturing of the nerve 
specimen. Considering the necessity for attuning of crystalline/amorphous properties, it was 
noted that formulations exhibiting intermediate %CrI between 50-57% seemed to possess 
adequate tensile strength (±12MPa, as established by Peng et al., 2012) compared to those 
featuring %CrIs within the lower 42-49% and higher 58-66% ranges, particularly at the end 
of the 30 days hence indicating the improved ability to maintain its mechanical integrity while 
matching the tensile properties of native nerve tissue. 
 
5.3.7. The effect of MgOl and NAC induced crystallinity transitions on PHBV fibre 
hydrodynamic and erosion properties 
The hydration and wettability of a biomaterial is an imperative factor affecting the type of 
biological response initiated by cells following its implantation into the body. PHBV, being a 
thermoplastic polyester polymer, is generally hydrophobic in nature and requires some 
modification to enhance its interaction with protein adsorption and resulting cellular 
adhesion. It is generally considered that a moderately hydrophilic material surface is optimal 
for tissue biocompatibility. However, a highly hydrophilic material may decrease cell 
adhesion. In addition to cellular interactions, the hydration and water-uptake properties of a 
drug-loaded matrix system is pertinent to elucidating its erosion and drug-release 
mechanisms as drug release is the process in which drug solutes dissolve in a fluid before 
being able to migrate out of the polymer matrix via diffusion and into the surrounding media 
or tissues. 
 
Firstly, it was noted that the 4 NAC-free formulations, F15, F13, F12 and F6, demonstrated 
the highest water-uptake during the first 24 hours and over the 30-day study period with 
hydration values of 247.31%, 173.29%, 166.67% and 173.96%, respectively as shown in 
Figure 5.17. When compared directly to formulations equivalent in PHBV and NAC 
concentrations, it was found that increasing MgOl concentration from 0.1g/g to 0.6g/g 
decreased water-uptake of the films.  This is attributed to the hydrophobicity imparted by the 
wax-like composition of MgOl which inhibits water penetration. NAC-loaded formulations F9 
and F14 presented with the lowest water-uptake capacity. The maximum concentrations of 
both NAC and MgOl seemed to decrease water-uptake properties. Overall, it was noted that 
the less crystalline formulations F4, F6, F12, F13 and F15 with %CrIs in the range of 42-52% 
underwent greater moisture uptake compared to formulations F7, F10 and F11 of %CrIs 
between 64-66%. A study by Wang et al., 2007, showed the effect of crystallinity on 
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wettability of PHBV where it was reported that decreased crystallinity of PHBV films imparted 
improved wettability. 
 
Furthermore, from SEM imaging, it was noted that formulations composed of the maximum 
0.6g/g MgOl formed thicker, coated fibers with a reduced number of inter-fibre spaces 
whereas those composed of the minimum 0.1g/g MgOl presented with thinner fibers and a 
greater number of open inter-fibre spaces. These interstices between the fibers during fibre 
deposition onto the collecting foil may be able to hold water thereby contributing a water-
holding capacity to the fibrous films. Formulations high in MgOl content were observed to 
have occluded interstices resulting from a surface coat of excess MgOl over the fibers thus 
preventing water entry decreasing the hydration properties. The degree of water contact with 
the polymer surfaces affects its rate of erosion. 
 
Formulations (F6, F13, F15, F12 and F4) exhibiting increased water uptake presented with 
low erosion rates (Figure 5.17). Similarly, formulations containing 0.6g/g MgOl underwent 
faster erosion compared to those containing the minimal concentration. NAC-containing 
formulations F7, F11, F9 and F1 which presented with the second highest change in weight 
after hydration in PBS when compared to NAC-free formulations, demonstrated increased 
erosion. In general, a higher %crystallinity index was noted to lead to increased erosion 
rates of the experimental formulations. The NAC-containing formulations exhibited enhanced 
erosion compared to NAC-free derivatives due to the loss of sample mass resulting from the 
dissolution of NAC particles into the surrounding media. Since PHBV undergoes enzymatic 
erosion via depolymerases as well as via hydrolysis (Rathbone et al., 2010) and surface 
erosion, MgOl slows it erosion rate by inhibiting water interaction with the polymer surface. 
The trait of progressive surface erosion further allows maintenance of the mechanical 
strength of the fibers over a longer duration compared to materials which undergo rapid bulk 
degradation due to increased water ingress into the core of the polymeric structure. In the 
case of the former, the inner core of the polymeric fibers remains unaffected by erosion 
processes occurring on the outermost surface. 
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Figure 5.17: Dissolution studies showing %water-uptake (left panel) and %erosion (right 
panel) over a study period of 30 days in PBS pH 7.4. 
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5.3.8. The effect of MgOl and NAC induced crystallinity transitions on NAC release 
and kinetic modelling 
From the drug release profiles in Figure 5.18, it is noted that F1, F4, F7, F10, F11 and F14 
present with increased release rates of NAC whereas F3, F5, F8 and F9 exhibit a slower 
release profile. Formulations F10 and F11 demonstrated particularly increased bioactive 
release rates among the 11 NAC-loaded experimental formulations. Increased MgOl content 
resulted in slower rates whereas increased PHBV polymer content was noted to increase 
NAC release rates. Understandably, formulations containing 4%w/w NAC released more 
bioactive compared to those a containing 2%w/w concentration as a result of an increased 
quantity of NAC particles available, per area unit, for dissolution into the surrounding media. 
 
The rate of drug release is affected by a number of intrinsic physicochemical properties of 
the individual materials used and the resulting final formulation. Since PHBV is a non-
swelling polymer that is unable to absorb water, the predominant drug release mechanisms 
governing NAC release are most likely diffusion-controlled and chemically-controlled. A 
chemically-controlled drug release mechanism is thought to encompass surface erosion, 
bulk degradation and other chemical interactions or processes occurring within the polymer 
matrix. PHBV is classed a surface eroding polymer since its water-uptake is slower than its 
erosion and hydrolysis is confined to the outer surface of the polymeric device whereas the 
interior of the matrix remains unaffected (Alexis, 2005). The bioactive release is therefore 
primarily erosion-controlled however, factors such as chemical composition, 
hydrophilic/hydrophobic properties and degree of crystallinity affect water diffusivity and 
hence the ultimate degradation pattern of the polymeric formulation.  
 
Although, it is commonly thought that amorphous regions of a polymer are more susceptible 
to water penetration and hydrolytic attack contributing to faster bioactive release rates, the 
contrary was observed in the present study. The formulations demonstrating faster NAC 
release profiles contained a lower concentration of MgOl and consequentially contained 
more crystalline regions than those with an increased MgOl content. Such formulations also 
exhibited greater water-uptake during the first 24 hours and thereafter and presented faster 
erosion rates compared to those composed from higher MgOl quantities. The results reveal 
that erosion of the fibrous films and water penetration is directly affected by MgOl 
incorporation and its resulting crystallinity transitions of the formulations. It is proposed that 
increasing crystallinity imparts a hydrophilic property to the formulation resulting in increased 
water interaction at the fibre surface. Increased water contact initiates hydrolytic chain 
scission leading to surface erosion where escape of NAC molecules can easily occur via 
diffusion into the dissolution medium. In addition, accelerated erosion of the fibre surface 
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predisposes the entrapped NAC particles to dissolution and diffusion. Furthermore, 
increases water interaction in the crystalline formulations resulting in dissolution of the water-
soluble oligomers contribute to the likely formation of microporous channels via erosion and 
hence further allows water penetration and release of NAC molecules via diffusion. 
 
In addition to physicochemical factors, the morphological properties and general topography 
of the formulations play a role in modulating bioactive release. As shown in SEM imaging, 
formulations featuring high %crystallinities contained thinner fibers with open interstices and 
a rough surface morphology. The highly irregular surface of the fibers increases the total 
surface are of the films thereby creating a greater number of contact points for water 
interaction and hydrolytic degradation hence promoting rapid NAC release. Although MgOl 
decreased %crystallinity, excessive amounts resulted in the coating of the fibre surface, as 
seen in the SEM imaging. MgOl, of a wax-like consistency, is hydrophobic thereby a 
imparting a water-resistant property to the fibrous films. Since drug release is dependent on 
the ability of water penetration into the matrix, reduced water entry and hydrolysis decreases 
NAC diffusion and its erosion-controlled release thereby imparting a slower release rate to 
the formulation. With regards, to the fibre topography, MgOl incorporation produces the 
formation of thicker but smoother fibers which decreases surface area available for water 
interaction contributing to a slower release rate. 
 
Mathematical modelling, shown in Table 5.6, of the release data using the n-value derived 
from the Korsmeyer-Peppas model revealed a series of Fickian-diffusion, non-
Fickian/anomalous transport and super case II transport where the R/F value derived from 
the Peppas-Sahlin model indicates the contribution ratio of relaxational release over Fickian 
diffusion of each formulation. The drug release of formulations of low %crystallinity were 
ascribed a Fickian-diffusion based release and presented lower R/F values suggesting 
diffusion to be the dominant contributing mechanism rather than case-ll relaxational release. 
Formulations F4 and F5 presented with non-Fickian/anomalous transport featuring a coupled 
diffusion and polymer relaxational mechanism hence, presenting with higher R/F ratios of 
0.035 and 0.015, respectively, thus indicating the predominant role of relaxational release. 
The drug release mechanism of F10, F11 and F14, of high %crystallinity were established to 
occur via combined polymer relaxation ensuing erosion and diffusion. 
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Figure 5.18: In vitro release profiles of NAC conducted in PBS pH 7.4. 
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Table 5.6: Kinetic modelling results of NAC release from the respective PHBV-MgOl electrospun fibrous films. 
 
Formulation 
Zero-
Order 
First-Order Higuchi 
Korsmeyer-
Peppas 
Peppas-Sahlin Hopfenberg Best-fit model 
 
R² R² R² R² n R² K₁ K₂ R/F Ratio R² 
 
1 0.897 0.896 0.913 0.941 0.231 0.897 0.009 0.00003 0.003 0.897 Higuchi 
2 0.965 0.975 0.981 0.948 0.284 0.993 0.015 0.00020 0.014 0.965 Higuchi 
3 0.953 0.960 0.935 0.851 0.378 0.966 0.013 0.00010 0.008 0.953 First-Order 
4 0.963 0.929 0.876 0.911 0.615 0.980 0.009 0.00030 0.035 0.963 Zero-Order 
5 0.894 0.913 0.953 0.979 0.547 0.972 0.027 0.00040 0.015 0.894 Higuchi 
7 0.904 0.908 0.925 0.875 0.221 0.953 0.016 0.00020 0.012 0.904 Higuchi 
8 0.964 0.955 0.884 0.794 0.294 0.971 0.006 0.00010 0.016 0.964 Zero-Order 
9 0.976 0.950 0.904 0.828 0.151 0.983 0.009 0.00010 0.011 0.976 Zero-Order 
10 0.984 0.910 0.961 0.952 1.440 0.984 0.026 0.00001 0.0004 0.984 Zero-Order 
11 0.919 0.934 0.927 0.973 1.133 0.946 0.028 0.00030 0.011 0.919 First-Order 
14 0.929 0.950 0.952 0.964 1.272 0.949 0.031 0.00030 0.010 0.929 Higuchi 
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5.3.9. The effect of MgOl and NAC as neuronal cell proliferation promoters and 
neuroprotective agents 
The level of proliferation of PC12 cells were used to confirm the neuro-protectant and growth 
factor-like properties of MgOl and NAC, as shown in Figure 5.19. Peripheral nerves such as 
the sciatic nerve, commonly used as an injury model for in vivo studies, are known to contain 
up to 45% oleic acid. It has been established that the synthesis and release of oleic acid 
promotes neuronal differentiation via its specific incorporation into the growth cones thereby 
acting as a potential neurotrophic factor (Velasco et al., 2003). Oleic acid may further assist 
in promoting axonal growth and neuronal clustering via upregulation of GAP-43 in addition to 
accelerating tissue repair mechanisms (Tabernero et al., 2001; Velasco et al., 2003; 
Bonferoni et al., 2014 and Chen et al., 2014). Magnesium has been studies as a supplement 
for improved peripheral nerve regeneration. Vennemeyer et al., 2015, successfully utilized 
magnesium metal filaments as physical guidance cues to assit the regeneration potential of 
transected nerve injuries. NAC is known protect cells from oxidative damage, promote 
neuronal cell survival as well as possess anti-inflammatory effects (West et al., 2007 and 
Saleh, 2015). Previous studies have considered it of potential therapeutic benefit for the 
treatment of peripheral nerve injuries and neuropathies. 
 
The MTT proliferation studies indicated that the PHBV-MgOl composite fibrous films were 
capable of efficiently supporting the growth of PC12 cells compared to the control (cultured 
directly on a TPP-treated surface) over an investigation timeframe of 72hrs thus indicating 
biocompatibility of the fibrous films (Figure 5.19a). Increased MgOl concentration from 0.1g/g 
to 0.6g/g was seen to enhance cell growth. Likewise, NAC-loaded formulations increased 
neuronal cell proliferation compared to NAC-free fibrous films (Figure 5.19b). It has already 
been established above, that increased MgOl content of the fibers inhibited bioactive release 
thereby providing a slowed release of NAC. The release rates of NAC from formulations 
containing the maximum and minimum concentration of MgOl, respectively (F5 and F7; F9 
and F11; F14 and F10) was compared to assess the effect on the growth of PC12 cells. It 
could be that a slower release of NAC may favour cell proliferation as opposed the release 
of larger quantities. A highly saturated media, consisting of NAC crystals as a solute, 
resulting from increased drug release rates may impede cell growth by formation of a 
hypertonic media thereby altering cell tonicity. 
 
Furthermore, a synergistic or additive effect on neuronal survival and promotion of growth 
may be acquired with the simultaneous incorporation and dissolution of MgOl and NAC. 
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Figure 5.19: Representation of the MTT assay showing the proliferative effects of a) 
increased MgOl concentrations and b) NAC-loading on PC12 cells. 
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5.3.10. Optimization of the Box-Behnken experimental design 
Minitab® V15 statistical software was employed to generate the optimal variables and 
response outcomes based on the results of the Box-Behnken experimental design, for the 
establishment of an optimized formulation. In order to fulfil the chemical and therapeutic 
requirements of the guidance cues, as established in Chapter 1, NAC was pertinent to the 
formulation for its bioactive properties in inducing neuronal proliferation. It was noted that 
%water-uptake conflicted with tensile strength resulting in the computation of lower tensile 
strength values. Tensile strength is an important factor determining the maintenance of the 
architectural features of the fibers in vivo; hence, the computation of the experimental design 
optimised against the responses of maximised tensile strength and minimised %erosion 
yielded the ideal NAC-loaded formulation. As shown in the desirability plots in Figure 5.20, 
the predicted ideal concentrations of 7.5%w/v PHBV, 0.35g/g MgOl and 2%w/v NAC could be 
used to obtain the optimized NAC-loaded formulation. The derived optimised NAC-loaded 
formulation was equivalent in composition to the experimental design centre points F3, F4 
and F8. The predicted response outcomes for desirable tensile strength and %erosion were 
15.67MPa and 19.06%, respectively after 15 days of in vitro dissolution. An optimized 
formulation being composed of the midpoints of the upper and lower variable limits is 
plausible as according to the surface response analyses and main effects plots of tensile 
strength (Figure 5.12) and %erosion (Figure 5.13), the midpoints represented the maxima for 
tensile strength (PHBV and NAC) and the minima for %erosion (PHBV and MgOl) of the 
acquired bell-shaped curves. 
 
Figure 5.20: Statistical optimization yielding the desirability plots depicting the variables and 
predicted response outcomes for the NAC-loaded optimized formulation. 
PHBV (%w/v)
10.0
[7.50]
5.0
Tensile Strength
Maximum
y = 15.670
d = 1.0000
%Erosion
Minimum
y = 19.0567
d = 1.0000
Optimal
d = 1.0000
Hi
Opt
Lo
MgOleate (g/g)
0.6
[0.350]
0.1
NAC (%w/v)
4.0
[2.0]
0.0
  
213 
 
5.4. Concluding Remarks 
The study pertaining to the incorporation of MgOl with PHBV demonstrated its ability to act 
as a nucleating agent for the modification of PHBV electrospun-fibre crystallinity and tensile 
strength. Through its actions of increasing crystallisation rates and decreasing spherulite 
size, as shown by DSC and XRD, MgOl could be used to attune the mechanical properties 
of tensile strength, flexibility, extensibility and toughness via the formation of amorphous 
regions as reflected by FTIR analysis. The addition of NAC in combination with controlled 
quantities of MgOl was observed to improve PC12 neuronal cell proliferation via its function 
as neuro-protectant agents whereas SEM imaging established the deposition of fairly linear-
orientated fibers serving as a potential for enhanced cell directionality. The blending of MgOl 
was advantageous due to its dual and simultaneous therapeutic and non-toxic plasticising 
effects. Statistical optimization of the Box-Behnken experimental design generated the 
variable concentrations and predicted response outcomes for the attainment of the ideal 
formulation based on the current findings. The derived optimized formulation resulting from 
this investigation requires further in vitro and in vivo assessment of its capability to be 
employed as a guidance cue component when integrated within a hollow nerve repair 
conduit. 
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CHAPTER 6 
ASSEMBLY AND IN VIVO ANALYSIS OF THE BIOSIMULATED NERVE REPAIR 
DEVICE IN THE RAT SCIATIC NERVE MODEL  
 
 
6.1. Introduction 
With the gradually inclining incidences of peripheral nerve injuries, the investigation and 
design of artificial scaffolds for nerve repair and adequate functional recovery is 
indispensable. The conventional treatment procedures comprising end-to-end suturing on 
short gap injuries (< 10mm) and autograft repair in long gap injuries (> 10mm) have several 
drawbacks. Direct end-to-end repair encounters issues of increased tension across the gap 
defect and reduced stretching capacity of the transected nerve ends due to fibrosis, tissue 
adhesion and Wallerian degenerative processes (Madduri et al., 2010). Although autograft 
repair could result in the attainment of satisfactory functional recovery and is currently 
considered the gold standard of treatment, it is associated with difficulties in donor tissue 
harvesting, donor site morbidity, multiple surgery sites and additional scar formation. The 
disadvantages accompanying the conventional treatment modalities for nerve repair 
necessitates the need  for artificial, biodegradable and biocompatible nerve repair conduits 
with the goal of attaining functional recovery levels equivalent to or greater than that 
achieved with the gold standard of treatment (Belkas et al., 2013 and Mukhatyar et al., 
2014). 
 
Artificial nerve repair conduits are synthesized from various synthetic or natural-based 
polymeric materials or a blend of both. The intent of a nerve conduit is to provide a 
favourable internal environment permissive of neuronal survival, support and regeneration in 
addition to the provision of a stable neuroprotective barrier for the regenerating and newly 
regenerated tissues including a basic bridging function across the nerve gap defect. An 
environment conducive to axonal regeneration may further be obtained via the inclusion of 
and ability of the conduit to deliver a range of neurotrophic factors (Nerve growth factor, 
Glial-derived neurotrophic factor and Brain-derived neurotrophic factor) other biological 
actives (ECM molecular components and small-molecular weight therapeutic agents) in a 
sustained-release manner. 
 
As previously outlined in Chapter 2, Table 2.1, a key characteristic of any nerve repair 
conduit is its mechanical properties. A nerve conduit should possess sufficient mechanical 
strength to withstand physical handling and surgical procedures whilst maintaining its 
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structural integrity from the time of implantation and throughout the duration of tissue 
regeneration. Simultaneously, it should be texturally compatible and appropriately flexible so 
as to accommodate any native tissue movements without causing additional pain or 
discomfort therefore enhancing biocompatibility (Ramburrun et al., 2014). 
 
Proficiency of hollow-lumen nerve conduits in the promotion of functional recovery may 
further be attained through the implementation of various intraluminal support scaffolds or 
fillers which function as physical guidance cues to assist cellular attachment, axonal 
elongation and direction towards the target tissues thereby reducing the occurrence of 
mismatched innervation. A number of strategies could be utilized for the implementation of 
intraluminal guidance structures consisting of gel or liquid fillers, nano-fibrous linings and 
fillers and arrays of hollow tubular mutli-channels (Madduri and Gander, 2012). 
 
The present study entails the in vivo investigation in Sprague Dawely rats on the nerve 
regenerative potential of the previously described optimized pristine PMMA-particle 
intercalated Gel-Xan hydrogel conduit (Chapter 4) in combination with the optimized 
electrospun PHBV-MgOl-NAC aligned nano-fibrous films (Chapter 5) as intraluminal 
guidance scaffolds featuring a trio guidance cue mechanism. The final assemblage of the 
Gel-Xan hydrogel conduit and the intraluminal PHBV-MgOl-NAC composite fibers yield the 
Biosimulated Nerve Repair Device (BNRD) which aims to mimic the architecture of native 
nerve tissue as improvements in neuro-compatibility and promotion of functional recovery 
outcomes. The inclusion and sustained delivery of NGF and diclofenac sodium and the 
presence of Mg2+ ions, oleic acid and NAC as bioactives function as a means of assisting the 
innate physiological and biological repair mechanisms ensuing nerve regeneration and 
healing. 
 
The components of the BNRD system aim to improve nerve regeneration and functional 
recovery via provision of the following conduit features and types of guidance cues: 
 
6.1.1. The PMMA-intercalated Gel-Xan hydrogel conduit pH-responsive in situ 
particulate leaching technique for porosity formation 
Controlled and gradual induction of porosity allows for enhanced mechanical and resilience 
properties while simultaneously providing a mechanism for the dual controlled release of 
proteins and other small-molecular weight drugs. Furthermore, porosity induction imparts a 
degree of matrix permeability for the uninterrupted gaseous and nutrient exchange to the 
regenerating tissues. 
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Ionically crosslinked hydrogel matrix: 
Utilization of a highly hydrophilic hydrogel matrix allows the potential absorption of excess 
bleeding and inflammatory fluids. The potential absorption and ionic binding of influxing 
calcium ions, entering the axoplasm, by the hydrogel matrix may assist wih calcium-ion 
homestasis and prevention of calcium-induced axonal degeneration (Schlaepfer, 1974; 
LoPachin and Lehning, 1997 and Coleman, 2005). 
 
Bridging and barrier function: 
Basic bridging function of the conduit serves as a macro-guidance scaffold with a protective 
barrier against infiltration of fibrotic tissue. In this way the conduit is capable of sustaining an 
enclosed suitable microenvironment for neuronal regeneration. 
 
6.1.2. The PHBV-MgOl-NAC composite fibers 
Physical cue: 
The linear arrangement of the electrospun nanofibers ensure enhanced uni-directionality of 
axonal growth with the provision of a solid structure simulating the presence of a basal 
lamina-type substrate for cellular interaction. Slight roughening of the fiber surface imparted 
by the addition of NAC crystals (as shown in Chapter 5, Figure 5.10) provide a topographical 
cue for cellular attachment with an increased surface area. 
 
Chemical cue: 
The promotion of cell adhesion to the electrospun fibers and the native basal lamina may be 
improved by the presence of positively charge surface molecules of NGF, Mg2+ and the 
cysteine protein moiety of NAC. Oleic acid present as an oleate bound to magnesium ions 
has shown potential in PC12 proliferation via its function as a GAP-43 activator for neuronal 
growth (Velasco et al., 2003). Axonal growth is believed to occur chemotactically towards the 
direction of such bioactives.  
 
Therapeutic cue: 
The BNRD system offers 3 types of therapeutic agents: neuro-protective, proliferative and 
differentiation and anti-inflammatory. The neuro-protective agents, NAC and magnesium, 
promotes the survival of axons upon injury and during the inflammatory degenerative 
processes. The provision of NGF to the axons during the early phase of injury ensures tissue 
viability while promoting axonal elongation and differentiation thereby assisting the body with 
growth factors until sufficient Schwann cells have been recruited to take over the role of 
growth factor production (Madduri and Gander, 2010). Diclofenac sodium was included for 
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its anti-inflammatory effects for the targeting of fibrotic tissue infiltration and reduction in the 
Wallerian degenerative effects causing potential and extensive tissue damage. 
Prior to in vivo evaluations, the final assembled BNR device underwent characterisation of 
its NGF release kinetics, textural and mechanical profiling and PC12 cell compatibility to 
confirm its in vitro efficacy, safety and mechanical integrity. Procession of the study, utilizing 
the rat sciatic nerve injury model, involved a 4-week behavioural study consisting of weekly 
monitoring of walking track analysis and grid walk for assessments of functional recovery 
followed by muscle mass measurement as an indicator of target tissue innervation and 
histological analysis at termination of the study. The study aimed to elucidate the efficiency 
of the proposed BNRD system in promoting neuronal regeneration and functional recovery 
via the provision of a trio physical, chemical and therapeutic guidance cues. 
 
6.2. Materials and Methods 
6.2.1 Materials 
Gellan gum (low acyl GelzanTM CM)(GG), xanthan gum (XG), poly(3-hydroxybutyric acid-co-
3-hydroxyvaleric acid) (PHBV) (PHV content 12mol%) natural origin, diclofenac sodium, N-
acetyl-L-cysteine (NAC) (≥99% TLC), 2,2,2-trifluoroethanol (≥99% GC) and dialysis tubing 
cellulose membrane (molecular weight cut-off = 14000Da) were purchased from Sigma 
Aldrich, Steinham, Germany. Polymethyl methacrylate (PMMA) (Eudragit S100) was 
purchased from Evonik, Midrand, Johannesburg, South Africa and was used without further 
modifications. Propylene glycol (PG), sodium hydroxide pellets, chloroform, oleic acid 
vegetable (extra pure) and Span 80 were purchased from Merck, Darmstadt, Germany and 
calcium chloride (CaCl2) anhydrous was purchased from Rochelle Chemicals, 
Johannesburg, South Africa. Magnesium sulphate heptahydrate CP (MgSO4.7H2O), 
methanol, acetone and isopropyl alcohol were purchased from Associated Chemical 
Enterprises, Southdale, Johannesburg, South Africa. Ethanol (99% absolute) was purchased 
from LabChem, Edenvale, Johannesburg, South Africa. PeproTech® recombinant human β-
nerve growth factor (NGF) and corresponding ELISA kits were sourced from Celtic Molecular 
Diagnostics, Cape Town, South Africa.  Milipore water was used for washing of preparations. 
Dulbecco’s Modified Eagle Medium (DMEM), Donor Equine Serum (DES) and Fetal Bovine 
Serum (FBS) were procured from Hyclone, Separations, South Africa. 
Pencillin/Streptomycin/Amphotericin B (P/S/AB) solution and the Roche Cell Proliferation Kit 
I was purchased from Lonza, USA and Sigma-Aldrich, USA, respectively. Ethilon® black 
nylon monofilament 9/0 sutures with needle 5.1mm 3/8C taperpoint were procured from 
Ethicon, Johnson and Johnson Medical (Pty) Ltd, Gauteng, South Africa. All other surgical 
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materials and consumables used were obtained from the Central Animal Services (CAS) of 
the University of the Witwatersrand. 
 
6.2.2 Fabrication of the biosimulated nerve repair device 
6.2.2.1. Synthesis of the Gel-Xan hydrogel hollow conduit 
As per the predicted optimised formulation, 722.88mg gellan gum and 277.12mg xanthan 
gum powders were dissolved in 100mL deionised water to form a 1%w/v gel solution. After 
solubilisation of the gum powders, propylene glycol and calcium chloride were added as the 
plasticiser and crosslinker in concentrations of 5%w/v and 0.05%w/v, respectively. Thereafter, 
sufficient diclofenac sodium was added to form a 0.4%w/v concentration.  The gel blend was 
then heated to and maintained at 100˚C for 10 minutes. Addition of polymethyl methacrylate 
(PMMA) nano-sized particles was introduced into the gel blend, at a concentration of 0.25g 
per gram of dry polysaccharide powder blend, after cooling the solution to 60˚C. Cylindrical 
moulds, measuring 50mm in length and 12mm in diameter, were constructed. A removable 
glass rod of 1.88mm diameter was inserted into the centre of the mould to form the lumen of 
the conduit. A volume of 3mL of the polymer gel suspension was carefully syringed into pre-
lubricated cylindrical moulds and allowed to set at room temperature for 20 minutes before 
being removed and left to air-dry, while on the glass rods, in a fumehood for 24 hours. The 
dried conduits were cut into 14mm lengths for further characterisation and implantation 
where each piece contained approximately 4mg diclofenac sodium. 
 
6.2.2.2. Synthesis of PHBV-MgOl-NAC electrospun fibrous film guidance cues 
The polymer solutions for electrospinning were prepared by dissolving the chemical 
constituents in a mixture of chloroform and trifluoroethanol (3:2 ratio) under continuous 
magnetic stirring at 60˚C. MgOleate was synthesized as described in Chapter 5.2.2.1. The 
optimized NAC-loaded formulation utilized 7.5%w/v PHBV, 0.35g/g MgOleate and 2%w/v 
NAC. For fabrication of the NAC-loaded and NAC-free films, 5mL of the PHBV-MgOleate 
solutions with or without NAC were loaded into a syringe for electrospinning 
(NanoSpinner24, Inovenso, Turkey) onto Span 80-coated aluminium sheets attached to a 
rotating drum set at 1200rpm, using a voltage of 25kV, a flowrate of 2mL/hour and a nozzle 
distance of 150mm.  
 
6.2.2.3. NGF-loading into hydrogel conduit 
Due to the extremely small concentration and volume of NGF used, its accurate loading into 
the hydrogel conduits was performed according to the technique utilized by (Madduri et al., 
2010). Using a micropipette, 20uL (200ng) of NGF solution in distilled water was carefully 
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pipetted into the centre of a 14mm length hydrogel conduit and allowed to soak in and dry in 
a sterilized fumehood for 8 hours. 
 
6.2.2.4. Assembly of the final device 
For the purposes of improved visualisation and mechanical stability of the conduit during 
surgical handling and implantation, the conduit ends were coated with a 10%w/v solution of 
PMMA in isopropyl alcohol. The electrospun films were cut into 10mm×20mm lengths, folded 
in half width-ways to form a 10mm×10mm square film and rolled into a tight cylinder before 
being inserted into the lumen of the hollow conduits. The layers of the rolled film opened to 
line and form a loose spiral pattern inside the conduit thus creating an open structure (Figure 
6.1). 
 
Figure 6.1: Depiction of the final assembled device and the arrangement of the intraluminal 
fibers. 
 
6.2.3. Characterisation of the biosimulated nerve repair device components 
6.2.3.1. Textural profiling and biaxial testing 
6.2.3.1.1. Compression 
Textural analysis characterization using a Texture Analyser (TAXTplus Stable Microsystems, 
Surrey, UK) fitted with a 10mm diameter delrin probe was undertaken on hydrated conduit 
samples with and without the electrospun fibrous films at pre-determined sampling points. 
The Matrix Resilience (MR), Deformability Modulus (DF) and Fracture Energy (FE) were 
determined. MR (N.sec) was determined by the ratio of the areas under the compression 
and decompression curves generated by Force-Time textural profiles. This represented the 
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ability of the hydrogel conduit to recover to its original form after application of an external 
deforming stress. The Area under the Curve (AUC) from the Force-Distance textural profile 
allowed the determination of the FE (N.mm) which equates to the energy in joules required 
to cause rupture of or a break in the matrix of the hydrated swollen conduits. The DM 
(N/mm) is an indication of the hydrogel matrix flexibility and was computed from the gradient 
of the Force-Distance profile from zero to the point of the peak force.  The textural analysis 
parameters utilized include a pre-test and post-test speed of 1.00mm/sec, a test speed of 
0.5mm/sec, a trigger force of 0.5N and a load cell of 5kg with a target mode of 10% strain. 
 
6.2.3.1.2. Biaxial tension 
Biaxial tensile analysis of the optimized Gel-Xan hydrogel matrix and PHBV-MgOl-NAC 
electrospun fibrous films were performed using the BioTester5000 Biaxial Test System 
(CellScale, Waterloo Instruments Inc., Waterloo, Ontario, Canada) equipped with a 250mN 
load cell. An 8mm × 8mm sample, dusted with powdered graphite for improved visibility, was 
attached to the actuators via 4 0.7cm width tungsten pins on each side and stretched along 
a 90˚ and 180˚ axis simultaneously as shown in Figure 6.2. A strain magnitude of 10% and 
100% were applied on the electrospun fibers and hydrogel matrix, respectively, for 60 
seconds. The measured data points were represented as Force-Time plots. Further tracking 
of the measured data points in terms of displacement and strain are presented in the 
attached video files. 
 
Figure 6.2: Depiction of directional strain and sample mounting for biaxial testing of a) the 
hydrogel matrix and b) the electrospun fibrous film. 
 
6.2.3.2. In vitro release studies of NGF from the final assembled device 
In vitro release studies were performed using 10mm samples of conduit each loaded with 
200ng NGF. Samples were placed in glass vials containing 1mL PBS pH 7.4 and stored in 
an orbital shaking incubator.  At pre-determined time intervals, 0.5ml of dissolution media 
was removed and stored at -80˚C. The removed media was replaced with an equal fresh 
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volume to maintain sink conditions. Samples were analysed for the quantity of NGF using an 
NGF-ELISA kit read at 405nm with background subtraction at 650nm with an absorbance 
multi-plate reader (BioTek, USA). Further insight into the drug-release mechanisms was 
obtained via kinetic modelling of the drug-release profiles using the models listed in Table 2. 
 
6.2.3.3. MTT proliferation assessment 
Rat adrenal gland pheochromocytoma PC12 mixed adherent/suspension cell line from 
Cellonex (Separations, South Africa) was cultured in tissue culture treated (TPP) T-75 flasks 
using DMEM supplemented with 10%v/v DES, 5%v/v FBS and 1%v/v P/S/AB solution in a 
humid 5% CO2 atmosphere at 37˚C. The culture medium was replaced at 75% every 2 days. 
 
For the detection of cell proliferation in response to the exposure of the various device 
components, the MTT-based Roche Cell Proliferation Kit I was utilised. Samples of size 
10mm×10mm were sterilized under UV light for 12 hours before overnight incubation in 
400μL culture medium containing 10%v/v DES, 5%v/v FBS and 1%v/v P/S/AB in a 48-well 
plate maintained at 37˚C at 5% CO2. PC12 cells were seeded onto the film samples at a 
density of 2×104 cells/well and incubated for 72 hours. Thereafter, 40μL MTT solution was 
added to each well followed by a further 4-hour incubation period after which 400μL 
solubilising agent was added to dissolve the formazan crystals. The entire well contents 
were aspirated off, placed into 2mL Eppendorf tubes and centrifuged at 2000rpm for 5 
minutes to separate suspended cells. The resulting supernatant was transferred into a 96-
well plate and measured for absorbance at 550nm, with a background subtraction at 690nm, 
using a multi-plate reader (BioTek, USA). 
 
6.2.4. In vivo analysis and experimental design 
6.2.4.1. Animal procurement 
The Sprague Dawely rat utilized for the sciatic injury model in this study where procured 
from the Central Animal Services of the University of the Witwatersrand. Ethics clearance for 
the study was obtained from the Animal Ethics Screening Committee of the University of the 
Witwatersrand (Ethics clearance number: 2014/42/C, see Appendix C1).  
 
6.2.4.2. Experimental design 
A total of 42 Sprague Dawely rats, male and female, with weights in the 250-300g range 
were utilized for the study. The rats were randomly assigned to 5 groups consisting of 6 rats 
each (n=6), as shown in the Figure 6.3, whereas 12 rats were used as cadavers for 
refinement of surgical skills prior to commencement of the experiment. The experimental 
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groups were used to assess the in vivo performance of the Gel-Xan hydrogel conduit and 
the final assembled device using drug-free and drug-loaded formulations as well as the gold 
standard of nerve repair as the comparative: 
Group A: Comparative group 
The animals in this group received the current gold standard treatment of nerve repair 
consisting of a reversed autograph after induction of injury. 
Group B: Placebo hydrogel bioactive-free group 
Animals in this group received an implantation of the bioactive-free and hollow hydrogel 
conduit. 
 
Group C: Experimental hydrogel bioactive-loaded group 
Animals in this group received an implantation of a hollow hydrogel conduit loaded with 
100ng NGF and 4mg diclofenac sodium. 
 
Group D: Placebo NAC-free biosimulated device 
Animals in this group received an implantation of the final assembled device consisting of 
NAC-free fibres, 100ng NGF and 4mg diclofenac sodium. 
 
Group E: Experimental NAC-loaded biosimulated device 
Animals in this group received an implantation of the final assembled biosimulated nerve 
repair bioactive-loaded device consisting of 0.7mg NAC, 100ng NGF and 4mg diclofenac 
sodium. 
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Figure 6.3: Flowchart representation of the in vivo experimental design and analyses. 
 
6.2.4.3. Animal husbandry and acclimatization  
Animals were individually caged at ambient temperature and kept at a 12 hour light/dark 
cycle. Standard laboratory rodent chow (65% carbohydrates, 15% fat and 20% protein) and 
water were provided ad libitum. Weekly monitoring of weight was used as an indication of 
their general state of well-being. Prior to the experimental procedures, the rats were 
acclimatized to the laboratory environment and trained for 5 days (twice a day for 15 
minutes) on a walking track and grid walk apparatus in preparation for the behavioral 
analyses. Animal care and housing were executed in accordance with the standard 
operating procedures (SOPs) of the CAS and conforming to the South Africa Standard for 
the use and care of animals for scientific purposes. 
 
6.2.4.4. Surgical procedures 
The surgical procedures and techniques were first practised on rat cadavers to establish 
optimised surgical procedures before initiating it in live animals. This assisted in minimising 
potential further damage and animal suffering post-surgery while improving the surgery 
duration and ease. Figure 6.4 shows the practice trials of the autograft repair and conduit 
repair using 2 techniques. Figure 6.4b depicts the repair involving suturing of the transected 
nerve ends to the external edges of the conduit whereas Figure 6.4c (the optimised 
technique used for the study) involved insertion of the nerve ends inside the conduit using 
the suturing technique depicted in Figure 6.5. 
Total Study Group: 30 
Sprague-Dawley Rats
Group A: 6 Rats 
Control Group 
receiving drug-free 
nerve conduits
Group C: 6 Rats 
Comparative 
Autograft  Group 
receiving a reversed 
nerve autograft
Group B: 6 Rats 
Experimental Group 
receiving 
NGF/Diclofenac sodium 
loaded nerve conduits
Behavioural testing to obtain a base line prior to surgery 
Behavioural testing: 
walking track and 
grid walk at 7, 14, 21 
and 28 days post-
injury
Histological and 
morphometric 
studies
Muscle mass 
measurement
High-frequency 
ultrasound imaging 
at 14 and 28 days 
post-injury
Group D: 6 Rats 
Group receiving a 
bioactive-loaded 
biosimulated nerve 
repair conduit
Group E: 6 Rats 
Group receiving a 
bioactive-free 
biosimulated nerve 
repair conduit
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Figure 6.4: Photographs of the surgery practice trials of a) the autograft repair b) external 
conduit repair and c) internal conduit repair. 
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Figure 6.5: Illustration of the surgical suturing technique used for the nerve repair 
procedures. 
 
6.2.4.4.1. Induction of sciatic nerve transection injury 
The surgical procedures were performed according the methods described by Xu and co-
workers (2002; 2003), Madduri and co-workers (2010) and Mohammadi and co-workers 
(2013). Rats were anaesthetised with a mixture of ketamine (100mg/kg) and xyalazine 
(5mg/kg) administered intraperitoneally. Anaesthesia was maintained during the surgery 
using a mixture of isoflurane with oxygen. Thereafter, the rats’ left thigh and hind limb were 
shaved and the area of incision cleaned with F10 germicidal disinfectant. To expose the left 
sciatic nerve, a 2-3cm incision was made along the thigh and the gluteus maximus muscle 
was retracted. After freeing the nerve from the surrounding tissue a 5mm piece of nerve was 
excised, using microscissors, at the mid-thigh level proximal to the tibial and peroneal 
bifurcation. The retracted proximal and distal nerve stumps were pulled to create a 10mm 
nerve gap defect. The nerve gap defect was bridged by the implantation of a conduit or 
reversed nerve autograph before closure of the muscles and fascia layers with 4/0 vicryl 
absorbable sutures followed by closure of the skin with single 4/0 non-absorbable nylon 
sutures. For optimal tissue visualisation and precise implantation of conduits at the nerve 
transection site, all surgical procedures were performed using surgical loupes. 
 
6.2.4.4.2. Autograft repair procedure 
The autograft repair was performed as described by Yang et al., 2007. After induction of 
sciatic nerve transection injury, the excised nerve segment was reversed 180˚ and re-
implanted across the nerve gap defect using a single 9/0 epineurial nylon suture at the top 
and bottom of the proximal and distal nerve stumps as shown in Figure 6.6. The proximal 
Nerve ends 
pulled 2mm 
inside conduit
Nerve end
Path of needle and 
suture through conduit 
and epineurium Final closed stitch
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and distal transected nerve stumps were secured in place using 16mm 25 gauge needles to 
prevent spontaneous retraction of the nerve ends during suturing (Figure 6.6). 
 
 
Figure 6.6: Depiction of the autograft repair procedure. 
 
6.2.4.4.3. Conduit implantation and repair 
Implantation of the nerve conduit across the nerve gap defect was performed as described 
by Xu and co-workers (2002; 2003) and Madduri and co-workers (2010). The conduits were 
sterilized via a 18-hour exposure to UV light. Immediately after induction of nerve transection 
injury, the proximal and distal nerve stumps were inserted a length of 2mm deep into the 
ends of a 14mm long hollow (Figure 6.7a) or fiber-loaded (Figure 6.7b) conduit and secured 
in place with two 9/0 polypropylene epineural sutures on the top and bottom of either ends of 
the conduit. Thereafter, the musculature was closed with single 4/0 vicryl sutures and 4/0 
nylon stitches were used to close the skin.  
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Figure 6.7: Photograph of the conduit repair procedure utilizing a) the hollow conduit and b) 
the final assembled fiber-loaded conduit. 
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6.2.4.5. Post-operative care 
Immediately after surgery, animals were administered naloxone for anaesthesia reversal and 
kept in an incubator warmed to 25˚C until consciousness was regained. As post-surgery pain 
management, animals were administered 01.mL buprenorphine twice daily for 3 days. All 
animals were monitored twice daily for any signs of pain or distress. Auto mutilation of the 
affected limb was prevented by the oral administration of acetaminophen (65mg/kg) daily for 
further pain management when required. In addition to this, animals were housed singly to 
avoid further damage or mutilation of the affected site by other animals sharing the same 
cage. Food and water were provided ad libitum.  
 
6.2.4.6. Functional evaluation 
6.2.4.6.1. Walking track analysis 
Sheets of plain white paper were stained with 0.5%w/v bromophenol blue/acetone solution 
and then air-dried. The rats’ 2 hind limbs were carefully dipped in water and each rat walked 
a total of 3 times across a 150cm confined wooden walking track lined with the bromophenol 
blue-stained paper. Contact with the rats’ wet feet on the paper resulted in the immediate 
appearance of foot prints on the paper. After air-drying, the captured foot prints were 
analysed for functional recovery in terms of the sciatic function index (SFI) calculated using 
Equation 6.1. The following measurements were taken for the experimental left hind limb (E) 
and the normal right hind limb (N): the lengths between the third toe and the heel: print 
length (PL); the first toe and the fifth toe: toe spread (TS); the second toe and the fourth toe: 
intermediary toe spread (IT) (as shown in Figure 6.8) (Brown et al., 1991).  
 
SFI = -38.3 × (EPL – NPL)/NPL + 109.5 × (ETS – NTS)/NTS + 13.3 × (EIT – NIT)/NIT – 8.8 
Equation 6.1 
 
A SFI value near zero represents normal nerve function whereas a SFI of -100 indicates 
complete nerve dysfunction. Increasing SFI values will indicate improvement in functional 
recovery. Walking track analysis was conducted before injury induction as a baseline 
recording and at days 7, 14, 21 and 28 post-injury. 
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Figure 6.8: Depiction of the foot measurements required for calculation of the SFI. 
 
6.2.4.6.2. Grid walk analysis 
The grid walk test (Figure 6.9) was used as an assessment of fine motor control and gait 
movement. At 7, 14, 21 and 28 days post-surgery, rats were conditioned to walk across a 
100cm long metal wire grid with a distance of 2cm between the wires. The rats were 
observed for their walking motions along the grid. 
Figure 6.9: Grid walk setup for observation of motor control and gait movements. 
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6.2.4.7. High-frequency ultrasound imaging 
The Vevo 2100 High-Frequency Ultrasound System (VisualSonics, Inc., Toronto, Ontario, 
Canada) equipped with an ultrasound probe of 40-MHz and a 6-mm focal depth with a 
spatial resolution of 40x80x80μm3 at focus was utilized for imaging at 14 and 28 days post-
surgery to visualise the implanted conduit. Rats undergoing ultrasound imaging were 
restrained on a heated stage while maintained under anaesthesia of 1.5% isoflurane in 
oxygen. 
 
6.2.4.8. Muscle mass measurement 
Muscle mass assessment of the gastrocnemius muscles was made at the end of the study 
at 28 days. The gastrocnemius muscle from both the left and right sides were dissected out 
immediately after euthanasia of animals with 100mg/kg pentobarbital i.p. The muscles were 
weighed while still wet using an electronic balance. The increase or decrease in muscle 
mass was used as a measure of functional recovery and target organ re-innervation.  
 
6.2.4.9. Histology 
Histological analysis of the nerve tissue for observation of axon and myelin sheath 
regeneration was done after euthanasia of animals with 100mg/kg pentobarbital 
administered intraperitoneally; the implanted nerve conduit was dissected out after 14 and 
28 days post-implantation. The complete conduit containing the nerve tissue were fixed with 
2.5% glutaraldehyde in a 0.1M phosphate buffered saline (PBS) solution for 2 hours before 
being fixed in 1% osmium tetraoxide for 1.5 hours. After washing with PBS and dehydration 
with ethanol, the specimens were embedded in wax blocks and sectioned into 5-6μm 
sections using a microtome. The cross-sections were stained with haematoxylin and eosin 
and viewed under a light microscope. Similarly, the dissected gastrocnemius muscle was 
assessed for the extent of muscle atrophy. 
 
6.3. Results and Discussion 
6.3.1. Textural profiling and SEM visualisation of the Biosimulated Nerve Repair 
Device 
Textural profiling was conducted at weekly intervals over a 4-week study period in PBS pH 
7.4 of the hollow and fiber-containing hydrogel conduits to assess the transition in 
mechanical properties induced by the addition of an intraluminal filler. The incorporation of 
pristine PMMA particles in the gellan-xanthan hydrogel for pH-responsive particulate 
leaching resulting in the formation of a porous matrix has previously been established 
(Ramburrun et al., 2017) and presented in Chapter 4 of this thesis.  
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Figure 6.10a shows the %matrix resilience profiles obtained over 4 weeks for the hollow 
conduit and that containing intraluminal fibers. An improvement in matrix resilience of up to 
56.90% at the end of 28 days is noted upon addition of the intraluminal filler compared to 
42.01% achieved with the hollow conduit. Usually, the presence of empty voids dispersed 
within a polymer matrix allows the matrix to undergo a transient change in shape upon 
compression to a certain extent before reverting to its original form and shape after removal 
of the compressive force; however, singular and increasingly large unoccupied voids such as 
the hollow lumen would potentiate a decrease in resilience due to compromised resistance 
against compressive stress. The incorporation of the electrospun fibers in a spiral 
configuration within the conduit lumen improved resilience via partial occupation of the rather 
large void present in the hollow lumen of the conduit. The coiled-spiral configuration of the 
electrospun fibrous films enhanced the resilience of the guidance scaffolds as opposed to 
flat sheets of the film. Whereas induction of porosity from PMMA particulate leaching could 
improve permeability of the hydrogel thereby facilitating uninterrupted physiological 
processes, the improved resilience of the conduit imparted by the filling of the lumen resulted 
in enhanced ability of the system to recover upon subjection to compressive forces which 
may arise from contact with the surrounding tissues during in vivo implantation.  
 
The improved resilience of the system corresponds to the reduced deformability moduli 
observed in Figure 6.10b as compared to the hollow conduit from 1.26N/mm to 0.47N/mm at 
the end of 28 days. Decreased deformation indicates the shift from a rigid towards a more 
flexible scaffold. The layers of the coiled fibrous film, of delicate thickness (10μm), would 
less likely resist deformation compared to fibers thicker in diameter. Furthermore, declined 
deformability moduli and increased flexibility does not imply weakened mechanical strength 
of the system. As noted in Figure 6.10c, the intraluminal fibers impart increasing fracture 
energies over the 28-day study period indicating the expenditure of higher energies required 
to initiate rupture or breakage of the system compared to the hollow conduit, particularly at 
the end of the study where the fracture of the final assembled device exceeds that of the 
hollow conduit at 0.19N.mm and 0.17N.mm, respectively. An easily deforming matrix has the 
ability to disperse energy generated from an applied force to undergo a temporary change in 
shape rather than resisting the energy causing immediate fracture of the scaffold. An implant 
should possess sufficient flexibility and toughness to withstand forces generated from body 
movements and conforming to the tissue shape rather than to resist deformation creating the 
potential for discomfort and pain resulting from textural incompatibilities with the native body 
tissues. 
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Figure 6.10: Textural analysis profiles depicting between the hollow conduit and the final 
assembled device a) %matrix resilience b) deformability moduli c) fracture over a 4-week 
study period conducted in PBS pH 7.4. 
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Biaxial analysis presented with varying tensile strengths in the 90˚ and 180˚ axes (Figure 
6.11). This was particularly noted with the electrospun fibrous films which demonstrated a 
distinct pattern and enhanced tensile strength in the force-direction parallel to the fiber 
orientation (180˚) whereas the pull in the opposing direction (90˚) exhibited weaker strength 
(Figure 6.11a). This characteristic is imparted by weak inter-fiber adhesion points associated 
with the pattern of fiber deposition which further indicates the aligned orientation of the 
electrospun fibers as depicted in SEM imaging in Figure 6.15. As illustrated in Figure 6.12a, 
application of a tensile force in the direction perpendicular to the fiber alignment results in 
separation of the individual or grouped fiber strands whereas force applied in the direction 
parallel to the fiber arrangement results in slight stretching of the fibers prior to the onset of 
mechanical failure. Tensile failure of the fiber, in the 180˚ axis, is noted at 14 and 26 
seconds with a break force of 88mN. Failure points at 5, 13 and 40 seconds along the 90˚ 
axis indicate separation of individual or bundles of fibers with forces of 30mN, 14mN and 
17mN, respectively.  
 
Likewise, the hydrogel sample demonstrated similar mechanical properties but varying 
strengths in the pull along the 90˚ and 180˚ axes (Figure 6.11b).  Superior mechanical 
properties were noted along the 90˚ axis with failure occurring at 2539mN at 6 seconds 
whereas breakpoint along the adjacent axis was acquired at 2021mN at the same time point. 
This is possibly due to the crosslinking and subsequent molecular arrangement of the 
polymer chains around the longitudinal plane of the glass rod, during conduit synthesis, as 
opposed to the circumferential plane as depicted in Figure 6.12b. The superior tensile 
strength in the observed direction is favourable since tensile strain resulting from suturing of 
the conduit to the nerve ends would be subjected to the longitudinal aspect of the conduit as 
shown in the suturing technique in Figure 6.5. 
 
The accompanying video files (see CD inside the back cover of this thesis), depicting 
computational tracking of the data points, show increased displacement in the direction 
where superior tensile strength is noted (Video 6.1 and Video 6.2 showing displacement 
tracking of the electrospun fibers and hydrogel, respectively) whereas the changing yellow 
and red strain colour-blocks indicate the durable and failing areas, respectively, of the 
sample during subjection to the applied force over the test duration (Video 6.3 and Video 6.4 
showing strain tracking of the electrospun fibers and hydrogel, respectively). 
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Figure 6.11: Biaxial mechanical testing of a) the electrospun PHBV-MgOl-NAC guidance 
fibers and b) the gellan-xanthan hydrogel conduit in its dry state. 
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Figure 6.12: Illustration of the effect of fiber and potential molecular arrangement on biaxial 
tensile properties of a) the electrospun PHBV-MgOl-NAC guidance cues and b) the gellan-
xanthan hydrogel conduit. 
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6.3.2. In vitro release and mathematical modelling of NGF release kinetics 
The delivery of the neurotrophic growth factor, NGF, is crucial in attaining adequate neuronal 
survival, growth promotion and, foremost, differentiation of the regenerating axons in vivo. 
Therefore, its release profiles from the hollow and fiber-loaded conduits were evaluated over 
a 4-week study period. A few studies have shown that the release of high doses of NGF may 
hinder nerve regrowth due to down-regulation of TrkA receptors in the presence of excessive 
NGF molecules. Although large variations exist, lower doses of exogenous NGF are 
generally required as the neuronal tissue is capable (depending on the extent of the injury) 
of synthesizing its own NGF in the case of nerve injury after the Wallerian degeneration 
phase is terminated. The objective, therefore, would be to assist the body in repairing itself 
rather than implementing aspects to coerce repair processes. 
 
The inclusion of the PHBV-MgOl-NAC intraluminal fibers imparted a decrease in the overall 
fractional release of NGF over the 4-week in vitro study period compared to the hollow 
conduit, as shown in Figure 6.13, with fiber-loading producing a 61% decrease fractional 
release at 28 days. Conduits containing the intraluminal fibers demonstrated a maximum 
release of 5.5% of the total loaded NGF whereas the hollow conduit presented a slightly 
rapid release reaching 14% at the end of 4 weeks. This observed decrease in release could 
be attributed to the further entrapment of NFG molecules upon its escape from the 
crosslinked gellan-xanthan hydrogel matrix. It was noted, from the previous study utilizing 
bovine serum albumin as a model protein, that the release of NGF was much lower. This 
change in drug release patterns was ascribed to the ionic charge of the polymer matrix and 
the bioactive release agents. Both gellan and xanthan gum are anionic polymers whereas 
NGF, at pH 7.4, carries a positive charge, hence its potential ionic adhesion to the dissoluted 
polymer chain fragments. In this case, gellan is mostly crosslinked with xanthan and the 
released NGF molecules become entrapped within the negatively charged unreacted PHBV 
chains resulting in reduced escape and release of the peptide outside the conduit system. 
The lack of NGF release at days 1 and 3, similarly, could be attributed to such an ionic 
interaction between peptide and polymer molecules. Such a release pattern and entrapment 
of NGF acquired with implementation of the intraluminal guidance fibers could be favourable 
as it decreases the likelihood of NGF wastage and unnecessary leakage out of the conduit 
system. In this way, the released NGF molecules would be confined to the interior of the 
conduit lumen where it would be readily available to the regenerating axons as opposed to 
escape outside the conduit extremities. Furthermore, any attached NGF molecules onto the 
PHBV fiber surface could enhance neuronal cell interaction and adhesion along the fibers 
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thereby improving the physical guidance ability of the fibers towards innervation of the target 
muscles and functioning as a chemical cue in addition to its action as a therapeutic cue. 
 
Figure 6.13: In vitro NGF release profiles from the hollow and fiber-containing conduits over 
28 days in PBS pH 7.4. 
 
Mathematical modelling was performed to determine the drug release mechanisms 
governing NGF release from the conduit systems. Mathematical modelling of the release 
data, shown in Table 6.1, revealed that NGF release imparted by the addition of the 
intraluminal fibers is best described by the Higuchi model whereas release from the hollow 
conduit conforms to the zero-order model, indicating the central role of diffusion in the 
control of NGF release from the hydrogel matrix to the PHBV-fiber matrix and out the 
scaffold.  
 
The diffusional exponent, derived from n of the Korsmeyer-Peppas equation, indicates that 
NGF release from both the fiber-containing (n = 0.622) and hollow conduit (n = 0.850) 
indicate a non-Fickian anomalous transport encompassing a coupled-diffusion and 
relaxation mechanism. The contribution of Fickian diffusion (F) and Case-II relaxational (R) 
release of the system, determined from the R/F values derived from the K1 and K2 
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parameters in the Peppas-Sahlin equation, suggest a predominating release via the Case-II 
relaxational (increased R/F of 27.121) mechanism for the fiber-loaded conduit whereas 
Fickian diffusion (decreased R/F of 1.978) mainly controls NGF release from the hollow 
conduit. In each of the formulations, the K2 values exceed that of the K1 values (Table 6.1) 
thus indicating the increased contribution of the Case-II relaxational release mechanism as 
opposed to the Fickian diffusion in the overall release mechanism of NGF. Since NGF could 
be bound to the polymeric components via an ionic interaction, polymer relaxation ensuing 
erosion would be required for the peptide’s subsequent release; hence the Case-II 
relaxational mechanism determined form kinetic modelling. 
 
Table 6.1: Kinetic modelling results of NGF release from the fiber-loaded and hollow 
hydrogel conduits 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.3.3. PC12 proliferation in response to the nerve repair device components 
MTT assay for the growth of PC12 cells on the various scaffolds components and the final 
assembled device were determined over a 72-hour incubation period as shown in Figure 
6.14. The DS-loaded hydrogels and the NAC-loaded fibers showed improved cell growth 
compared to the corresponding bioactive-free derivatives (Figure 6.14). The NAC-loaded 
fibers were shown to better support cell growth than the DS-loaded Gel-Xan hydrogels 
Mathematical Model  Conduit + Fibers Conduit 
Zero-Order     
R² 0.960 0.907 
First-Order 
R² 0.962 0.904 
Higuchi 
R² 0.975 0.884 
Hopfenberg 
R² 0.961 0.905 
Hixson-Crowell 
R² 0.961 0.905 
Korsmeyer-Peppas  
R² 0.821 0.958 
N 0.622 0.850 
Peppas-Sahlin   
R² 0.828 0.907 
K₁ 185.630 262.240 
K₂ 5034.400 518.640 
R/F Ratio 27.121 1.978 
Best-fit model Higuchi Zero-Order 
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alone. Of interesting note, the NAC-loaded fibers and the final assembled BNRD (integrating 
the individual bioactive-loaded hydrogel and fiber components) exceeded the growth of the 
control. Pristine electrospun PHBV did not efficiently enhance PC12 proliferation compared 
to the PHBV-MgOl and PHBV-MgOl-NAC composite fibers (Figure 6.15a-b). The observed 
enhanced growth reflects the favourable bioactive effects of MgOl and NAC incorporation 
with PHBV as the base polymer. It is noted that pristine PHBV fibers and the bioactive-free 
Gel-Xan hydrogel (denoted by DS-F in Figure 6.14) showed reduced cell viability in 
comparison to the control which could be due to the degradation of the carboxylic acid 
moieties present in these polymers (PHBV: butyric and valeric acids; Gellan and xanthan 
gum: glucuronic and pyruvate acidic moieties) thus creating a sudden decrease in pH 
thereby inducing a form of cellular stress resulting from the change in environmental pH.  
Furthermore, the uneven textured and bead-like topography of the pure PHBV fibers (Figure 
6.15c) could further reduce cell compatibility and interaction 
 
Similarly, DS exhibited potential as a neuronal-growth promoter as noted in the PC12 growth 
response in Figure 6.14. Combinations of DS, MgOl and NAC could function synergistically 
for improved PC12 cell growth as presented by the significantly improved proliferation level 
achieved with the BNRD (Figure 6.14). The enhancement of PC12 cell growth on the BNRD 
system could be mainly attributed to the combined neuro-protective actions (Hart et al., 
2008) of DS, Mg2++ ions and NAC where the presence of elemental magnesium is indeed 
noted in the EDS analysis in Figure 6.16a-b. Increased neuronal survival suggests a greater 
number of viable cells available for further proliferation via prevention of apoptotic cell death 
resulting from exposure to stress and sudden cellular environmental change. Furthermore, 
the presence of oleic acid, despite its presence in an oleate form, could enhance cell 
proliferation via action as a neurotrophic growth factor (as discussed in Chapter 5 Section 
5.3.9). In addition, NAC could prevent cellular oxidative damage whilst simultaneously 
enhancing the cell adhesion ability of the cells on the scaffold surface. As per the MTT 
assay, the final BNRD system shows adequate PC12 cell viability and biocompatibility, 
thereby allowing its further investigation in an in vivo model. 
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Figure 6.14: MTT PC12 viability studies in response to the drug-free (DS-F) and drug-
loaded (DS-L) PMMA-intercalated Gel-Xan hydrogel conduits; the NAC-free (NAC-F) and 
NAC-loaded (NAC-L) electrospun guidance fibers; 100% electrospun PHBV and the final 
assembled biosimulated nerve repair device (BNRD) (n=3). 
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Figure 6.15: SEM imaging of a) the optimized NAC-loaded formulation b) the optimized 
NAC-free derivative c) pure electrospun PHBV. 
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Figure 6.16: EDS analysis depicting the elemental composition of a) the NAC-loaded 
optimized fibers and b) the NAC-free optimized fibers. 
 
6.3.4. Assessment of nerve regeneration by implantation of various conduits across 
the rat sciatic nerve defect 
6.3.4.1. Walking track analysis 
Pre-operatively, the mean SFI determined from baseline walking track experiments, was -
8.17 (± - 4.15) lying closer to zero, thus indicating normal nerve function of the animals 
employed (Iohom et al., 2005). After the injury and surgical procedures, 0-48 hours, the foot 
of the injured hind limb was completely flaccid in the plantar flexion position, as shown in 
Figure 6.17a, indicating total paralysis. Within 3-5 days, the rats started gaining control of the 
  
248 
 
affected limb thus assuming the original neutral orientation of the foot, as shown in Figure 
6.17b of a rat in Group E. At 7 days post-injury, SFI values decreased to -75.05, -102.70, -
83.52, -84.95 and -84.54 for Groups A (autograft repair), B (DS-NGF-free hollow conduit), C 
(DS-NGF-loaded hollow conduit), D (DS-NGF-loaded, NAC-free device) and E (DS-NGF-
loaded, NAC-loaded device) respectively, indicating substantial loss of function whereas an 
SFI value of -100 or less (as noted with Group B) implied complete nerve dysfunction. Over 
the 28-day study period, the SFI values for Groups A-C were seen to progressively 
decrease, indicating deteriorating nerve function whereas SFI values of Group D remained 
fairly constant between -82.53  a̶nd -84.95 and that of Group E showed slight improvements 
from -84.54 to -80.17 from 7 to 28 days (Figure 6.18). The noted increases in the SFI values 
of Group E over the 4-week study denote the effective functioning of the final assembled 
BNRD system. Group B, receiving the DS-NGF-free hollow conduit, performed poorly over 
the 28-day study and obtaining the lowest SFI of -106.12 after 4 weeks. Group C, containing 
an identical but DS-NGF-loaded conduit, exhibited improved function compared to Group B 
with an SFI of -97.32 at 28 days therefore suggesting the importance of the reparative role of 
the anti-inflammatory DS and neurotrophic NGF in the treatment of peripheral nerve injuries. 
Introduction of the aligned intraluminal support scaffolds within the hollow conduit lumen 
further improved functional recovery outcomes, as depicted by the SFI values in Figure 6.18, 
where the inclusion of NAC in the electrospun fibers (Group E) enhanced functional 
recovery. These results suggest effective action of MgOl and NAC in further protecting and 
promoting neuronal growth (as evidenced in the MTT assays in Figure 6.14) while the 
provision of aligned physical guidance fibers could improve target muscle innervation, hence 
the improving walking ability noted. In addition, the obtained NGF release kinetics in Figure 
6.13 could be deemed adequate for nerve injury treatment and regeneration. 
Figure 6.17: Photograph of rat in group E at a) day of surgery and b) 3 days post-surgery. 
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Figure 6.18: Sciatic function indices determined from walking track analysis of the various in 
vivo experimental groups over a 28-day test period. 
 
6.3.4.2. Grid walk observations 
Grid walk observations and recordings showed that all groups, at 4 weeks, showed slow 
recovery of fine motor control of the injured hind limb compared to the recordings taken 
before induction of injury. Curling and contraction of the toes on the foot of the injured limb 
prevented toe-spreading and the ability of the animal to grip onto the wire grids while 
walking. Although fine motor recovery return was gradual, minimal to no slippage of the 
affected hind limb was noted as the rats were able to manoeuvre across the grid via an 
exaggerated motion of the hip producing a hopping-like movement. Groups D and E, 
containing the intraluminal fibers, were observed to attain slightly improved motor function as 
animals in this group were able to consciously place the foot of the injured limb onto the wire 
grid as they walked, thus indicating the return of improved functional recovery as additionally 
noted with SFIs values acquired. 
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6.3.4.3. Ultrasound imaging and macroscopic examination of the implanted conduits 
Ultrasound imaging of the injured left hind limb at 2 weeks post injury and implantation 
revealed the presence of an intact cylindrical-shaped conduit as noted in Figure 6.19a and b. 
At 4 weeks the architecture of the implanted conduit could no longer be identified and was 
probably due to obscuring resulting from the formation of inflammation, scar tissue or 
potential vascularisation of the conduit surface. Imaging of the animals receiving the 
autograft repair (Group A) exhibited a continuous thin linear-traversing structure depicting 
the intact repair of the transected nerve at both 2 and 4 weeks as depicted in Figure 6.19c. 
However, no abnormalities, implant rejection or detachment from the nerve ends were 
observed during ultrasound imaging.  
 
At the end of the 4-week study, dissections, as shown in Figure 6.20, revealed the 
maintenance of an intact and hydrated conduit with minimal erosion and adequate 
mechanical strength as the conduits were still secured to the nerve ends at the suture points 
and no structural deformations were noted. A maximal swelling of the conduits up to 1.5mm 
was noted. A decline in swelling compared to that obtained in previous in vitro dissolution 
studies (Ramburrun et al., 2017) could be attributed to the exposure of a lower fluid volume 
in the thigh-sciatic nerve region and the potential binding and subsequent crosslinking of 
plasma Ca2+ ions with the gellan-xanthan hydrogel, thereby strengthening polymer network 
and limiting its swelling and erosion capacity.  Partial concealment of the implanted conduit 
by a thin network of vascular and connective tissue or inflammation could result in the poor 
conduit visibility noted at 4 weeks of the ultrasound scanning. 
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Figure 6.19: Ultrasound imaging conducted at 2 weeks post-implantation a) Group C: hollow 
conduit b) Group E: final assembled device and c) Group A: autograft repair at 2 and 4 
weeks post-surgery. 
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Figure 6.20: Photographic representation of the 4-week dissections showing the intact 
presence of the implanted conduits a) Group B b) Group C c) Group D d) Group E and e) 
Group A autograft repair. 
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6.3.4.4. Muscle mass and histological analyses 
The incorporation of DS, MgOl and NAC elicited positive effects in the in vitro growth of 
PC12 cells via its collective neuro-protectant and growth-promoting actions. A similar effect 
was noted on the tissue appearance of the gastrocnemius muscle shown in Figure 6.21 
where treatment with the aforementioned bioactives promoted the muscle fiber health as 
indicated by the presence of numerous interstitial cell nuclei. After 28 days of implantation of 
the various conduits, the gastrocnemius muscles were excised to assess the muscle mass 
preserved after injury-induction and subsequent surgical and conduit repair. Muscle mass 
has been utilized as an effective indicator of recovery outcomes from peripheral nerve 
injuries. Increased muscle mass suggests reduced occurrence of muscular atrophy from lack 
of mobilization and improved muscle re-innervation by the regenerating axons. From the 
%muscle mass remaining values depicted in Figure 6.22, introduction of the PHBV-MgOl-
NAC aligned (as depicted in the SEM imaging in Figure 6.15a) guidance fibers via 
placement into the hollow Gel-Xan hydrogel conduit (Group E) improved recovery compared 
to the hollow hydrogel conduit (Groups B and C) alone and with slightly improved function 
than the comparative autograft repair (Group A) where %muscle mass remaining 40.96% for 
Group A and 43.05% for Group E (Figure 6.22). Although the NAC-free guidance fibers 
(Group D) was outperformed by the autograft Group A, it achieved higher preservation of 
muscle mass (34.74%) compared Groups B and C. Groups B and C comprising of the 
bioactive-free and DS-NGF-loaded hollow hydrogel conduits, respectively, exhibited 
increased muscle atrophy with only 22.44% and 21.71% muscle mass remaining at the end 
of 28 days. Despite Group C (receiving DS-NGF treatment) exhibiting a slightly decreased 
muscle mass compared to Group B (receiving no DS-NGF treatment), improved SFIs of 
Group B from walking track analysis suggest the return of improved muscle functionality. In 
addition, histological imaging in Figure 6.21b and c depicts similar muscle tissue appearance 
in Groups B and C. Improved muscle mass in Groups D and E indicate enhanced axonal 
guidance resulting in improved target muscle tiisue re-innervation and functional recovery 
upon implementation of the trio-functionalized composite guidance scaffolds into the hollow 
hydrogel conduits. The appearance of improved muscle tissue regeneration, indicated by the 
presence of increased muscle interstitial cell nuclei (Tedesco et al., 2010; Melacova and 
Puri, 2012 and Ceafalan et al., 2014) and reduced muscle cell shrinkage, is noted in Group 
E of the BNRD (Figure 6.21f) compared to Group C (Figure 6.21g) who received a hollow 
DS-NGF-loaded conduit thereby proving the success of the intraluminal guidance cues in 
achieving improved levels of muscle re-innervation via formation of neuromuscular junctions 
between the newly-regenerated axons and the existing muscle fibers. The indication of 
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improved muscle health in Group E is further supported by the acquired improving SFI 
values and observations of fine motor control during the grid walk analysis. 
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Figure 6.21: Histological imaging of the excised gastrocnemius muscle featuring interstitial 
cells (arrows) a) Group A b) Group B c) Group C d) Group D and e) Group E at 10× 
magnification and f) Group C and g) Group E at 20× magnification at the end of the 4-week 
study period. 
 
Figure 6.22: Representation of the %muscle mass remaining after 28 days following 
surgical nerve repair of the respective in vivo groups (n=3). 
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Histological analysis, depicted in Figure 6.23, on the regenerated nerve samples at the mid-
portion of the conduit after 2 and 4 weeks were performed to assess the degree of nerve 
regeneration achieved and the cellular components involved in the process. All specimens 
collected from the 5 in vivo groups demonstrated a mild inflammatory response mainly 
attributed to the presence of foreign material such as the sutures used, the conduit matrix 
and the guidance scaffolds. 
 
The autograft repair Group A presented with normal peripheral nerve tissue at 2 weeks 
progressing to increased cellularity from spindle and Schwann cell proliferation at 4 weeks. 
Certain areas however, revealed karyopyknosis: an event leading to nuclear apoptosis. The 
specimens collected from Group B (receiving the bioactive-free hollow conduit) presented 
with normal nerve tissue with prominent interstitial spindle and Schwann cell proliferation 
accompanied by a few lymphocytic cells. The presence of spheroids was indicative of axonal 
damage. At 4 weeks, the increased presence of spindle cells and granulomatous 
inflammation obscured most of the underlying peripheral nerve tissue, however, an 
interlacing formation of the spindle cells were representative of reactive Schwann cells. 
Inflammation responses consisting of lymphocytes, plasma cells and mast cells were 
present along the interstitium. After 2 weeks of the study, Group C receiving the DS-NGF-
loaded hollow hydrogel conduit presented with a notable proliferation of spindle-shaped 
Schwann cells which appeared to form interlacing bundles with a neural-type arrangement 
pattern. This, however, progressed to extensive proliferation of interstitial cells and 
granulomatous inflammation consisting of epitheloid macrophages at 4 weeks. Group D, 
receiving the DS-NGF-loaded conduit with NAC-free intraluminal guidance scaffolds, 
presented with prominent macrophages, lymphocytes and plasma cells in the surrounding 
connective tissue. Spindle cells, numerous capillaries, red blood cells and fibrin deposition 
were noted. Granulomatous inflammation was mostly present at the ends of 4 weeks. Group 
E, receiving the final BNRD system, exhibited moderate interstitial and Schwann cell 
proliferation accompanied by inflammation consisting of lymphocytes, plasma cells, 
epitheloid macrophages and neutrophils. Evaluation of the collected specimens after 4 
weeks, showed similar inflammatory reactions but with the prominent appearance of 
neovascularization as seen in Figure 6.23 (which was not evident in Groups A, B and C). 
 
Although granulomatous inflammation was evident, in response to the conduit components 
as foreign material, the absence of excessive fibrotic tissue may suggest the effective role of 
DS as an anti-inflammatory agent thereby reducing the quantity of functionless scar tissue. 
Peripheral nerve regeneration requires the Schwann cell proliferation, which was evident in 
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the histology sections collected from the current study. Schwann cell proliferation, 
particularly noted in Group C and E, is pertinent for the production of intrinsic neurotrophic 
factors and myelin basic protein which are crucial for effective growth promotion and 
regeneration of damaged nerve tissue (Chung et al., 2011). 
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Figure 6.23: Pictographs showing histological examination of the sciatic nerve regeneration 
across the various treatment groups where SC represents Schwann cell proliferation. 
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6.4. Concluding Remarks 
Analyses of textural profiling, PC12 MTT assay and NGF release kinetics showed adequate 
in vitro biocompatibility, durability and performance of the biosimulated nerve repair device 
comprising a polysaccharide hydrogel conduit and intraluminal aligned nano-fibrous 
guidance cues hence its further assessment in an  in vivo model: the rat sciatic nerve gap 
model. A thermal ionic crosslinking mechanism using the divalent calcium ion resulted in 
sufficient holding and biodegradability of the gellan-xanthan hydrogel network over a 4-week 
implantation period (Ramburrun et al., 2017). In vivo behavioural evaluations, for the 
determination of functional recovery outcomes post-injury, comprising walking track-derived 
SFI and grid walk analysis suggest improved functional recovery and return of fine motor 
control in animals receiving implantation of the fully assembled BNRD system where SFI 
values were noted to progressively increase over the 4-week study period. Further 
morphometric analysis of gastrocnemius muscle mass remaining revealed reduced muscular 
atrophy in animals treated with the PHBV-MgOl (34.74%) and PHBV-MgOl-NAC (43.05%) 
composite intraluminal guidance cues compared to those treated with the bioactive-free 
(22.44%) and bioactive-loaded (21.71%) hollow hydrogel conduit alone. Histological analysis 
of the regenerated nerve segments at 2 and 4 weeks post-implantation indicated the 
presence of prominent Schwann cell proliferation, neural-type cellular arrangement and 
neovascularization in Groups D and E as compared to Groups A, B and C. These 
observations suggest successful implementation of the intraluminal guidance scaffolds in 
simulating a neuronal microenvironment conducive of axonal repair. The degree of Schwann 
cell proliferation, neovascularization, muscle mass remaining and SFI values collectively 
present outperformance of the autograft repair in Group A by the BNRD system in Group E 
thus demonstrating the effectiveness of aligned nano-constructs within a hydrogel conduit in 
emulating the intrinsic architecture of peripheral nerve tissue via provision of long-term and 
sustained physical, chemical and therapeutic guidance cues. 
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CHAPTER 7 
CONCLUSIONS, RECOMMENDATIONS AND FUTURE OUTLOOK 
 
 
7.1. Conclusions 
The increased frequency of road and motor vehicle accidents is one of the leading causes 
for the inclining numbers of peripheral nerve injury sufferers globally, estimated at 2 million 
incidents annually. Traumatic injuries of peripheral nerves, particularly transection injuries, 
often culminate in permanent and lifelong debilitation causing further decline in a patient’s 
quality of life initiated by the onset of chronic neuropathic pain, severe muscle atrophy, loss 
of functional recovery and diminishing social and psychological wellbeing. 
 
Nerve tissue has an innate, but limited, capacity of regeneration post-injury depending on 
the severity of injury, the resulting inflammatory mechanisms and the time between injury 
detection and treatment. The gold standard of nerve repair currently remains the nerve 
autograft, however, several drawbacks and resultant morbidities associated with this 
treatment modality has necessitated the search for an effective yet uncomplicated strategy 
for promoting the innate regenerative abilities of peripheral nerves. Ongoing research has 
established that successful nerve regeneration and restoration of functional recovery 
requires an advancement of the simple bridging conduits, commercially available, towards 
sophisticated repair constructs capable of emulating, or preferably exceeding, the 
characteristics and outcomes of the autograft.   
 
The research presented in this thesis involved facets of advanced drug delivery, polymer 
science and tissue engineering for the design and formulation of the BNRD system for 
enhanced peripheral nerve regeneration via provision of a mechanically stable, biomimetic 
and bioactive-releasing repair conduit. An extensive analysis comprising physicochemical, 
physicomechanical and in vitro studies of a Box-Behnken experimental design confirmed the 
theory of pristine-polymer-particle intercalation for extended bioactive release via a pH-
responsive in situ porogen leaching effect in both cationic and anionic crosslinked 
polysaccharide matrices. Further cell cyto-compatibility studies and subsequent in vivo 
analysis in the rat sciatic nerve gap model validated efficacy of the repair device compared 
to the gold standard autograft repair.  
 
The core aim of the research study was to develop a unique strategy for the controlled 
release of bioactives in treating peripheral nerve injuries which was achieved via the 
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successful implementation of pH-responsive pristine-polymer-particle intercalation within a 
hydrophilic swellable polymer matrix. Elucidation of the mechanisms behind the concept of 
particle-intercalation for extended bioactive release and improved matrix resilience 
properties were established utilizing indomethacin-entrapped poly-ionically crosslinked 
chitosan spheres as model components prior to application of the technique in a hydrogel-
based scaffold suitable for nerve tissue repair. 
 
The subsequent implementation of pristine-PMMA-particle intercalation within a novel gellan-
xanthan coupled thermo-ionic crosslinked IPN hydrogel conduit offered the concurrent 
release of 2 bioactive types: a protein-based molecule (BSA and NGF) and a small 
molecular-weight non-steroidal anti-inflammatory drug (diclofenac sodium). The PMMA-
intercalated hydrogel system was effective in extending NGF and diclofenac sodium release 
over 30 days while maintaining bioactivity and molecular integrity of the growth factor as 
detected by ELISA assays. The formulation of a gellan-based IPN hydrogel system via ionic 
and thermal crosslinking with the graded incorporation of xanthan gum yielded and effective 
strategy for the modulation of deformation and fracture properties of the resulting scaffold 
whereas PMMA-intercalation and imparted improved resilience attributed to the formation of 
a porous network upon dissolution and leaching.  
 
Advancement of the hydrogel conduit was further implemented via the design and 
integration of aligned electrospun nano-fibrous guidance cues for the provision of 3 key cue 
types: physical, chemical and therapeutic. The technique of high-speed rotational 
electrospinning yielded the formation of aligned PHBV nano-fibers blended with a metal-
oleate salt, MgOl, functioning as a nucleating agent for modulation of PHBV crystallinity and 
resulting mechanical properties as well as simultaneous action as potential bioactives in 
treating peripheral nerve damage. Integration of the electrospun sheet in the form of a loose 
coiled intraluminal scaffold within the hollow gellan-xanthan hydrogel conduit provided the 
physical and topographical guidance cue via the presence of longitudinally aligned fibers 
whereas the amalgamation of MgOl and NAC with the PHBV base polymer, in conjunction 
with the bioactives loaded in the hydrogel conduit, offered the chemical and therapeutic 
guidance cues for enhanced cellular interaction and neuronal survival.  
Cell studies, utilizing the PC12 neuronal cell line, demonstrated the proliferative effects of 
the various bioactive-loaded and bioactive-free components of the device. The polymeric 
matrices, although biocompatible and capable of supporting cell growth alone, proved to 
augment cell proliferation upon the loading and consequent concomitant controlled release 
of the various bioactives including DS, MgOl and NAC.  
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In vivo analysis of the final assembled optimized BNRD system in the Sprague Dawley rat 
sciatic nerve model served to assess the performance of the device in peripheral nerve 
repair and treatment. Behavioural, morphometric and histological analyses established the 
level of functional recovery achieved and the extent of nerve regeneration evident post 
injury-induction and in response to treatment with the BNRD system and its individual 
components in comparison to the nerve autograft. Increasing cellular activity, Schwann cell 
proliferation and vascularization from histological analysis corresponded to the improved 
muscle preservation and functional recovery in terms of SFI observed during the behavioural 
assessments. The release kinetics of NGF and DS, as determined from in vitro dissolution 
studies, from the BNRD system demonstrated successful execution in promoting nerve 
regeneration and improving functional recovery outcomes over the 4-week test period 
compared to that achieved with the autograft repair. 
 
The BNRD system developed and reported in this thesis was shown to be capable of 
adequate peripheral nerve regeneration and restoration of functional recovery, including fine 
motor recovery, exceeding the outcomes achieved with the autograft repair thus indicating 
the efficacious design and implementation of a biomimetic construct combined with a unique 
strategy for the long-term and concurrent release of at least 2 bioactives in treating 
peripheral nerve injuries and achieving the goal in attaining an alternative repair tactic 
equivalent to and potentially surpassing the gold standard of nerve injury treatment.  
 
7.2. Recommendations 
The current thesis presented extensive discussions pertaining to the design, fabrication, 
characterization and in vitro analysis of the proposed BNRD system for the treatment of 
traumatic peripheral nerve injuries. Analyses of the device were performed up to the 
preclinical stage of in vivo evaluation in an animal model: the Sprague Dawley rat. Although 
the collected evidence indicated enhanced in vivo performance of the device compared to 
the autograft repair as established via muscle mass, histological and SFI walking track 
analysis over the 4-week test period, it may be suggested that the performance evaluation of 
the BNRD system be conducted over a longer test period extending 4 weeks and preferably 
towards 8-12 weeks or more. While studies over 4-6 weeks provide information on the early 
regenerative effects of the proposed treatment, long-term studies extending over several 
months could assist in the collection of data relating to the maximal levels of function 
recovery that could possibly be attained and further insight into the repair mechanisms 
employed by the body to bring about complete tissue healing and regeneration. The 
increased study time frames could be combined with an increased number of animals 
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employed in the study to account for the existence of natural variances and differences in 
the innate healing capacities among individual animals. Additional potential influencing 
factors affecting the outcome of peripheral nerve regeneration could be implemented in the 
study, such as the effects of diet and nutrition and regular physiotherapy exercises to assist 
with the prevention of muscle atrophy  ̶  as would typically be included in the full therapeutic 
regimen of a human being. Although the present study focused on the restoration of 
functional recovery in terms of motor control, behavioural analyses for the evaluation of 
sensory recovery should further be investigated. 
 
A limitation to the present in vivo study was that the effects of delayed nerve repair were not 
investigated. The in vivo study conducted and described in this thesis was based on the 
immediate repair of the transected nerve following induction of injury. In a real world 
scenario, the time between acquirement of the injury, its detection and subsequent repair 
could vary between a few hours to days depending on the nature of the injury i.e. motor 
vehicle accidents and bone fractures. During that time of potential delay in nerve injury 
detection and treatment, the course of inflammation and fibrotic tissue infiltration has already 
initiated causing probable variability in the extent of tissue healing achieved. The 
aforementioned preclinical investigations would be essential prior to commencement of 
clinical trials in human subjects. 
 
The nerve repair device presented in this thesis could further be utilized and investigated for 
the concurrent release of other neurotrophic growth factors and conventional therapeutics 
employed in the treatment strategy of peripheral nerve injuries including nutrients, 
analgesics and corticosteroid anti-inflammatories. A critical aspect influencing the 
commercialisation and ultimate clinical use of the BNRD system, in addition to mass 
production and requirement of specialised equipment and moulding devices, concerns 
effective sterilization techniques and subsequent packaging of the device to maintain sterility 
as well as chemical and mechanical integrity of the device with optimum preservation of 
bioactivity of the incorporated bioactives and fragile protein molecules from the time of 
manufacture till the moment it is required for implantation. Although a large component of the 
BNRD system utilizes affordable, naturally-sourced and renewable polymeric materials for its 
construction, the technique of nano-fiber synthesis for fabrication of the intraluminal 
guidance cues via electrospinning could be costly and time consuming regarding the large 
scale production of the device and therefore would require specialised instrumentation for 
rapid production and excellent reproducibility of the guidance scaffold component. 
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7.3. Future Outlook 
A pH-responsive IPN hydrogel scaffold was designed and optimized of the specific repair 
and treatment of traumatic peripheral nerve injuries through the further implantation of an 
independent nano-fibrous scaffold forming an intraluminal guidance cue component for 
enhanced resemblance of the device to the architecture of native nerve tissue. The 
functional recovery results obtained from the preliminary in vivo studies has shown superior 
performance of the BNRD compared to the gold standard of nerve repair and thus holds 
potential for patenting, clinical trials and commercialization of the device for both human and 
veterinary use. 
 
Although the polymeric components of the device presented in this thesis has been 
assembled specifically as a repair strategy for transected peripheral nerve injuries, the 
individual components and bioactive-release system could be modified and utilized in tissue 
regeneration applications of other organ systems which require long-term biodegradable and 
controlled-release scaffolds for tissue repair and healing. Simple customizable moulding and 
modification of the gellan-xanthan IPN hydrogel matrix through alteration of polymer and 
crosslinker concentration and particle-intercalation, for tailored matrix resilience, flexibility 
and rigidity, yields a method for adapting the system for neural (spinal cord and brain) 
cartilage, vascular (arterial and venous patch-up) and wound repair strategies. In addition, 
the approach to attaining sustained-release for the delivery of various bioactives employing 
the novel pH-responsive pristine-polymer-particle intercalation technique could be applied to 
and implemented in other hydrophilic polymer systems for either single or dual drug delivery 
encompassing a variety of drug classes employed in tissue-engineering and targeted drug 
delivery applications such as peptide-based growth factors, anti-inflammatories, antibacterial 
compounds and chemotherapeutics. As mentioned elsewhere in this thesis, the electrospun 
fibers possess alternate uses as bioactive-releasing dressings and linings or it could be 
utilized on its own as intraluminal guidance scaffolds in conjunction with any marketed 
hollow nerve conduit. 
 
Furthermore, the use of naturally-derived biocompatible, biodegradable and renewable 
bacterial polysaccharides (gellan, xanthan and PHBV) in the key polymeric construct of the 
device implies an economical yet environmentally sustainable approach to the utilization of 
materials required for production of such a device thereby further supporting the trending 
notion of green-chemistry in the development of pharmaceuticals, as embraced by global 
pharmaceutical companies (Tucker and Faul, 2016). 
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In conclusion, the research and resulting developed device documented in this thesis holds 
potential not exclusively confined to nerve tissue regeneration but extends into the domain of 
various other tissue-engineering and regenerative medicine applications requiring the 
amalgamation of advanced drug delivery techniques. 
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APPENDIX B1 
 
 
Design of Hydrogel Matrices with Intercalated Pristine-Polymer-
Particles for Enhanced Porosity and Extended Bioactive Release 
via In situ pH-Responsive Particulate Leaching 
 
Poornima Ramburrun, Yahya E. Choonara, Pradeep Kumar, Lisa C. du Toit and 
Viness Pillay 
 
Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and 
Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the 
Witwatersrand, Johannesburg, 7 York Road, Parktown, 2193, South Africa. 
 
Purpose: 
The release kinetics of bioactive molecules and the structural integrity of the delivery scaffold 
are pertinent in achieving optimal tissue healing. This study investigates the effect of 
pristine-polymer-particle intercalation on mechanical properties and bioactive release from 
chitosan matrices for extended drug release in tissue regeneration. 
Methods: 
  Preparation: Sodium tripolyphosphate ionically crosslinked polysaccharide-based 
(chitosan) matrices were loaded with quantities between 50-200%w/w of pristine polymethyl 
methacrylate (PMMA) anionic nanoparticles.  
  Drug release: Chitosan spheres were loaded with indomethacin as a model drug. In vitro 
release studies in phosphate buffered saline (PBS) pH 7.4 and UV spectroscopy were used 
to quantify drug release.  
  Porosity analysis: Porosity imparted by particulate leaching of PMMA particles were 
examined via Porositometric analysis in accordance with BET and BJH models. Surface 
morphology and pore visualisation was conducted on an FEI Quanta 400 FEG scanning 
electron microscope prior to gold-palladium sputter-coating of samples. 
  Textural profiling: Changes in mechanical properties of the matrices over 30 days of PBS 
immersion was evaluated in terms of resilience, deformation and fracture using the 
TAXT.plus StableMicrosystems texture analyser.  
Results: 
Drug release from chitosan spheres loaded with pristine PMMA particles was controlled via 
the pH-responsive dissolution (pH 7.4) of PMMA leading to the simultaneous formation of 
pore structures on the matrix surface and polyelectrolyte complexation (PEC) between the 
opposing charged polymers. PEC formation improved matrix fracture point and extended 
indomethacin release over 144 hours in a first-order manner as opposed to PMMA-free 
matrices providing release for only 72 hours. Increase in PMMA particle concentration led to 
enhanced resilience (27.27% increase) via increased number and size (10.77nm increase in 
diameter) of pores formed as validated by porositometric analysis and SEM imaging.  
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APPENDIX B2 
 
 
Intercalation of Hydrogel Tissue-Repair Scaffolds with Pristine-Polymer-Particles for 
Enhanced Porosity and Extended Bioactive Release  
Poornima Ramburrun, Yahya E. Choonara, Pradeep Kumar, Lisa C. du Toit and Viness 
Pillay 
Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and 
Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of 
the Witwatersrand, Johannesburg, 7 York Road, Parktown, 2193, South Africa. 
 
Purpose: To investigate the effect of pristine-polymer-particle intercalation on mechanical 
properties and bioactive release from anionic and cationic hydrogel matrices for tissue 
regeneration. 
 
Methods: Polysaccharide-based (chitosan and gellan/xanthan gum blend) ionically 
crosslinked hydrogel matrices with intercalated pristine polymethyl methacrylate (PMMA) 
nanoparticles were used to investigate the effects on drug release of model bioactives 
indomethacin (chitosan), BSA and diclofenac (gellan/xanthan). In vitro release studies and 
UV spectroscopy were used to quantify bioactive release. Porosity imparted by particulate 
leaching of PMMA particles was examined via Porositometric analysis in accordance with 
BET and BJH models. Mechanical properties in terms of resilience, deformation and fracture 
were evaluated at predetermined time points during erosion. Thereafter, matrix surface 
morphology and pore visualisation was conducted on a scanning electron microscope to 
assess the matrix erosion mechanisms and pore-formation. 
 
Results: Drug release from chitosan loaded with pristine PMMA particles was controlled via 
the pH-responsive dissolution (pH 7.4) of PMMA leading to the simultaneous formation of 
pore structures and polyelectrolyte complexation. PMMA intercalation extended 
indomethacin release over 144 hours in a first-order manner as opposed to PMMA-free 
matrices (72 hours). PMMA pristine particles enhanced resilience (27.27% increase) via 
increased number and size (10.77nm increase in diameter) of pores formed as validated by 
porositometric analysis and SEM imaging. Similarly, varying degrees of crosslinked 
gellan/xanthan matrices containing 75%w/w pristine PMMA particles exhibited improved 
resilience (45-56%) compared to formulations containing 25%w/w (31-40% resilience). 
Pristine PMMA particles, with the synergistic retarding property of xanthan gum, reduced 
release rates for both BSA (37-75% release over 20 days) and diclofenac sodium (14-20% 
release over 30 days). Although PMMA particle intercalation hastens erosion rates 
particularly after dissolution and leaching, swelling of the matrices remained steady. 
 
Conclusions: Intercalation of PMMA pristine nanoparticles for in situ pH-responsive 
particulate leaching resulted in pore formation and polyelectrolyte complexation which were 
key mechanisms for enhancing mechanical properties and extending drug release 
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APPENDIX B3 
 
ABSTRACT 
TITLE: Design of Hydrogel Matrices with Intercalated Pristine-Polymer-Particles for 
Enhanced Porosity and Extended Bioactive Release via In situ pH-Responsive Particulate 
Leaching 
PURPOSE: To investigate the effect of pristine-polymer-particle intercalation on mechanical 
properties and bioactive release from anionic and cationic hydrogel matrices for tissue 
regeneration. 
METHODS: Polysaccharide-based (chitosan and gellan/xanthan gum blend) ionically 
crosslinked hydrogel matrices were loaded with quantities between 25-200%w/w of pristine 
polymethyl methacrylate (PMMA) anionic nanoparticles. Sodium tripolyphosphate 
crosslinked chitosan spheres loaded with indomethacin and calcium crosslinked 
gellan/xanthan tubes loaded with BSA and diclofenac sodium were used as the model 
matrix-bioactive systems.  In vitro release studies and UV spectroscopy were used to 
quantify bioactive release. Porosity imparted by particulate leaching of PMMA particles were 
examined via Porositometric analysis in accordance with BET and BJH models. Changes in 
mechanical properties were evaluated in terms of resilience, deformation and fracture using 
the TAXT.plus StableMicrosystems texture analyser. Matrix surface morphology and pore 
visualisation was conducted on an FEI Quanta 400 FEG scanning electron microscope prior 
to gold-palladium sputter-coating of samples. 
RESULTS: Drug release from chitosan loaded with pristine PMMA particles was controlled 
via the pH-responsive dissolution (pH 7.4) of PMMA leading to the simultaneous formation of 
pore structures on the matrix surface and polyelectrolyte complexation. The latter extended 
indomethacin release over 144 hours in a first-order manner as opposed to PMMA-free 
matrices providing release up to 72 hours. Increase in PMMA particle concentration led to 
enhanced resilience (27.27% increase) via increased number and size (10.77nm increase in 
diameter) of pores formed as validated by porositometric analysis and SEM imaging. 
Similarly, varying degrees of crosslinked gellan/xanthan matrices containing up to 75%w/w 
pristine PMMA particles exhibited improved resilience (45-56%) compared to formulations 
containing 25%w/w of PMMA particles (31-40% resilience). Pristine PMMA particles, with the 
synergistic retarding property of xanthan gum, assisted in reducing release rates for both 
BSA (37-75% release over 20 days) and diclofenac sodium (14-20% release over 30 days). 
Although PMMA particle intercalation hastens erosion rates particularly after dissolution and 
leaching, swelling of the matrices remained steady. 
CONCLUSIONS: A strategy involving the intercalation of PMMA pristine nanoparticles for in 
situ pH-responsive particulate leaching resulting in pore formation and polyelectrolyte 
complexation as key mechanisms of enhancing matrix mechanical properties and extension 
of drug release was studied. The features of enhanced matrix resilience, porosity, minimal 
swelling and controlled drug release appeals to implanted scaffold designs for the repair of 
injured tissues where sustained delivery of growth factors and other bioactives are 
imperative. 
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APPENDIX B4 
 
 
Title: Bioactive-releasing neurodurable porous hydrogel bioscaffolds for tissue-repair 
Poornima Ramburrun, Pradeep Kumar, Yahya E. Choonara, Lisa C. du Toit and Viness 
Pillay* 
 
Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and 
Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of 
the Witwatersrand, Johannesburg, 7 York Road, Parktown, 2193, South Africa. 
 
Introduction: The purpose of this study was to investigate the effect of pristine-polymer-
particle intercalation and crosslinking on mechanical properties and bioactive release from 
interpenetrating networks of microbial expo-polysaccharide hydrogel matrices for tissue 
regeneration. 
Methods: Ionically crosslinked microbial polysaccharide-based hydrogel matrices were 
loaded with quantities between 25%w/w-75%w/w of pristine polymethyl methacrylate (PMMA) 
anionic particles. The model matrix-bioactives utilized were BSA and an NSAID. Changes in 
mechanical properties, at different dissolution time points, were evaluated in terms of 
resilience, deformation and fracture using the TAXT.plus StableMicrosystems texture 
analyser. In vitro release studies with UV spectroscopy was used to quantify bioactive 
release. Scaffold morphology imaging was conducted on an FEI Nova NanoLab 600 
scanning electron microscope. 
Results: The concentration-dependent intercalation of PMMA enhanced matrix resilience 
from 31% to 56% and provided a near zero-order release of BSA (37-75% fractional release) 
and NSAID (14-22% fractional release) over 20 and 30 days, respectively. Increased 
crosslinker concentrations from 0.05%w/v to 0.1%w/v results in 20% declined resilience, 
higher fracture energies ranging from 0.14-0.16N.mm to 0.19-0.24N.mm and low matrix 
flexibility of 1.6-1.9N/mm whereas low crosslinking concentrations promoted scaffold 
flexibility with values in the 1.6-2.9N/mm range. Fracture and flexibility gradually decreased 
as erosion continued over 30 days, reaching lower values of 0.11-0.15N.mm and 0.1-
1.3N/mm, respectively.  
Discussion: In addition to the large macro-porous architecture of the scaffold, matrix 
resilience was enhanced by the in situ pH-responsive (pH 7.4) particulate leaching effect of 
the pristine-polymer particles which produced porous channels throughout the hydrogel 
matrix and similarly, modulated the mechanism of sustained bioactive release. Crosslinking 
influenced the mechanical strength of the scaffolds via formation of rigid polymer chains of 
varying flexibility and water-uptake upon hydration. The features of enhanced matrix 
resilience, porosity, and controlled drug release appeals to implanted scaffold designs for the 
repair of injured tissues. 
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